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ABSTRACT 
 
 
 
ECONOMIC DEVELOPMENT IN THE MASSACHUSETTS LIFE SCIENCES 
CLUSTER: SHARED PROSPERITY OR A BIG TRADEOFF? 
 
December 2014 
 
 
 
Brandynn Holgate, B.A. University of California, Davis 
M.B.A., University of Massachusetts, Boston 
 
 
 
Directed by Professor Mary Huff Stevenson 
 
 
 
 
Policies aimed at economic development can be judged by two criteria: efficiency 
and equity. -Policies that result in both greater efficiency and greater equity lead to 
shared economic prosperity for a region. The innovation economy includes some of the 
fastest growing industries which generate new wealth in the U.S. Within this context, the 
life sciences industry has been a prime target for economic development for individual 
states. This case study examines the economic development agenda in the Massachusetts 
life sciences industry and whether these efforts result in both sustaining competitive 
advantage (i.e., continuous innovation that improves productivity and product and service 
quality) and supporting greater equity – particularly equality of opportunity and a fair 
distribution of outcomes. In addition to examining how economic development supports 
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sustained competitive advantage, the study focuses on the extent to which equity goals 
are defined, implemented, and realized by employers and stakeholders in this fast 
growing sector.  
This case study design employs both quantitative and qualitative methods, 
between 2000 and 2010. I find that the life sciences industries in Massachusetts have 
sustained competitive advantage with growth and concentration intensifying in the 
second half of the decade. Growth in the life sciences has benefited the highest skilled 
workers, but left many others behind. Industry concentration in downstream operations 
(e.g., manufacturing and clinical trials), which is thought to benefit mid-skilled workers, 
has not been realized in Massachusetts. However, there is some evidence that economic 
benefits are spreading. Growth has concentrated not only in the Boston-Cambridge core, 
but also in the Worcester I-495 region. Although women and minorities have been 
underrepresented in the innovation economy, they have had greater access to employment 
opportunities in the life sciences when compared to other high tech sectors.  
In the interest of supporting equity goals in economic development, possible 
policy solutions are numerous. Growth in the life sciences sector results in increased state 
tax revenues. This increase in revenue is more than sufficient to cover existing economic 
development efforts and might also cover initiatives in the local services sector and 
increase initiatives that address workforce diversity.  
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CHAPTER 1 
INTRODUCTION 
 
 
 
This research seeks to discover whether the economic development agenda in the 
Massachusetts life sciences industries can simultaneously ensure efficient outcomes for 
industry while encouraging more equitable outcomes for different communities or groups 
of workers within the state. Specifically, efficiency is defined as sustained competitive 
advantage for Massachusetts’ biotechnology and other life sciences sectors. Sustained 
competitive advantage is defined in turn as continuous innovation to improve 
productivity and product or service quality. Equity is defined as a fair distribution of 
economic benefits. For example, greater equity might be achieved by improving access to 
employment opportunities over time for groups and communities that have not been 
immediate beneficiaries of the innovation economy. This case study takes a close look at 
economic development policies and stakeholders in the life sciences industries. It 
examines how economic development supports sustained competitive advantage and the 
extent to which equity goals are defined, implemented, and realized by employers and 
stakeholders in this fast growing sector. Ultimately, the case study seeks to discover 
whether these economic development efforts result in a tradeoff between sustained 
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competitive advantage and equitable outcomes or if they contribute to shared economic 
prosperity for residents of the state.  
 
The relationship between efficiency and equity in public policy 
In the field of economics, the concept of Pareto efficiency is used to understand 
how a competitive market allocates goods and services. In a competitive market, 
consumers use their income (which is derived from selling labor and other factor inputs 
such as land and capital) to purchase the goods and services they want. Prices for goods 
and services “arise” based on the costs of factor inputs to firms, their profit maximization 
goals, and the willingness of consumers to pay. The result is Pareto efficient if the 
allocation of goods and services is such that no one person could be made better off 
without making someone else worse off (Weimer & Vining, 1999). This idea that 
competitive markets are efficient is often the basis for advocating for minimal 
government intervention in the economy. However, efficiency is not the only thing we 
value as a society. Equity is an example of another such value. The market economy 
alone does not ensure an equitable distribution of benefits across all members of society. 
Economic inequality produced by market forces contributes to social exclusion, erodes 
democratic processes and civic life, and impedes a broad conception of economic 
prosperity. In many contexts, public policy has been used to bolster efficiency and steer 
or redistribute the economic benefits of capitalism in more equitable ways (Okun, 1975).  
In fact, public policy can be judged by these two criteria: its effect on efficiency 
and its contribution to equity. With these criteria in mind, there are four possible 
3 
 
outcomes for society. These logical policy outcomes are: a) more equitable and more 
efficient; b) less equitable, but more efficient; c) more equitable, but less efficient; and d) 
less equitable and less efficient. Policies with an a) outcome (more equitable and more 
efficient) are highly desirable and most likely to lead to shared economic prosperity. 
Outcomes b) and c) are the result of a tradeoff -- a policy outcome that sacrifices one 
value for another. Arthur Okun (1975) argued most policies that are intended to help 
direct market outcomes are the result of a tradeoff that society makes between efficiency 
and equity. Therefore, society must make decisions (e.g., through the policy making 
process) about how much efficiency will be sacrificed for equity and vice versa. Lastly, 
policy outcome d) is not desirable by either criterion and should be avoided. 
 
Efficiency and equity in the innovation economy 
In the context of economic development and the “innovation economy,” how 
might one consider policy options with respect to efficiency and equity? The innovation 
economy has been defined as the high-tech industry sectors or clusters that are generating 
new wealth driven by rapid technological advancements and globalization (see, for 
example, Massachusetts Technology Collaborative, 2014). The innovation economy 
contains some of the most prosperous industries and receives a wealth of private 
investment and public support. For example, there are 11 key sectors in Massachusetts 
including financial services, software and communication services, and biopharma and 
medical devices. Efficiency in the innovation economy can be thought of as Pareto 
efficiency, but there are a number of other market outcomes that stem from efficiency 
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that are important as well. Increased productivity -- getting more out of a given set of 
inputs, such as achieving higher total shipments of a good given a certain employment 
level -- is one such outcome. Innovation is another outcome. The development of new or 
improved products, services, or processes (e.g., increases in patents, research and 
development spending, and venture capital) are indicators of innovation (Massachusetts 
Technology Collaborative, 2014). Overall, one outcome incorporates all of this – 
sustained competitive advantage. Sustained competitive advantage might refer to a 
specific region (such as a state) where continuous innovation improves productivity and 
product or service quality (Bluestone, Stevenson & Williams, 2008).  
Following the logic of market efficiency described above, we do not expect 
sustained competitive advantage in the innovation economy by itself to ensure an 
equitable distribution of economic gains across a region or among a set of individuals. In 
fact, industry research in the U.S. has pointed to the high skilled nature of employment in 
the innovation economy and its concentration in a few key regions, especially California 
and Massachusetts (Batelle Technology Partnership Practice, 2010). But greater equity 
might be achieved through public policy. For example, public policies that encourage 
firms in the innovation economy to locate in underutilized regions or help connect public 
education to key sectors in the innovation economy will support more equitable outcomes 
and greater access to the economic benefits provided by these sectors. 
Currently, within the U.S. innovation economy, state (or regional) economic 
development projects use a variety of policy tools to improve or sustain the competitive 
position of particular industry sectors. These projects target high-technology, high-skilled 
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industries. These projects seek to foster innovation and entrepreneurship in order to attain 
or sustain competitive advantage and regional economic prosperity. Well-designed 
regional or state development projects are expected to result in an increase in export base 
jobs (i.e., jobs that produce products and services that attract buyers from outside the 
region), venture capital investment and educational attainment; thereby, employing more 
people in well-paying jobs and increasing tax receipts (Bluestone et al., 2008; Clark & 
Christopherson, 2009; Cooke, 2001, 2004; Porter, 2003a, 2003b). 
Competitive advantage for a region is subject to decay over time. Therefore, 
sustaining competitive advantage and ensuring regional prosperity from an economic 
development perspective requires continually injecting resources into a region’s firms 
and infrastructure. Economic development projects require a long-term perspective in 
order to support continual innovation and resource development (e.g., human resources 
and public infrastructure). Economic development in the innovation economy includes 
promoting and supporting research and development and encouraging entrepreneurial 
risk, but also includes public and private investments that work to sustain competitive 
advantage over time (Bluestone et al., 2008).  
The Massachusetts biotechnology and life sciences sector is an example where a 
specific region is engaged in economic development to support sustained competitive 
advantage in the innovation economy. In Massachusetts, this sustained competitive 
advantage in biotechnology and other life sciences has primarily relied on growing 
research and development activities (Sum et al., 2007b). The state is now well known for 
and highly ranked in this area. In the past decade, sustained competitive advantage has 
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also meant growth in “downstream” activities (e.g., manufacturing and clinical research) 
and improved coordination between the system of higher education, demand for labor, 
and industry training needs. Economic development policies have focused on supporting 
these industry activities. At the same time, industry research has shown that the 
expansion of the life sciences primarily benefits highly skilled workers and specific 
regions in the state. What is less well understood with respect to economic development 
in the life sciences is the extent to which the value of equity is represented in these 
policies. Further, more should be uncovered to understand equitable outcomes in this 
sector. For example, how has workforce diversity grown as life sciences employment has 
expanded and to what extent have low or moderately skilled workers been incorporated 
into the life sciences sector? 
 
Research questions 
The development and use of biotechnology and other life sciences applications in 
Massachusetts, particularly in the field of human health, serves as a critical case example 
of sustained competitive advantage supported by state economic development efforts in 
the innovation economy. Massachusetts is the leading state ranked by the Biopharma 
Innovation Index (Milken Institute, 2004). Biotechnology and other life sciences 
industries have been expanding in Massachusetts for many decades. The state’s trade 
association, (Massachusetts Biotechnology Council, 2010) reports that between 2000 and 
2009, employment in Massachusetts’s biotechnology sector grew 60% and that 
biopharmaceutical manufacturing grew 25%.  
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Since about 2005, there have been a number of new economic development 
initiatives launched to support the life sciences in Massachusetts. Economic development 
activity picked up momentum following the announcement that Bristol Meyers Squibb 
would be locating its largest biologics facility in Devens, Massachusetts. The 
announcement of the new facility reinforced to state officials and industry stakeholders 
that Massachusetts was able to attract substantial production activity and there were 
viable locations in the state for biomanufacturing (Heuser, 2006).  
Examples of private economic development initiatives have included the New 
England Biomanufacturing Collaborative’s apprenticeship program (est. 2004), the 
Massachusetts Life Science Education Consortium convened by MassBio’s Education 
Foundation (est. 2009) and MassBio’s BioReady campaign (est. 2008). Other efforts have 
been made through formal policies, such as the establishment of tax credit and workforce 
programs through the Massachusetts Life Sciences Center. The Massachusetts Life 
Sciences Center was founded in 2008 under the Massachusetts Life Sciences Act. 
Overall, this has resulted in a package of policy tools and private initiatives to help meet 
the workforce and local infrastructure needs of life sciences employers and maintain 
Massachusetts’s competitive position in the industry. While the primary policy goal has 
been to improve the state’s competitive position, secondary goals have included meeting 
the needs of the workforce across a range of skills and throughout the state. This case 
study asks whether the package of economic development tools has benefited the state’s 
workforce by providing good jobs at various skill levels and growing employment 
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opportunities across different sub-regions within the state. The research questions for this 
case study follow. 
 
1. The first research question seeks to confirm that Massachusetts is sustaining its 
competitive advantage in the life sciences and that the sector is expanding its 
downstream operations. How can sustained competitive advantage in the 
Massachusetts life sciences industry be measured, and have downstream operations 
(e.g., manufacturing and clinical trials) expanded? 
a) Has Massachusetts sustained competitive advantage in the life sciences since 
2000 and, if so, how does it compare to other high tech sectors in the innovation 
economy? 
b) To what extent has sustained competitive advantage been achieved in the 
“downstream” activities of the life sciences (e.g., in manufacturing and clinical 
trials)? 
2. Massachusetts has a strong and growing industry cluster in the state with many 
important assets, particularly its university and health systems and its access to 
venture capital. This growth has contributed to the stock of good jobs. Jobs in the life 
sciences are highly paid even at entry level and are well benefited. The second 
research question is concerned with the distribution of that job growth. Has the 
growth in good jobs in the core life sciences industry been accompanied by more 
equitable outcomes and, in particular, have the number of life sciences jobs grown in 
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regions outside of the metropolitan core, and has workforce diversity expanded along 
with industry growth? 
a) Has sustained competitive advantage in the Massachusetts life sciences been 
accompanied by an increase in earnings inequality? 
b) How have jobs grown across different regions in the state and how does this 
growth align with different economic development investments? 
c) How, if at all, has workforce diversity (e.g., in skill level, sex, race, ethnicity, 
veteran status, and nativity) expanded in the life sciences? 
d) How have “downstream” activities contributed to the industry mix across the state 
and the occupational structure within the industry? 
e) To what extent has the Massachusetts core life sciences industry contributed to 
more equitable outcomes with respect to sub-state regional growth and workforce 
diversity when compared to the rest of the innovation economy? 
3. Given what is learned about sustained competitive advantage and equitable outcomes 
from answering research questions 1 and 2, do stakeholders view the balance between 
the two as a tradeoff or as an opportunity for shared prosperity? The third research 
question seeks to shed light on how equity goals and interests are incorporated into 
the economic development agenda. In concrete terms, how do stakeholders (e.g., 
development intermediaries, educators, and employers) view equity and efficiency as 
it relates to their role in supporting and growing the life sciences industry in 
Massachusetts? 
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a) What are stakeholder views on industry outlook and regional competitiveness, 
particularly with respect to “downstream” operations? 
b) How do stakeholders view the objectives of economic development policies and 
initiatives with respect to efficiency and equity? 
c) How have employers engaged in regional economic development initiatives and 
what have they gained? 
 
Summary 
 This study aims to understand whether economic development efforts contribute 
to both efficiency and equity, how the policies address these criteria, and the degree to 
which equitable and efficient outcomes are evident in the Massachusetts life sciences 
sector. In the context of the innovation economy, efficiency is defined as sustained 
competitive advantage or the continuous innovation of processes, products, and services. 
Equity is defined as increased access to economic benefits and a fairer distribution of 
economic outcomes. Here, economic development policy is evaluated based on these two 
criteria to show the extent to which it is possible to develop and implement a policy 
agenda that includes both in the interest of shared economic prosperity.  
The innovation economy has become a prime target for state economic 
development efforts. In Massachusetts, the highly ranked life sciences industries provide 
a critical case example of how public and private stakeholders have invested in initiatives 
to help the region (the state) sustain competitive advantage in this sector. The research 
asks whether the range of economic development initiatives and the efforts of many 
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stakeholders have resulted not just in sustaining competitive advantage for the region, but 
whether that state’s workforce has benefited from the provision of good jobs at various 
skill levels across the state. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
 
This literature review starts by highlighting the work of Arthur Okun (1975) as he 
framed the debate between equity and efficiency as a tradeoff; arguing that policies often 
require decision makers to weigh economic efficiency against economic equity. Okun’s 
book, Equality and Efficiency: The Big Tradeoff, and his ideas have been influential in 
mainstream politics since in the 1970s. However, tradeoff thinking is not necessary in all 
policy domains. There are other ways to understand the relationship between efficiency 
and equity, particularly through the social bargains framework provided by Robert 
Kuttner (1984) and, more recently, in the editorial writings of Paul Krugman (2014a, 
2014b, and 2014c). While Krugman’s emphasis is on an economy operating below full 
employment, a situation in which it is more  likely that government spending to stimulate 
the economy will be both efficient (making use of idle capacity) and more equitable 
(benefiting unemployed workers), Kuttner’s social bargains framework argues that policy 
can be devised under conditions that set efficiency and equity as complementary. 
Compared to other countries, the U.S. has been challenged to do that. Kuttner attributes 
this to weak labor market institutions that are not conducive to strong social bargains. 
13 
 
Second, this literature review defines efficiency. For this case study, efficiency 
needs to be understood in terms of its relevance to the innovation economy. The 
innovation economy is made up of some of the fastest growing industries which are 
producing new wealth in the economy. This sector of the economy does not just rely on 
market dynamics to flourish, but also requires a strong public sector that contributes to 
the development of technology, workforce skills, and infrastructure. Instead of defining 
efficiency in traditional terms, such as Pareto efficiency as defined in the introduction, 
this study has defined efficiency as sustained competitive advantage. Relying on Michael 
Porter’s (1990) work on competitive advantage and industry clusters, we understand that 
growth and prosperity in the innovation economy is accompanied by two important 
conditions. As industry concentrates in particular regions, it benefits from positive 
externalities that  include knowledge spillovers and firm linkages, which facilitate 
learning and development across the industry. Also, this industry concentration 
contributes to the export base as more products and services are demanded from 
consumers outside of the region. 
Next, the life sciences industries in Massachusetts are an example in the 
innovation economy where industry and government are both key stakeholders in 
economic outcomes. One of the main avenues for government to participate in the 
economic success of the life sciences industries is through economic development. In the 
past 10 years, state governments have learned about cluster strategies. Industry clusters 
form as firms locate in proximity of rivals. These agglomeration economies benefit from 
positive externalities, like established labor pools and common infrastructure. In turn, 
14 
 
state governments have used a variety of tools to support their growth. One of the most 
popular tools has been tax credits, but governments have developed other demand-side 
strategies, including low interest loans. Supporting the demand side of a regional 
economy means helping meet the needs of existing and new businesses; helping 
businesses control costs or helping fund small companies and startups. Governments have 
also focused on supply-side strategies in their regional economies through educational 
institutions and infrastructure development. Supply-side strategies support workforce 
development, technology parks, and utility needs. 
As a condition of government support (such as tax credits), industry is encouraged 
to engage in these projects. Employers make choices regarding the nature of their 
contribution to economic development projects, and the literature on labor markets and 
industrial relations helps us understand the employer’s position. Overall, policies studied 
here seek to engage employers, but do not require their participation. Economic 
development efforts have in general treated employers as customers with the hope of 
engaging them in education and training and job creation initiatives. 
Ultimately this literature review helps to further explain the criteria of efficiency 
and equity in judging policy and how this applies to economic development in the 
innovation economy. Further, it helps define important terms used in the study and helps 
focus the research questions. 
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Equity and efficiency according to Okun 
Standard neoclassical economic theory states that a market economy, when left to 
operate on its own, makes efficient decisions on the use of resources. However, the 
market economy does not necessarily ensure an equitable distribution of benefits across 
all members of society (Weimer and Vining, 1999). If left unattended, economic 
inequality produced by market forces contributes to social exclusion and erodes 
democratic processes and civic life. In many contexts, public policy has been used to 
steer or redistribute the economic benefits of capitalism in a more equitable way. For the 
purpose of evaluating public policy (as described by Andersen (1979) this research 
focuses on the two criteria of efficiency and equity. According to Arthur Okun (1975), 
the use of policy to help direct market outcomes usually results in a tradeoff between 
efficiency and equity. In other words, society must make decisions on how much 
efficiency will be sacrificed in the interest of equitable outcomes. 
Okun argues that at times the market can undermine our rights and contribute to 
income inequality. Despite this, the market – or the American capitalist system – is the 
most efficient way we know to organize the production of material goods. This system 
favors innovation, flexibility, and entrepreneurship. However, in this system we tolerate a 
significant amount of inequality. Okun defines efficiency as “getting the most out of a 
given input (p. 2)” and posits that the production of goods and services match with what 
consumers want to buy. He defines greater equity as families having “a maintainable 
standard of living,” which implies “lesser . . . disparities of income and wealth than 
currently exist (p. 3).” 
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Today, there is cause for concern with respect to income inequality. Research has 
documented growth in inequality in the past 30 years for the U.S. Inequality is driven by 
increasing income for top earners (McCall & Percheski, 2010). The tax and transfer 
system has had little effect on this trend (Heathcote, Perri, & Giovanni, 2010). Overall, 
this is expected to impede intergenerational mobility, reduce consumption, impede 
economic growth, and negatively impact morale and productivity (Krueger, 2012). 
Further, the job market has become increasingly polarized into high-skilled/high-wage 
and low-skilled/low-wage jobs (Autor, 2011). 
For Okun, equality of opportunity is related to both equity and efficiency. 
Equality of opportunity means ensuring a level playing field with respect to access. It 
also means making the most of a given set of inputs. For example, jobs in science and 
engineering have historically favored white men. Improving educational programs, 
developing mentors with diverse backgrounds, and changing hiring practices to benefit 
women and minorities increases access to jobs for underrepresented groups (Hill, Corbett 
& St. Rose, 2010). At the same time, these types of efforts broaden the available pool of 
labor, making hiring more efficient. Increasing equality of opportunity helps make the 
race more fair while at the same time improving efficiency. However, in the context of 
great inequality, achieving equality of opportunity can be difficult.  If that is the case, the 
tradeoff between equity and efficiency is likely to remain. In these instances, the pursuit 
of greater economic equity requires difficult choices.  
Okun (1975) devises a thought experiment called “the leaky bucket” and uses the 
tax and transfer system as an example. The leaky bucket experiment helps demonstrate 
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how decision makers might consider a tradeoff between efficiency and equity. The 
bucket redistributes income. It collects taxes from the rich and delivers transfers to the 
poor. In the transfer process the bucket leaks due to administrative costs and disincentives 
to work, save, and invest. Decision makers can choose how much leakage is tolerable for 
society and evaluate different policy alternatives. In other words, there is a cost 
associated with equity. However, these are short-term costs. Recent research suggests that 
over the long term, sustaining economic growth requires a reduction in inequality. Other 
authors have argued that it is possible to reconcile efficiency and equity and not treat 
them as a tradeoff (Berg & Ostry, 2011). 
Given Okun’s work, Kuttner (1984) argues that the field of economics has put too 
much emphasis on the tradeoff between equity and efficiency and that more often than 
not policy can reconcile the two. Reconciling equity and efficiency is a political choice 
that depends on institutional forms and the distribution of power. Instead of focusing on a 
tradeoff or technical economic arguments, Kuttner uses the terminology of social 
bargains. Such a focus emphasizes the political nature of setting policies that address both 
equity and efficiency.  
Kuttner provides a wealth of examples, both historic and contemporary, of how 
social bargains are used to reach compromises between equity and efficiency. However, 
the weak labor market institutions in the U.S. inhibit social bargaining. While Okun 
argued that our existing institutions were sufficient, Kuttner comparatively demonstrates 
that the U.S. lacks institutional forms conducive to social bargains, mostly because we 
have a weak labor movement (e.g., fragmented and declining unions). In Northern 
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Europe and some western European countries the labor movement has a stronger political 
presence. There, the labor movement is associated with a political party (e.g., the Social 
Democratic party), it is highly centralized, and it works on broad egalitarian goals (e.g., 
full employment). In contrast, unions in the U.S. have been rapidly declining, even more 
so since Kuttner’s writing. They are fragmented and often on the defensive. Changes for 
the Wisconsin teachers’ unions are a recent case in point. Every local union now has to 
bargain separately with each school district and is forced to choose between either layoffs 
or decreased benefits and increased workloads. Collective bargaining for the Wisconsin 
teachers’ unions has been clearly posed as a tradeoff between efficient school budgets 
and protection of the progress made to compensate teachers fairly by the Republican 
governor (Greenhouse, 2014). 
Weak institutions in the U.S. have resulted in tradeoff thinking, even when there 
is plenty of examples elsewhere that social bargains can be struck. However, weak 
institutions lack the political status needed to negotiate for efficient and egalitarian 
outcomes. Kuttner (1984) describes the U.S. employment services as focused on 
transferring benefits to the unemployed. Federal and state employment services have not 
been a strong force in intervening in job training and re-training and job placement; 
thereby, not contributing to a decrease in unemployment. Whereas the Swedish model of 
active labor market policy achieves its goal of full employment by offering wage 
subsidies and job placement for dislocated and unemployed workers. The low level of 
intervention in the U.S. does not lead to egalitarian outcomes – and not necessarily 
efficient outcomes either. Greater equity results from political power to negotiate social 
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bargains. Much of this political power is stripped away from our labor market 
institutions. 
More recently, Paul Krugman (2014a, 2014b, & 2014c) has been writing about 
how inequality hampers economic growth and efforts to increase equity appear to be 
benign. New evidence provided by the International Monetary Fund supports these 
assertions, as do recent experiments at the state level. Over the long run, Krugman argues 
that in order to support sustained economic growth, inequality needs to be reduced. He 
also explains in the short run that individual states can make progress. For example, 
California instituted recent tax hikes that have been accompanied by positive outcomes 
such as job growth, an increase in the number of people with health insurance, and a state 
budget surplus. 
 
Equity and efficiency in the innovation economy 
The innovation economy is a term used to identify the industry sectors in the 
economy that produce new wealth,
1
 compete globally, and contribute to the development 
and use of new technologies (Massachusetts Technology Collaborative, 2014). The 
innovation economy includes some of the most prosperous industries, like biotechnology 
and the life sciences, as well as other high-tech industries and clusters. Although Arthur 
Okun (1975) was not specifically concerned with the innovation economy, his work 
provides a starting ground for operationalizing equity and efficiency within a particular 
policy domain. There are a few ways to apply Okun’s theory to the innovation economy. 
                                                 
1
 New wealth is primarily generated by increasing access to the stock market. Successful development and 
use of technology is an important avenue through which companies and individuals get access to the stock 
market (The Economist, 2001). 
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First, increasing new wealth alone does not suffice in achieving a fair distribution of 
economic benefits. Second, increasing equality of opportunity in the innovation economy 
is also efficient. Greater equality of opportunity means improved access to jobs for a 
wide range of people and regions, but also means a larger labor pool to draw upon. Okun 
argues that greater equality of opportunity does not result in a tradeoff with efficiency. 
Therefore, so long as new wealth is being generated, society should continue to strive for 
equality of opportunity. Third, in the pursuit of equitable outcomes through a distributive 
mechanism (other than the market), society must make decisions on how much efficiency 
can be sacrificed for the sake of equity. If tradeoffs do exist, the “leaky bucket” thought 
experiment can help us do this; however if efficiency and equity are complimentary and 
institutional power is sufficient Kuttner ‘s (1984) social bargains framework should be 
deployed. 
 
Sustained competitive advantage as efficiency in the innovation economy 
Michael Porter defined competitive advantage in his 1985 book Competitive 
Advantage. Firms gain a competitive advantage either through differentiation or low-cost 
strategies. In order to differentiate products and services or control costs of production, 
firms can deploy new technologies, make changes to address new buyer needs, take 
advantage of opportunities in new industry segments, keep costs low, and address new 
government regulations. Competitive advantage can erode over time. Sustaining that 
advantage  is a dynamic (not static) process. Therefore to sustain competitive advantage 
firms must continue to innovate in order to either improve the efficiency of their 
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production or to develop higher quality products. Evaluating a firm or an industry in this 
regard requires looking at how new products and processes are improved over time and 
how they increase productivity. Firms sustain competitive advantage over time by 
becoming more sophisticated. They rely on a highly skilled workforce, they attract 
investment, they behave strategically, given their position in the value chain, and engage 
in constant improvement (Porter, 1990). Ultimately, economic prosperity for a region 
depends on firms’ ability to stay ahead and sustain its advantage. This includes “constant 
research and development, innovation, and creation of new resources (Bluestone et al., 
2008, p. 180).” 
Additionally, a region’s firms can benefit from agglomeration economies by 
capturing the effects of externalities. Industry clusters in Porter’s terms develop as firms 
choose to locate in geographic proximity of rivals. Industry clustering allows firms to 
benefit from knowledge spillovers, established labor pools and infrastructure. In this 
context, sustained competitive advantage through differentiation requires high-quality 
resources. These resources include labor, natural resources, knowledge, capital (i.e., 
financial backing), and common infrastructure. The quality of these resources depends on 
linkages and connections across the cluster that involve the interworking of business, 
government and educational institutions (Bluestone et al., 2008). 
Competitive advantage also relates to export base theory (Bluestone et al., 2008). 
Export base theory focuses on the demand side of a region’s economy. The demand side 
includes new and existing firms. In export base theory for a state (or other region), a 
product is an export if it attracts buyers from other regions. In other words, the demand 
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for particular products and services reaches beyond the state’s boundary. The location 
quotient is one way to measure whether an industry is part of the export base within a 
region (such as a state). The location quotient can be used to measure the concentration of 
an industry’s employment in a state relative to the U.S. as a whole. Location quotients 
greater than one represent an export base industry for the state. Although the measure is 
less than precise because it does not measure actual amounts of product or service that 
are purchased by a consumer outside of the region, it does indicate whether a state has a 
greater proportion of industrial activity and can generate income by selling products or 
services to other states (or countries) (Bluestone et al., 2008). Jobs in an export base 
industry stand in contrast to local services jobs. For example, a dry cleaner is likely not 
selling its services to consumers outside of a particular locality; whereas high tech 
services are likely to attract consumers outside of a local region. Export base jobs are 
important to understanding prosperity for the state. When export base jobs get created, 
there is often a multiplier effect in that jobs are also created in the local service economy. 
A multiplier effect occurs when an increase in spending results in an increase in income 
and consumption that is greater than the original amount spent (Bluestone et al., 2008). 
For example, Sum et al. (2007a) calculated a number of multiplier effects for the 
life sciences industries in Massachusetts. They showed that a one million dollar increase 
in was associated with an increase of seven new jobs in research and development and 
nearly two jobs for manufacturing in the life sciences. Additionally, this increase in sales 
volume was also associated with new jobs in the local service sector. A one million dollar 
increase in sales in the life sciences industries is associated with one new job each for 
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Accommodation and Food Services, Retail, and Administrative/Waste Management 
services. 
The life sciences constitute an important export base industry for Massachusetts. 
Such regional industries generate income by selling goods and services to other regions, 
which is the primary way a region generates wealth. Life sciences jobs also have a strong 
multiplier effect. Competitive advantage, as it applies to Massachusetts life sciences 
industries, means that when firms locate in Massachusetts they have a good chance of 
differentiating themselves through innovation because of the high skills available in the 
labor force, as well as other cluster assets (or externalities). Sustaining competitive 
advantage means continually innovating in a region that is known to provide access to 
unique technologies, reputations, and skills (e.g., knowledge spillovers).  
Sustaining competitive advantage in an export base industry is a common 
rationale for economic development policy. However, since a region’s exports will 
change over time, it is important for regions to emphasize the supply side of the region’s 
economy. A focus on the supply side is not specific to an industry per se but seeks a 
longer term perspective on improving skills of the labor force and improving 
infrastructure, thereby providing a region with the resources it needs to continually 
innovate and create products and services that add to the export base (Bluestone et al., 
2008). 
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Sustained competitive advantage and equity 
There is a significant amount of research on industrial agglomeration, the 
geographical concentration of industries in the life sciences and other high tech industries 
that stems from the above ideas about regional development and competitiveness. Most 
recently, this research has identified the industrial, institutional, and social components 
that support clusters and innovation systems. The geographic concentration of high 
technology development and commercialization is primarily attributed to strong 
academic anchors, sufficient venture capital, the continuous injection of new entrants or 
startups, and the presence of multinational enterprises (Cooke, 2001, 2004). Historical 
trajectories, geographies, institutions, and the quality of networks shape the social context 
within which economic activity occurs and these factors give rise to variation in clusters 
across different regions (Christopherson & Clark, 2007; De Laurentis, 2009; Gertler, 
2009; Pinto, 2009; Powell et al., 2010; Saxenian, 1994; Youtie & Shapira, 2008).  
Importantly, policies and strategies that support spatial agglomeration and 
industry clusters also imply intra-regional inequities. For example, as industry activity 
continues to concentrate in certain areas of a state or in a particular metropolitan area 
other areas within the region are left out. Research is mixed with regard to whether or not 
the growth of a cluster within a region produces growth overall for that region (Chetty et 
al., 2013). In the context of sustained competitive advantage, industry agglomeration, and 
economic development, equity comes to the fore in some of the literature. A few 
examples follow. 
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Clark and Christopherson (2009) provide an overview of two types of regionalism 
that have evolved in the U.S. First, investment regionalism mirrors the economic 
development efforts seen in the Massachusetts life sciences cluster. Investment 
regionalism focuses on clusters and regional innovation systems. Governments invest in 
tax subsidies as a way to grow more jobs. These efforts are influenced by businesses in 
the region and are good for development and sustained competitive advantage. However, 
they are associated with growing more inequality because there is little consideration of 
the distributive outcomes. In other words, issues of equity across a region are not 
addressed while investment regionalism emphasizes innovation and entrepreneurship. 
This stands in contrast to distributive regionalism.  
Distributive regionalism projects, as defined by Clark and Christopherson (2009), 
originate from community-based coalitions and organizations. This definition is primarily 
concerned about access, opportunity, and equity. Clark and Christopherson argue that 
regional projects focused on high tech sectors could become more progressive projects by 
focusing on the labor market as a whole, not just the high-skilled jobs. Focusing on the 
labor market as a whole helps define the region and acknowledge issues of equity and 
sustainability. Regional economic development in the innovation economy often fails to 
consider jobs beyond high tech export base industries. 
Bluestone and Stevenson (2000) document “a triple revolution” in Greater Boston 
from the 1970s thru the 1990s. Boston has undergone formative changes 
demographically, industrially, and spatially. Authors find that these changes in the metro 
area have impacted attitudes on race and ethnicity; decisions on where to live, and, 
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importantly, who benefits from economic growth. At the end of the 20
th
 century, Greater 
Boston was well positioned economically. Industry had shifted toward a “mind-based” 
economy (e.g., high technology). Additionally, the economy was boosted by a high 
concentration of higher education institutions and healthcare services. The labor force 
was supported by an influx of new immigrants. And unlike many other cities, Boston has 
fared well with respect to concentrated settlement in the city, including low income 
neighborhoods. Relative to other older cities in the Northeast and the Midwest, it has 
maintained population in its city core even while the suburbs have grown. Despite these 
successes, Boston still suffers from residential segregation, persistent poverty and high 
cost real estate. By 2000, Boston was in need of improvements in the public school 
system; finding ways to make higher education more affordable to a larger group of 
residents; and increasing the stock of affordable housing. Boston is also challenged with 
respect to inequality. Income inequality has continued to grow. As the region experiences 
high growth and a successful economy, these benefits have failed to improve conditions 
for low-income workers and families. 
Lastly, Porter applies his theory of competitive advantage to the “inner city” or 
low-income neighborhoods in the city core (1995). The inner city has some 
disadvantages. Including a lack of useable land and higher real estate costs when 
compared to the suburbs; real and perceived safety problems; lack of infrastructure that 
connects the inner city to the regional economy; unskilled workforce; low access to 
capital and debt; and anti-business attitudes. Porter argues that these disadvantages 
should be framed as an economic problem, not a social problem. For example, 
27 
 
disadvantages can be overcome by looking for economic solutions as opposed to social 
services. The role of government is to deal with the realities in the inner city market place 
and engage business around real profitability. Porter also argues that the inner city has a 
real set of advantages and opportunities. Inner cities have a substantial workforce that is 
under-employed – providing a source of unused labor. The inner city is located near 
downtown business districts. Businesses in the inner city that serve those business 
districts have a locational advantage. There is also unmet demand for services and 
products in the inner city neighborhoods. Businesses with well-considered plans to meet 
consumer demand will be profitable. It is also possible to connect the inner city 
businesses within regional clusters through economic development efforts. In addition to 
considering the effects of sustained competitive advantage on equity, it is important to 
remember equity in a broader economic context. While sustained competitive advantage 
may contribute to inequality within a region, there are other forces at play that contribute 
to inequality. Rapid increases in inequality since the late 1970s have been explained by 
Davidson (2013). In the 1950s, through unionization and social security, workers were 
able to gain benefits from economic growth. However, since 1978 the U.S. government 
has focused on deregulation, ignoring unionized labor, and resulting in a weakening 
welfare state. In these ways, government has contributed to growing inequality. 
Additionally, the increase in college educated workers coupled with technology 
development and management bias that favors higher educated workers have resulted in 
what is termed “skill-biased technical change.” For the last 20 years, research has 
implicated the Internet and computers as culprits of inequality, meaning that higher 
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skilled workers have benefited from information technology while lower skilled workers 
have been left behind. 
 
Economic development in the U.S. innovation economy 
Economic development is a broad policy domain that includes public and private 
efforts to improve economic conditions in a particular place and often for particular 
industries. These efforts focus on encouraging business development and expansion 
within a region. The end goal of economic development is to grow good jobs for a 
region’s residents and increase the tax base for a state or municipality. In other words, 
economic development is concerned with economic prosperity (although not necessarily 
shared economic prosperity) for a region – not just with the competitive position of firms 
(Bartik, 2003; Bluestone et al., 2008).  
National, state and local governments promote and invest in regions with strong 
biotechnology and other life sciences clusters in order to sustain competitive advantage 
within these regions as industry activity continues to expand. The life sciences industry 
cluster provides a good case example for learning how governments can best support 
industry and cluster growth in the innovation economy and contribute to the creation of 
new wealth for a region (Cooke, 2001, 2004; R. W. DeVol; Perry; Ki, Junghoon; 
Bedroussian, Armen; Koepp, Rob, 2004; Porter, 2003b). As an example, research 
conducted in Massachusetts has found that biopharmaceutical jobs provide higher pay 
and better benefit coverage than the average job in the state and provide a greater 
contribution to the state and local tax base on a per job basis (Khatiwada et al., 2007). 
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Therefore, the life sciences industries have been an attractive target for economic 
development efforts. 
States have increasingly focused economic development policy on the innovation 
economy – high tech sectors within a regional economy that are heavily driven by 
entrepreneurship and technological change. Not every state is as well positioned as 
Massachusetts or California to compete in these industries; however most states are 
investing in R&D capacity, supporting early stage capital needs, and offering R&D tax 
credits (Batelle Technology Partnership Practice, 2010). Economic development in high 
tech sectors, life sciences included, requires substantial investments most often beyond 
the scale and scope of a municipality (Bartik, 2003). State level efforts may have local or 
regional foci as well as spillover effects to neighboring states, but the role of the state in 
the U.S. innovation economy is important. Although, it may be true that industries cluster 
or concentrate in regions that cross state geopolitical boundaries (B. T. McCann & Folta, 
2008), state’s power to enact and support relevant policy tools far exceeds that of 
municipalities. A state level effort also reduces the need for localities to compete with 
each other in attracting high technology business, so long as the state effort is concerned 
with the distribution of development across the area. 
In the U.S., state economic development agendas focused on the innovation 
economy have relied on the construct of industry clusters (Porter, 1990). Governments 
and industry stakeholders have been big proponents of cluster strategies and regional 
efforts. Research and practice literature has advanced ideas about clusters, networks, 
competitive advantage and regional innovation systems using geographic and governance 
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frames that support industry agglomeration, innovation and entrepreneurship. In fact, 
Michael Porter himself, as an academic consultant, has helped shape the competitive 
agenda for Massachusetts life sciences cluster (Porter, 2003b). Most recently, states have 
developed new strategies that extend beyond just offering tax credits for large firms and 
incentives to attract new business. States have learned that most new job growth happens 
when existing businesses expand. This has resulted in a focus on smaller companies and 
entrepreneurs as well as small start-ups. New trends in state economic development 
include developing intermediaries to support business expansion and bringing together 
industry and community colleges to address industry-specific training needs and skill 
gaps (Sparks, 2013). 
Most of the research reviewed on economic development in the innovation 
economy supports supply-side government intervention. In general, policies focus on 
growth, not equity. The process of supplying industry with economic supports for growth 
detracts from other spending programs like welfare assistance – possibly sacrificing 
equity for efficiency. For example, Bartik (1996) found that cutting welfare spending to 
support economic development programs lifted the income for the top 4/5ths of a state, 
but left the bottom quintile out. Current economic development programs may not be 
doing all they could do with respect to distributing the benefits of new wealth more 
broadly across the state. For Massachusetts and other states, research and practice 
literature remains unclear on how this industry benefits the state’s residents broadly, 
including how jobs are being created, where are they located and why and who ultimately 
gets to work in them. 
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Economic development policy tools 
Overall, economic development policy tools seek to lower costs for firms and 
leverage private investments to produce beneficial outcomes for employers, workers, and 
residents. In the context of state economic development and high tech sectors, there is a 
range of policy tools, usually implemented in conjunction with each other as a package of 
different strategies. Each policy tool is more or less effective and briefly described in 
APPENDIX A.  
Importantly, states have engaged in significant supply-side investments related to 
education and infrastructure. Although research supports the use of supply-side 
initiatives, states also engage in a number of demand-side strategies which provide 
financial assistance to firms (Bluestone et al., 2008). A brief description of economic 
development strategies distinguished as either supply-side or demand side follows. 
Supply-side strategies: 
 Education and training programs and subsidies are intended to improve the 
quality of the labor force and increase productivity for firms. Community colleges 
have played a large role in corporate education and training programs. Subsidies 
help firms cover the cost of training. With respect to business retention,
2
 
economic development stakeholders accumulate information on business needs 
through surveys, visits, and business extension services (e.g., technology 
consultations which lead to productivity gains) that help identify education and 
                                                 
2
 Business retention is important. Existing businesses develop ties to their location and constitute about 85 
percent of new plant openings in any given region (Bartik, 2003). 
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training needs. However, for firms considering new locations, decisions are often 
based on the pre-existing labor force. The evidence is mixed on how public 
spending on education and training impacts employment (Bartik, 2003; Bluestone 
et al., 2008). 
 Infrastructure investments include transportation and utility improvements and 
enhancements and the development of industrial and technology parks. Business 
makes location decisions at least to some degree on the presence of high quality 
infrastructure. Additionally, some industries – like the life sciences – have 
particular infrastructure needs (e.g., waste water and exhaust systems). 
Infrastructure projects are often capital intensive and should be evaluated with 
respect to opportunity costs (Bluestone et al., 2008). 
Demand-side strategies 
 Purchasing and lobbying strategies increase government demand for products 
and services at the state and local level, as well as lobbying the federal 
government to contract with entities in a specific region (Bluestone et al., 2008). 
 Financing strategies help reduce the cost of capital and include grants, loans, and 
venture capital arrangements that help companies manage risk. Financing 
strategies through public intermediaries are desirable at a particular point in 
development. For example, the Massachusetts Life Sciences Center provides 
loans and grants for early stage research and startup companies. However, these 
kinds of financial resources (e.g., revolving loan programs, loan guarantees for 
higher risk companies, and providing incubator space and resources) produce 
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minimal benefit with respect to employment growth. They may offer some social 
benefits if they are focused on women and minority owned business (Bartik, 
2003; Bluestone et al., 2008). 
 Tax incentives are common in most states. They are often granted in exchange for 
job creation commitments. Studies show that tax credits related to training and 
hiring disadvantaged job seekers are not efficient or effective. Most research does 
not find that state and local taxes have a big impact on business location 
decisions; they are expensive and have modest results. Tax incentives can have an 
impact for a particular firm, at a particular point in time (Bartik, 2003; Bluestone 
et al., 2008). 
 Regulation and industrial policies vary at the state and local level, particularly 
zoning laws. Also, industry associations engage in lobbying (at multiple levels of 
government), not just to increase government demand, but to work on policy 
issues that impact the industry and its business environment (Bartik, 2003; 
Massachusetts Biotechnology Council, 2008). 
 
 
 
In addition, information and coordination services are of increasing importance 
in economic development, particularly with respect to the labor market, business services, 
and negotiating regulations (Bartik, 2003). Different organizations position themselves as 
intermediaries that work to improve the quality of information and networks for an 
industry or region. Improved information and coordination affects both the demand and 
supply side efforts. For example, Benner and other authors (Benner, 2002; Benner et al., 
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2003) provide a framework on labor market intermediation. This special group of 
intermediaries helps reduce transaction costs for workers and employers by coordinating 
labor market activity; they help build business and social networks by acting as third-
parties in the labor market; and help reduce risk brought about by economic volatility. As 
another example, MassBio operates as an intermediary for a purchasing consortium, 
business service referrals, funding development, and streamlining regulations 
(Massachusetts Biotechnology Council, 2008). 
 
Labor markets and industrial relations – the impact of internal firm job structure on  
labor market outcomes 
Especially, in the absence of unions, employers have significant say so on how 
they structure jobs, where they locate them, and how they recruit their workforce. From a 
policy perspective, economic development has conceded most of the decision making 
power about jobs to employers. Turning to the literature on industrial organization helps 
address some of the limits in the economic development research and policy literature. 
Economic development policy has had some influence on employer decision making by 
coaxing firms towards desirable outcomes. For example, in considering jobs, economic 
development initiatives have increasingly linked to training strategies, but these 
initiatives do not require employers to participate. Most often, employers engage (if at 
all) at particular points in time when the strategy meets their immediate needs. Further, 
even the most engaged employers in a particular training project are not required to hire 
training program graduates (Conway, 2011). Economic development policy has a limited 
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reach, particularly with respect to the labor market and the structure and conditions of 
jobs. Therefore, the field of industrial relations helps us understand more about the 
manner in which firms organize themselves, the structure of their operations, and the 
impact of competitive strategies on labor market outcomes.  
In The Second Industrial Divide, Piore and Sabel (1984) discuss the importance of 
a “craft alternative” in organizing the workforce as our economy shifts away from mass 
production towards flexible specialization. Among many things, the authors provide an 
argument for why workers and employers benefit from the establishment of associations 
based on occupations or technologies. The shift to flexible specialization means 
workforce training will meet particular challenges. As the front line workforce 
(production workers) is increasingly required to shift across jobs and collaborate with the 
architects of technology to solve problems and execute operations, it thus requires much 
broader training. “…[T]he more broadly skilled the workforce, the greater the danger that 
firms will economize on training costs.” Employers will seek workers already trained at 
another firm’s expense or they worry that workers they train will move onto another firm. 
This has been a visible dynamic in the life sciences, especially in manufacturing. 
Other authors (Benner, 2002; Herzenberg et al., 1998; Osterman et al., 2001) 
continued to stress the importance of worker associations in the flexible economy; 
arguing that these associations should be defined by occupations and technology. Public 
policy and worker associations are our best mechanisms for addressing career 
development, cross-firm career paths, skill standards, training institutions and job referral 
systems by working with groups of firms (not just a single employer). In the view of the 
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authors above, labor market policies need to shift away from the firm as the central 
institution and consider industrial and occupational clusters as the main locus of 
economic activity. These policies should be concerned with the learning process and not 
just training workers for discrete skills. Workforce policies need to build communities of 
practice and social networks alleviate the onus now often put on individual workers to 
navigate complex labor markets. Importantly, labor market efficiencies are not just 
achieved by the market alone, but also depend on the social context within which 
economic activity is embedded. 
Employers make choices in how they hire and fill open positions. In recent years, 
all kinds of employers have reported that they cannot find qualified candidates, which is 
often termed a skills gap, and has resulted in employers blaming the educational system 
for not producing work-ready graduates. Yet, at least some of what employers want is 
“work” skills, not “academic” skills (Capelli, 2013). So far, employers have conceded 
very little in trying to address these challenges. Their HR departments have declined, 
they do not reconsider how they screen and hire new recruits, they do not offer new ways 
to structure jobs, and they do not offer to raise wages. Instead, online screening and 
hiring has increased, employers are using overly detailed criteria that weed out otherwise 
qualified job applicants. Job descriptions have become too narrowly defined as employers 
search for the ideal “plug-and-play” candidate. For many firms, finding the ideal 
candidate means being able to minimize training costs (Cappelli, 2013; Popp, 2013). For 
now, workforce and economic development policy has focused on the needs of specific 
employers who engage in the system. Policy concedes control of labor inputs, wages, 
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number and type of jobs, and the structure of work to employers. Policy emphasizes 
engaging employers as customers in providing workforce services without interfering 
with their ability to compete (Giloth, 2004).  
A policy shift that focused more on industrial relations would recognize that 
workers move across firms. Workers interact with other firms just through their 
interactions with customers and suppliers alone. Further, most skills are not firm specific, 
but general and workers move jobs more frequently, worksites contain workers with 
multiple employers, and managers make decisions that have effects across entire supply 
chains (Benner, 2002). This shift would focus more on employers, challenge the 
misconception that labor market efficiency is guided by employers alone, and build new 
employment standards through policy and practice (Osterman & Shulman, 2011). 
 
Conclusion 
Standard definitions of efficiency emphasize that the market will adjust as 
conditions change and, if left unfettered, will result in producing the most output given a 
set of inputs and will provide what consumers want to buy. However, efficiency in the 
context of the innovation economy is defined as sustained competitive advantage. 
Sustained competitive advantage means continuously innovating to improve productivity 
and/or product and service quality.  
Okun’s definition of economic equity is useful when thinking broadly. He defined 
equity as implying lesser disparities in income across households and families than 
already exists. However, with respect to regional development projects, intra-regional 
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equity is defined as a fair distribution of the economic benefits that result from increased 
growth. Equality of opportunity, with respect to individuals, is having access to jobs or 
other economic benefits regardless of gender, race, class or other characteristics. With 
respect to sub-state regions, it is termed as having access to state and industry supported 
development projects regardless of intra-regional location. 
The combination of both economic growth and economic equity results in shared 
prosperity for the region or state. In this case study, shared prosperity is the result of 
increasing wealth accompanied by decreasing inequality. The extent to which economic 
development projects produce shared prosperity depends on policies and practices that 
regard greater equity as a desirable and relevant goal, not just growth. The extent to 
which equity is addressed by a regional development goal will depend on decision 
makers as they consider solutions to a tradeoff between greater spatial agglomeration and 
industry concentrations within the region and greater equity of opportunity and the 
distribution of outcomes. Additionally, through a social bargains framework, stakeholders 
may develop new ways to incorporate equity as a goal through collaborations. 
As biotechnology and life sciences industries have grown and flourished in 
Massachusetts and as the public sector has become increasingly involved in the economic 
success of this sector, it has become increasingly important to justify this growth as 
benefiting the state as a whole. One way to do that is to create jobs and economic 
opportunity that are accessible to residents in a variety of manners. For example, creating 
blue collar jobs in manufacturing that are located in the central, southern and western 
areas of the state would benefit the moderately skilled worker and help breathe new life 
39 
 
into those sub-state regions. This requires that stakeholders and decision makers think 
outside the “growth box” and pay attention to equality of opportunity and the distribution 
of economic gains. The research presented here seeks to illuminate how equity 
considerations are factored into economic development policies and the extent to which 
these policies contribute to shared prosperity. 
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CHAPTER 3 
 
CASE STUDY CONTEXT 
 
 
Context is crucial. This study examines the conditions under which biotechnology 
and life sciences companies have developed within the New England region. Contextual 
factors considered in this case study include types of relevant stakeholders, targeted 
policy efforts (especially since 2005), historical developments in the industry, and 
changes in the state economic development climate. The context is helpful in 
understanding the regional trajectory of the industry, the different kinds of actors that 
help shape it, and the potential influence of economic development activity. Further, the 
context provides a basis for using time series analytics when examining case study 
evidence. This section on context is presented in two parts: first is a discussion on 
stakeholders and second a chronological description of relevant policy and industry 
events. 
 
Targeted stakeholders – Employers, development intermediaries, and education and 
training providers 
The life sciences cluster in Massachusetts encompasses a league of stakeholders, 
especially in light of the university and hospital systems, the scientific community, and 
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the management and entrepreneurial networks. Many of these stakeholders were 
documented by the UMass Donahue Institute in the Life Sciences Talent Initiative 
(UMass Donahue Institute, 2008). This case study targets a subsection of these 
stakeholders: those related to workforce development and the expansion of downstream 
industry activities across the state. This includes large employers, contract research 
organizations, and contract manufacturing; development intermediaries focused on 
workforce programs or sub-state regional efforts; and education and training providers – 
namely community colleges. 
In the past decade, there has been a tremendous amount of economic and business 
development activity targeting life sciences companies in Massachusetts. This case study 
focuses on policies and initiatives that address workforce issues, regional development 
around the state, and downstream operations. These policies and initiatives, -- the product 
of significant planning and research, -- were implemented primarily in the second half of 
the decade (2005-2010). Discussed briefly in this section the policies are described in 
detail in Appendix A: Descriptions of Selected Economic Development Policies and 
Initiatives in the Massachusetts Life Sciences Industries. 
 
Large employers, contract research organizations, and contract manufacturers 
There has been a shift (in Massachusetts as well as in other states) in thinking 
about the life sciences workforce: Regional competitiveness depends on more than the 
presence of high-skilled workers. Mid-skilled workers -- those who possess the necessary 
technical skills to support biologics production and laboratory services in downstream 
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activities – are also crucial (Holzer & Lerman, 2007; UMass Donahue Institute, 2008). 
Large employers, contract research organizations, and contract manufacturers are the 
dominant firms driving downstream activity and they have an increasing demand for mid-
skilled workers. 
Not all of these Massachusetts employers engage in economic development and 
workforce and education initiatives. Employers who participate in such efforts are 
assumed to have an interest in collaborating on workforce and training investments. Their 
participation in regional investment strategies signals an economic perspective that 
collaboration with other parties across sectors is beneficial. To identify engaged 
employers, a search through the MassBio membership directory yielded a list of 301 
companies that were operating in a biotechnology related field such as contract research 
or the development of drugs or medical devices. Of those 301 companies, 78 had engaged 
in at least one of the economic or workforce education initiatives outlined in the case 
study’s timeline (described in a later section). All 78 companies were involved in more 
than one of the initiatives and about 20% were involved in four or more. Table 1 provides 
a list of the 15 employers most engaged in the state’s economic development initiatives 
who need a range of skills across their workforce, including technical abilities of mid-
skilled workers.  
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Table 1: MassBio member companies participating in four or more economic or 
workforce development initiatives 
Company Name Line of Business 
Main Office 
Location 
Employment 
(~approx.) 
Abbott Laboratories Drug Development Worcester 750 
AstraZeneca R&D 
Boston Drug Development Waltham 900 
Biogen Idec Drug Development Cambridge 2,300 
Bristol-Myers 
Squibb Drug Development Devens 320 
Caliper Life 
Sciences, Inc. 
Research Products 
& Instrumentation Hopkinton 401 
Charles River 
Laboratories 
Contract Research 
& Manufacturing Wilmington 970 
Cubist 
Pharmaceuticals, 
Inc. Drug Development Lexington 626 
EMD Serono, Inc. Drug Development Billerica  1,100 
Genzyme 
Corporation Drug Development Cambridge 4,356 
Microtest 
Laboratories, Inc. 
Contract Research 
& Manufacturing Agawam  85 
Millennium: The 
Takeda Oncology 
Company Drug Development Cambridge 1,050 
Millipore 
Corporation 
Research Products 
& Instrumentation Billerica  1,237 
Organogenesis, Inc. Drug Development Canton 450 
Shire 
Pharmaceuticals Drug Development Cambridge 1,500 
Wolfe Laboratories, 
Inc. 
Contract Research 
& Manufacturing Watertown 25 
 
Development intermediaries 
Four development intermediaries were identified in Massachusetts as having a 
broad interest in supporting economic and workforce development in biotechnology and 
other life sciences sectors across the state. First, the Massachusetts Life Sciences Center 
(MLSC) is a quasi-public economic development organization concerned with capital 
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investments and infrastructure, support for early research, job creation, and workforce 
development. The MLSC serves the life sciences industries, which includes 
biotechnology, but also major pharmaceuticals, medical devices, and diagnostics. Second, 
the Massachusetts Biotechnology Education Foundation (MBEF) is a nonprofit 
organization that provides education, training, and collaborative resources to 
biotechnology firms and employees as well as to the educational and workforce 
development systems.  MBEF is affiliated with MassBio. Third, MassBio, the state’s 
trade association, is also profiled in this section. MassBio, with over 600 members, is a 
strong state trade association, the oldest in the country.  MassBio offers a number of 
services that align with and support MBEF’s mission, including economic and business 
development services and announcements for open jobs in the industry. Lastly, the 
Massachusetts Life Sciences Collaborative was founded in 2006. The Collaborative is an 
industry and higher education partnership that works to support sector growth – including 
a specific initiative called the Biomanufacturing Roundtable. 
 
The Massachusetts Life Sciences Center (MLSC) 
In 2008, the Life Sciences Act was passed, which included the establishment of 
the Massachusetts Life Sciences Center (MLSC). MLSC was created as a quasi-public 
organization charged with implementing a 10-year, $1 billion economic development 
plan. Specific economic development programs provided through the MLSC include 
capital investments in infrastructure and tax incentives. Also, it offers programs related to 
workforce development, including the Internship Challenge and matching grants for 
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training equipment and supplies for education programs. In addition, the MLSC provides 
accelerator loans for early stage companies and matching research grant programs. In 
2011, the MLSC reported that its programs have invested $217 million in the life 
sciences industries, which created $754 million in matched private investment. MLSC 
programs have helped create 1,965 new jobs in the industry and provided numerous 
incentives to help retain business in Massachusetts. The Center has also created a 
corporate consortium attracting investments from multi-national enterprises like Johnson 
& Johnson and Sanofi Aventis (Massachusetts Biotechnology Education Foundation, 
2008b; Massachusetts Life Sciences Center, 2009, 2010, 2011; Windham-Bannister & 
Mudawar, 2010). 
 
The Massachusetts Biotechnology Education Foundation (MBEF) 
The nonprofit Massachusetts Biotechnology Education Foundation (MBEF) was 
founded in 2001. Closely affiliated with MassBio, the state’s trade association, MBEF’s 
core mandate is to provide educational support for the biotechnology sector. Current 
initiatives include an extensive professional development program for the public K-12 
education system (BioTeach), incumbent worker training, and industry leadership 
development. Although MassBio and its members are the key financial supporters of 
MBEF, the main rationale for developing it as an independent nonprofit organization is to 
assure its eligibility for external sources of funding (Hartford, 2010; Massachusetts 
Biotechnology Education Foundation, 2008a). 
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BioTeach is one of the longest running initiatives under MBEF. BioTeach 
provides professional development for teachers in the K-12 public school system. The 
program now includes 177 high schools of which 95 have a biotechnology elective for 
students. Since 2005, MBEF has helped supply training and equipment – a $3 million 
investment – to 177 public high schools which have exposed 500 science teachers and 
26,000 students to industry related training. MBEF also provides incumbent worker 
training through its Learning Center. Courses offered through the Learning Center 
include project management, introduction to clinical research, a science course for non-
science personnel, leadership development, presentation skills, and Current Good 
Manufacturing Practices (cGMP). Finally, MBEF operates a Resource Center that 
provides online tools and links students and professionals to speaking engagements, 
career panels, job shadowing, and company tours (Hartford, 2010; Massachusetts 
Biotechnology Education Foundation, 2009). 
The Massachusetts Life Science Education Consortium (MLSEC) is led by the 
MBEF and is of particular interest to this study. MLSEC was formed in 2009 to help 
create linkages between the higher education system and industry employers. The 
consortium is composed of college and university presidents and industry leaders. MBEF 
is responsible for facilitating the consortium and providing administrative oversight, staff 
support, and organizational resources. In 2011, additional external funding for the 
consortium was provided by a two-year grant from The Boston Foundation. The initial 
focus of the consortium has been to develop industry-endorsed standards and core 
competencies for community college curriculums. In December 2010, eight community 
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colleges received industry endorsements for their biotechnology related education and 
training programs. Silver endorsements went to programs offering curriculums that 
addressed a set of required competencies. The Gold went to programs that met the 
competencies but also provided internships (Hartford, 2010; Kriz, 2011). 
 
The Massachusetts Biotechnology Council (MassBio) 
The Massachusetts Biotechnology Council (MassBio) was established in 1985 
and today has nearly 600 members. The association’s membership includes dedicated 
biotechnology and other related companies, academic and research institutions, and 
organizations that offer business support services. MassBio functions as a connector in 
the biotechnology community and conducts public policy advocacy for its members. 
MassBio is the oldest state biotechnology trade association in the United States. The 
biotechnology related industry began growing in Massachusetts about a decade earlier 
than in any other state. Maintaining the state’s competitive position and industry lead is 
the number one priority for MassBio. This includes retaining and building talent at all 
levels in the labor market (Abair, 2011; Massachusetts Biotechnology Council, 2008). 
MassBio supports two staff lobbyists who work on legislative priorities, which 
include such important federal issues as stem cell research, healthcare reform, drug 
pricing, and funding from the National Institute of Health. The Economic Development 
department at MassBio has completed at least 60 community assessments for its 
BioReady campaign, which rates municipalities by their locational advantage in 
supporting biotechnology activity. BioReady community endorsements are based on a 
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number of criteria mostly related to local municipal policies that support the development 
of biotech industry operations. MassBio has also launched a purchasing consortium 
which aggregates the buying power for regional companies and connects them with 
suppliers. In addition to sponsoring the Massachusetts Biotechnology Education 
Foundation, MassBio hosts a well-used and well-regarded industry job board for hiring 
employers and potential applicants (Abair, 2011; Massachusetts Biotechnology Council, 
2008, 2009, 2010, 2011). 
 
The Massachusetts Life Sciences Collaborative 
The Massachusetts Life Sciences Collaborative was formed in 2006 and founded 
by a leadership council originally composed of representatives from Harvard, MIT, 
University of Massachusetts, and Genzyme. The Collaborative’s mission is to support 
growth in the life sciences, and its current priorities address the value chain, business 
environment, and human capital needs of the industry cluster. This includes a focus on 
manufacturing and clinical trials, as well as workforce development and community 
college training programs. Financial support for the Collaborative comes from The 
Boston Foundation, Harvard, MIT, UMass, the Massachusetts Technology Collaborative, 
and the Massachusetts Life Sciences Center. An initiative of the Collaborative, the 
BioManufacturing Roundtable, brings together industry, academia, and state officials to 
work on a growth strategy in life sciences manufacturing for the state (Massachusetts 
Life Sciences Collaborative, 2006, 2008). 
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Community colleges and workforce development 
Community college programs have received attention as a viable mechanism for 
building the mid-skilled and entry-level workforce in the Massachusetts biotechnology 
sector. Biotechnology programs offered through community colleges provide both two-
year associate degrees and one-year certificates. These programs prepare students for 
technician jobs in manufacturing and laboratory environments. Many of these programs 
have grown over recent years, and a few, like Middlesex Community College’s 
biotechnology technician program, have become well known 
There are 15 community colleges in Massachusetts. Eleven of them have 
biotechnology-related programs in place and are engaged in the Massachusetts Life 
Science Education Consortium (MLSEC) and/or have become known for their program 
through other means. Table 2 provides a list of these institutions and the corresponding 
program names. Also included in the table is a list of the employers (if available) that 
have engaged with a specific program. The table provides additional information on 
whether the program received an endorsement from the MLSEC, whether the program 
has had students participate in the MLSC Internship Challenge, and whether the 
program/institution has received equipment and supplies grants from the MLSC. 
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Table 2: Biotechnology related programs offered through Massachusetts community 
colleges 
Institution 
Name 
Biotechnology-
related Program 
Title(s) 
Engaged 
Employers 
MBEF – 
Com-
munity 
College 
Endorse-
ment 
Rating 
Student 
Partic- 
ipated in 
MLSC 
Intern-
ship 
Chal- 
lenge 
Received 
MLSC 
Equip-
ment/ 
Sup-plies 
grant 
Berkshire 
Community 
College 
Associate in Arts - 
Biotechnology 
Concentration 
Nuclea 
Biotechnologies Silver No 
Yes (w/ 
Nuclea) 
Bristol 
Community 
College 
Associate in Arts 
in Liberal Arts & 
Sciences - 
Biotechnology/Bio
medical 
Technology and 
BioManufacturing unknown n/a No Yes   
Bunker Hill 
Community 
College 
Biological Science 
Program unknown Silver 2010 n/a 
MassBay 
Community 
College 
Biotechnology/ 
Marine 
Biotechnology/ 
Forensic DNA 
Science Program 
SBH Sciences; 
Genzyme; 
Organogenesis; 
Mattech n/a 
2009/10/
11 Yes   
Middlesex 
Community 
College 
Biotechnology 
Technician, A.S. 
and Certificate 
Genzyme; 
Wyeth; 
Millipore; EMD; 
Biogen Idec Gold 2010/11 Yes 
Mount 
Wachusett 
Community 
College 
Biotechnology/ 
Biomanufacturing BMS Silver 2010/11 
Yes 
(w/BMS) 
Northern 
Essex 
Community 
College 
Associate in 
Applied Science in 
Laboratory 
Science unknown Gold No n/a 
North 
Shore 
Community 
College 
Biotechnology  
(1 and 2 year) Wyeth; Genzyme n/a No n/a 
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Quinsiga-
mond 
Community 
College 
Biotechnology 
Certificate (1 year) 
Genzyme; 
AstraZeneca; 
Athena 
Diagnostics; 
Charles River 
Labs Gold 2009/11 n/a 
Roxbury 
Community 
College 
Biotechnology 
Associate of Arts 
Degree Program Merck Gold 2010 n/a 
Springfield 
Technical 
Community 
College 
Biotechnology/ 
Biomanufacturing 
A.S. 
Microtest; New 
England Peptide Silver 2010/11 n/a 
 
Associate degree and certificate programs provide hands-on laboratory training in 
biotechnology, cell culture, protein purification, and recombinant DNA technology. 
Programs provide training in aseptic technique, media preparation, quality control/GMP, 
documentation, and validation. Many programs also highlight organizational and work 
skill training regarding communication, teamwork, and time management. Programs are 
designed to prepare students for entry-level jobs as research assistants, lab technicians, 
manufacturing technicians, and for positions in quality control, documentation, and 
instrumentation calibration. Program credit can be transferred to four-year programs 
(Holgate, 2009; Kriz, 2011).  
 
Other workforce development activity 
The state’s workforce development (WFD) system is charged with assisting the 
state’s administration in achieving economic development goals like those of the 
Massachusetts Life Sciences Center. Workforce development stakeholders support the 
sector’s need for high-skilled professionals, but also have an immediate interest in 
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expanding job opportunities for low-skilled and mid-skilled job seekers as well as serving 
particular demographic groups (e.g. displaced workers, veterans, and young adults). 
Workforce development programs try to target good jobs that offer career paths and 
training opportunities that allow individuals to increase their skills and earn a decent 
living. Entry-level technician jobs in the life sciences are one such example. Further, 
workforce development programs can be designed to specifically offer services to 
unemployed workers, especially during tough economic times. Workforce development 
programs also help ensure services for veterans and assist young adult’s transition from 
school to career (Executive Office of Labor and Workforce Development, 2008).  
Recently, Massachusetts WFD stakeholders have been focused on mid-skilled 
jobs and the shortage of appropriately trained workers. This mirrors the national focus. 
Workforce development stakeholders have launched a “skills2compete” campaign to help 
promote training and educational opportunities for mid-skilled workers, stating that 
everyone should be guaranteed at least two years of post-secondary education. According 
to recent research, about 45 percent of jobs in Massachusetts can be classified as mid-
skilled, but only 32 percent of workers have the credentials to fill them. Building the mid-
skilled workforce will help ensure long-term competitiveness for the state as well as help 
workers advance in the labor market (Skills2Compete et al., 2010). 
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Industry and economic development timeline for the Massachusetts life sciences 
industries 
The case study uses time series analytics (as described by Yin, 2003b) to 
investigate changes that have occurred due to the increased economic development 
activity in Massachusetts, especially during the last half of the decade. The timeline 
(Figure 1 and Figure 2) shows a number of policy tools and initiatives put in place that 
both invest in biotechnology jobs and attempt to address the distribution of jobs across 
different skill groups and sub-state regions. The timeline also shows that this uptake in 
policy strategies follows Bristol Meyers Squibb’s decision to locate its largest biologics 
manufacturing facility in the state of Massachusetts. Following Figure 1 and Figure 2 is a 
chronological description of economic development in the life sciences as well as some 
historical context prior to the 2000s in Massachusetts. 
 
Figure 1: “Biopharma” employment, 2000-10 
 
Source: MassBio (2010, 2011) 
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Figure 2: Timeline for economic development policies and initiatives in the 2000s 
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2007 
 
2008 
 
2009 
 
2010 
BMS initiates request for 
information from MA Dept. 
of Econ. Dev.; decides to 
locate in Devens, MA by 2005 
 
MassBio structures its own economic development division to support expanding and new business. Starts 
BioReady Communities Campaign in 2008  
 
MA Life Sciences Act, 2008; 
includes tax credits for job 
growth; targeted regional 
developments; workforce 
investments; est. MLSC 
 
LSTI report released; includes 
recommendations to improve 
system coordination with 
respect to WF issues 
 
STEM pipeline fund established by MA DHE in 2003; MA STEM initiative begins by 2006; core goal to increase the number of 
qualified graduates to fill STEM positions 
 
NBC2 establishes 
biomanufacturing 
occupational 
standards and 
apprenticeship 
program 
 
BCC, BHCC, and Mt. Wachusett added to the list of community college biotech 
programs and degrees 
 
WFD takes interest in biomanufacturing and clean room 
training; employer grants provided through WTF; interest 
in developing pathways to mid-skilled jobs 
 
MassBioEd convenes MLSEC - 
education and industry 
stakeholders - initiates CC 
endorsements by 2009 
 
MA Community 
Colleges begin 
designing courses 
and programs in 
biotechnology in 
the 1990s; as 
well as 
Minuteman VTE 
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1980s and 1990s 
Massachusetts is home to two of the longest established dedicated biotechnology 
firms in the nation, Biogen (founded 1978) and Genzyme (founded 1981 and now owned 
by Sanofi); as well as Boston Scientific (founded in 1978) which is often credited as an 
industry founder within the medical device technology cluster for the state. 
Massachusetts also has the oldest biotechnology state trade association in the nation 
(founded in 1985). As well, in 1996, MassMEDIC was formed as the state’s trade 
association for medical device and equipment manufacturers. 
During the 1980s, the state’s research universities played a dominant role in 
expanding technology in the life sciences. The 1990s then saw significant increases in 
venture capital investments for startup companies in the industry, which emphasized the 
entrepreneurial nature of moving science to industry (Powell et al., 2010). Thus, the 
1990s was a period of high growth for life sciences industries in Massachusetts, and by 
the end of the decade, the Massachusetts biotechnology cluster included 58 publicly 
traded companies and 33 firms with more than 100 employees (Brookings Institution, 
2002). Additionally, the medical equipment and device (MED) manufacturing sector 
grew during the 1990s. However, employment peaked in June of 1998 – as did other 
manufacturing in the state (Clayton-Matthews, 2001). 
In addition to the tremendous contributions of the state’s universities with respect 
to research, collaboration, and the production of a highly skilled workforce through 
baccalaureate and graduate programs, other education and training efforts began to 
develop through the community college system. Middlesex Community College 
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established the state’s first biotechnology program at a community college. This includes 
a certificate program and an associate’s degree program. Since 1990, the program has had 
about a 50 percent graduation rate. This compares favorably to average graduation rates 
for community colleges (about 20 percent). The program has engaged at least ten 
biotechnology employers that provide internships and most often hire graduates. Wyeth 
(now part of Pfizer) has been an important partner to the program, hiring about 40 
graduates within a ten-year period (UMass Donahue Institute, 2008). By 1996, Mass Bay, 
North Shore, Quinsigamond, and Springfield Technical community colleges had 
launched biotechnology related certificate and degree programs. Also, in 1995, 
Minuteman Vocational Technical High School established a biotechnology area of study 
for its regular high school students and another for participants in its adult education and 
training program (Breznitz, 2006). 
 
Early 2000s 
During the 2000s, the core life sciences industries, particularly those associated 
with biotechnology, have been high performers relative to the rest of the innovation 
economy. MassBio reported that employment in biotechnology grew consistently through 
the 2000s, suggesting that the industry was recession proof (Massachusetts 
Biotechnology Council, 2011). Many other high tech industries have not recovered to 
pre-2001 levels and have negatively impacted Massachusetts performance during the 
2000s (see for example, Bradbury & Kodrzycki, 2007). MED employment declined 
during the recession although total payroll increased. MED had some productivity gains 
57 
 
likely due to changes in the industry mix; higher paying jobs grew in electromedical 
apparatus manufacturing while relatively lower paying jobs in laboratory apparatus and 
furniture declined (Clayton-Matthews & Loveland, 2004). 
Biotechnology and other life sciences industries have been regionally 
concentrated within the state. Industry is clustered in Cambridge, Boston, Woburn, 
Waltham, Lexington, and Worcester (Breznitz, 2006). For example, in 2002, Cambridge 
had 30 percent of firms and 60 percent of employment in biotechnology (Breznitz & 
Anderson, 2005). A number of regional initiatives were formed to support innovation 
industries, particularly biotechnology. The Massachusetts Biomedical Initiative 
(established in 1985 in Worcester) provides business incubator space and other support 
for startup companies. In addition, the Pioneer Valley Life Sciences Institute formed in 
Springfield in 2002, LifeTech Boston, which was launched by the City of Boston in 
2003, and the John Adams Innovation Institute founded in 2003 and supported by the 
Massachusetts Technology Collaborative. 
With respect to education and training, MassBio formed the Massachusetts 
Biotechnology Education Foundation (MBEF) in 2001. This independent nonprofit 
organization was charged with assisting MassBio members with their training and 
education needs. It has developed into a unique intermediary that links education, 
industry, and government in support of furthering the state’s competitive advantage in 
biotechnology and the life sciences (Massachusetts Biotechnology Education Foundation, 
2009). 
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Late 2000s 
According to MassBio (Massachusetts Biotechnology Council, 2011), 
“biopharma”3 employment increased 23 percent from 2001 to 2005 and increased an 
additional 24 percent from 2005 to 2010 (see also Figure 1). This sustained employment 
growth in the sector has been driven by research and development services in 
biotechnology. Massachusetts has the highest concentration of bioscience research and 
development in the country. The location quotient (LQ) is a common measure of industry 
concentration; it is the ratio of industry employment to total employment for one region 
relative to the entire nation. The LQ provides an estimate of the extent to which an 
industry concentrates in a particular region. An LQ greater than 1 implies that an industry 
is concentrated in a region when compared with the nation as a whole. In 2010, the LQ 
for R&D in biotechnology was 7.42 in Massachusetts relative to the United States (the 
next highest state was Maryland with 3.74). Another indication of growth in “upstream” 
activities is that biotechnology companies in Massachusetts have captured a growing 
share of venture capital. In 2000, Massachusetts biotechnology companies received 12 
percent of venture capital financing for the sector; whereas in 2010 they had received 23 
percent (equivalent to $850 million in 2010). However, of concern to the industry, 
funding from the National Institute of Health (NIH) has been flat. In 2010, Massachusetts 
received about $2.4 billion in NIH funding. This amount has been level since 2003, with 
the exception of additional funding through the American Recovery and Reinvestment 
Act in 2009. 
                                                 
3
 MassBio defines “biopharma” as research and development in biotechnology and pharmaceutical 
manufacturing.  
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Since 2006, Massachusetts has added over 1,500 jobs in biopharma 
manufacturing – more than any other state in the sector. However, biopharma 
manufacturing employment for almost all states (including Massachusetts) was flat 
between 2009 and 2010. Also, research from the Center for Labor Market Studies at 
Northeastern University has shown that the location quotient for pharmaceutical 
manufacturing is close to one in Massachusetts, which does not indicate a strong 
concentration in the state (Khatiwada & Sum, 2006). Meanwhile, throughout the 2000s, 
MED manufacturing employment contracted from about 15,000 in 2001 to 10,750 in 
2010 resulting in a declining concentration of industry employment for the state (U.S. 
Department of Labor - Bureau of Labor Statistics, 2012b). 
In 2005, Bristol Meyers Squibb (BMS) indicated interest in locating in 
Massachusetts and submitted a request for information. Given the increase in biologics 
production in the past decade and the manner in which biotechnology and pharmaceutical 
companies are making new locational decisions at a global level, economic development 
actors in Massachusetts came to realize that the state needed to compete in attracting 
manufacturing activity. Other states such as California and North Carolina were engaged 
in similar efforts. The BMS case launched additional and ongoing economic development 
activity (Abair, 2011). The state’s significant efforts to meet the information and planning 
needs of BMS were rewarded and in 2006, BMS decided to establish new operations in 
Devens, Massachusetts. 
Responding to the BMS information request prompted MassBio to create its own 
economic development department, which is intended to serve the state. MassBio’s 
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economic development program works in collaboration with a number of state agencies 
and trade groups to help businesses with location decisions and to navigate the permitting 
process (Abair, 2011; Massachusetts Technology Collaborative, 2006). In 2008, the 
economic development program launched its BioReady Communities campaign, which 
provides ratings for municipalities across the state based on locational advantages for 
biotechnology companies (Massachusetts Biotechnology Council, 2008). 
A number of efforts were launched specifically for manufacturing from 2004 to 
2008. The Northeast Biomanufacturing Consortium (2004) helps coordinate education 
and training initiatives for the sector both locally and nationally. This included 
establishing an apprenticeship program for entry-level biomanufacturing jobs through 
grant funding from the National Science Foundation. In 2006, the Massachusetts Life 
Sciences Collaborative was formed. By 2008, the Collaborative helped establish the 
Biomanufacturing Roundtable – a sector specific working group to help establish growth 
strategies for the region (Massachusetts Life Sciences Collaborative, 2012; Northeast 
Biomanufacturing Center and Consortium, 2012). 
During this same period, state workforce and education policies or initiatives were 
taking root. One broad reaching initiative in Massachusetts is the Science, Technology, 
Engineering, and Mathematics (STEM) initiative, overseen by the Massachusetts 
Department of Higher Education. Since 2003, this large collaborative effort has worked 
to promote STEM careers, provide professional development for teachers and faculty, 
and help strengthen the pipeline of high-skilled workers in science, technology, 
engineering, and mathematics fields. This is also the time period when workforce 
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development stakeholders entered the playing field. One of the first WFD initiatives 
launched in the state to help develop needed mid-skilled jobs in biotechnology was called 
BIOTRAIN. This was a collaborative effort funded through the Commonwealth 
Corporation and included MBEF, and Bunker Hill and Middlesex community colleges.  
Community colleges programs are viewed as a viable mechanism for building the 
mid-skilled and entry-level workforce in the Massachusetts biotechnology sector. This 
focus has led to additional biotechnology programs offered through Bunker Hill, Bristol, 
and Mt. Wachusett community colleges. Mt. Wachusett (MWCC) is one of the newer 
programs; begun in 2007, the program offers a two-year associate’s degree and a one-
year certificate. MWCC received a $1.6 million three-year grant from the Department of 
Labor to build its credit programs and to develop a non-credit pre-employment 
workforce-training program. This capacity building grant effectively started in September 
2008 with a 15-week course. Non-credit training of this sort helps employers meet their 
immediate short-term needs (Holgate, 2009). 
In 2008, the Life Sciences Act was passed in Massachusetts. It established a $1 
billion, ten-year initiative to encourage innovation, accelerate products for 
commercialization, fill funding gaps, and expand the workforce available to relevant 
industries, including biotechnology (Executive Office of Housing and Economic 
Development et al., 2007). The Massachusetts Life Sciences Center (MLSC) was created 
under the Act as a quasi-public organization charged with implementing this large 
economic development initiative. MLSC is affiliated with, but not controlled by, the 
Executive Office of Housing and Economic Development (Massachusetts Life Sciences 
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Center, 2010; Windham-Bannister & Mudawar, 2010). The Act included a number of 
targeted investments using capital funds, research grants, and matching funds to spur job 
growth, support innovative research, and strengthen the training and education system. 
This included $15 million to invest in workforce development. The Act also created a tax 
credit program to encourage job growth which mandates that qualified companies create 
new jobs for full-time permanent employees ("An act providing for the investment in and 
expansion of the life sciences industry in the commonwealth," 2007; Patrick, 2007).  
Following the completion of the Life Sciences Talent Initiative in 2008, MBEF 
and other stakeholders strategized on ways to better connect industry with the state’s 
college and university programs. The LSTI report had indicated that there was a 
disconnect between the higher education system and industry. Evidence collected from 
focus groups and surveys suggested that employers did not understand what new efforts 
the system of higher education had implemented. Further, a survey of education and 
training programs showed that biotechnology and other industry relevant programs were 
many and varied. To address the apparent lack of information, The Massachusetts Life 
Sciences Education Consortium (MLSEC) was formed in 2009 under MBEF’s leadership 
to help create linkages between the higher education system and industry employers 
(Hartford, 2010). 
Most recently, Massachusetts workforce development stakeholders have been 
focused on the shortage of appropriately trained workers for mid-skilled jobs. This focus 
on the mid-skilled workforce is mirrored at the national level. Workforce development 
stakeholders have launched a skills2compete campaign to help promote training and 
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educational opportunities for mid-skilled jobs, stating that everyone should be guaranteed 
at least two years of post secondary education (Sasser Modestino, 2010; Skills2Compete 
et al., 2010). In 2011, the state community college system was awarded a three-year, $20 
million grant to improve coordination across education and training programs as well as 
with the workforce development system. These grant activities will focus on key 
industries for Massachusetts; this includes biotechnology and the life sciences. These 
efforts are targeting dislocated and unemployed workers. The goals of the grant are to 
increase the number of students able to complete these programs, experiment with 
accelerated curriculums, increase industry and Workforce Investment Board (WIB) 
involvement, and enhance student supports (Allen, 2011; Commonwealth Corporation, 
2011). 
This case study was conducted in a particular context – that of Massachusetts in 
the years 2000 to 2010 with particular stakeholders that have helped shape the economic 
development agenda. Public and private collaboration and investment has successfully 
spurred the industry. The question now is whether or not this increased economic 
development activity has not only supported industry and regional competitiveness, but 
has it identified and supported equity goals such as improving access to mid-skilled jobs, 
increasing workforce diversity, and helping different regions across the state grow. 
  
64 
 
 
CHAPTER 4 
METHODOLOGY 
 
 
This research uses standard case study methodology (Yin, 2003a, 2003b) to assess 
labor market and regional changes resulting from economic development policies. It 
examines the extent to which equity as opposed to efficiency is considered a goal of the 
policies and it takes a step toward defining the role of equity goals in supporting the 
innovation economy. Efficiency is defined here as sustained competitive advantage or 
continuous innovation to improve productivity and product and service quality. The 
research uses three measures of equity: broadly, equity refers to reduced disparity in 
worker income; in the specifics of the case, equity refers to an equitable distribution of 
economic benefits; equity is evidenced as equality of opportunity when individuals have 
access to jobs regardless of gender, race or other characteristics. The case study relies on 
several analytical strategies to demonstrate links between economic development 
initiatives and policies with labor market outcomes including time series analytics and 
comparisons of life sciences with other industries in the Massachusetts innovation 
economy. Case study findings and a case level analysis are reported along with a 
discussion of relevant policy issues. Case evidence is drawn from three sources: 
documentation, secondary data sets, and interviews with stakeholders.  
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Conceptual Framework 
The conceptual framework that guides this inquiry is depicted in  
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Figure 3. The largest rectangle marks the innovation economy, which is the 
context that surrounds the case study. The inner rectangle represents the critical case 
study of the Massachusetts Life Sciences industry cluster. Economic development is a 
broad field that works through public/private collaboration to increase jobs and tax 
receipts for a region. The creation of economic development agendas and project 
implementation occurs across the Massachusetts industry base. With respect to the life 
sciences, primary economic development tools have included financing strategies, 
infrastructure investments, workforce training, and tax incentives. The case study 
research connects economic development strategies to outcomes related to sustained 
competitive advantage and equity goals. Ultimately, the case study seeks to understand 
how shared prosperity might be achieved in Massachusetts given the life sciences 
industries; the extent to which increased wealth in the life sciences is accompanied by 
equality of opportunity and equitable (or fair) outcomes across the state. Finally, the case 
study examines a series of intervening factors drawn from the literatures on labor markets 
and industrial relations and regionalism. 
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Figure 3: Conceptual framework for a case study of the Massachusetts life sciences 
industries  
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Industry description and outlook for biotechnology and other life sciences 
In the United States, researchers using public data sets through the U.S. Census 
Bureau and the U.S. Bureau of Labor Statistics define regional biotechnology and life 
sciences clusters in one of two ways. One strategy defines firms and workers classified 
under the 2007 North American Industry Classification System (NAICS) 6-Digit code 
541711 or “Research and Development in Biotechnology.” This definition 
underestimates total biotechnology activity because it does not include firms and workers 
that use it, only those that develop it. Alternatively, some researchers (as is the case with 
Massachusetts) identify biotechnology as part of a larger cluster, that is, “Life Sciences.” 
This measurement strategy includes biotechnology R&D with associated industries in 
healthcare, pharmaceutical, and medical device manufacturing. This method 
overestimates the extent of biotechnology activity because it includes very large firms, 
which may only have a small proportion (if any) of their operations dedicated to 
biotechnology-related activity. At the same time, this treatment ignores biotechnology 
activity in industries outside of human health. Further, most researchers supplement their 
data with proprietary sources (Sum et al., 2007b; van Beuzekom & Arundel, 2009). 
The Massachusetts Departments of Economic Development and Labor and 
Workforce Development (2007) have identified the biotechnology and life sciences 
industries most relevant to the state. Industries are defined using the NAICS codes. The 
core life sciences industries include pharmaceutical, medical equipment and device, and 
instruments manufacturing as well as research and development services. Life sciences 
supporting industries include some additional manufacturing, wholesale, technical 
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services, health insurance, and healthcare providers. In addition, NAICS codes have been 
used to identify other high tech industries. Some high tech industries overlap with the life 
sciences, but also include computer and communications equipment and electronic 
components manufacturing. High tech service industries include architectural and 
engineering, data processing, and computer design. Core life sciences and high tech 
industries constitute the base of the innovation economy in Massachusetts. This case 
study analysis relies on NAICS codes to identify biotechnology and other life sciences 
and focuses on the core life sciences industries. When relevant comparisons can be made, 
data is used to describe the supporting life sciences industries and other high tech 
industries. (See APPENDIX B for a detailed list of NAICS codes and descriptions.) 
Based on the wealth of research available on industry performance in the core life 
sciences for Massachusetts, we know these industries are contributing to the state’s 
economy by providing a growing number of good jobs (i.e., high wages with benefits) 
and that research and development services have been the primary driver of that growth. 
Medical equipment and device manufacturing has restructured and declined some in the 
past decade, while pharmaceutical manufacturing has grown. However, it remains 
unclear whether pharmaceutical manufacturing employment growth will continue or 
achieve a high concentration relative to other states. During this past decade of growth, 
labor market research has emphasized the high skilled nature of many of the jobs in the 
life sciences cluster and a shortage of medical, business, and technical personnel 
(Clayton-Matthews & Loveland, 2004; Khatiwada & Sum, 2006; Massachusetts 
Biotechnology Council, 2011; Sum et al., 2007a; UMass Donahue Institute, 2008). 
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Definitions of biotechnology and its application in the life sciences 
Biotechnology is a set of processes and products that combine biology and life 
sciences with technology. The Organisation for Economic Co-operation and 
Development provides a standard definition of biotechnology: “the application of science 
and technology to living organisms, as well as parts, products and models thereof, to alter 
living or non-living materials for the production of knowledge, goods and services” 
(BioTalent Canada, 2008b; Industry Canada, 2000a, 2000b; van Beuzekom & Arundel, 
2009). The OECD also provides a list-based definition that includes firms that use and 
develop core technologies such as DNA/RNA applications, protein and 
peptides/enzymes, cell and tissue culture, and engineering, gene, and RNA vectors, 
bioinformatics, nanobiotechnology, process biotechnologies, and sub-cellular processes 
(van Beuzekom & Arundel, 2009). Biotechnology is also generally defined by its 
application within an industry sector, for example in human health, agriculture, and 
bioinformatics. Three quarters of all biotechnology activity worldwide occurs in the field 
of human health (BioTalent Canada, 2008b; Industry Canada, 2000a, 2000b; van 
Beuzekom & Arundel, 2009). 
Recent research has defined and measured economic activity within the life 
sciences in various ways. Common measurements used to define and track performance 
are counts of employment, job vacancies, payrolls, earnings and tax receipts; number of 
firms, types of firms and firm size; commercial sales, R&D expenditures, venture capital 
and government research funding; number of patents, number of products (,e.g., available 
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drugs), and number of clinical trials underway; location quotients, multiplier effects and 
social network analysis; alliances between firms through technology transfers, joint 
research and merger and acquisition activity (BioTalent Canada, 2008a, 2008b; 
Christopherson & Clark, 2007; R. W. DeVol; Perry; Ki, Junghoon; Bedroussian, Armen; 
Koepp, Rob, 2004; Industry Canada, 2000a; Sum et al., 2007b). 
 
Economic and occupational outlook for biotechnology and other life sciences 
The vast majority of biotechnology activity (both research and development and 
commercial) is in human health. The production of biotechnologies occurs over a long 
time horizon. In addition to developing a skilled workforce, industry players face 
challenges securing financial backing and addressing regulatory issues over the duration 
of a project. Other hurdles include consumer acceptance; lack of market information; 
access to technology; and, international harmonization. The United States has 
experienced impressive growth rates in biotechnology-related employment and has built 
up its export base in biopharmaceuticals (Industry Canada, 2000b; Sum et al., 2007b). 
The industry is organized around research and development, clinical trials, and 
production and commercialization activities. Research and development includes lab 
testing, discovery, applying for patents, and the pre-clinical trial phase. Once flagged as 
viable, a discovery enters into clinical trials. Venture capital or other financial resources 
are required to fund the trials until the product or process is approved for market. Once a 
biotechnology project has been approved and funded for production, then business and 
management expertise is required for commercialization. Overall, a strong industrial base 
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within a region will contain at least one academic anchor in basic research; a mix of firms 
(start-up, high-growth, and publicly traded), as well as a range of business services; and 
an institutional base that provides the infrastructure and processes needed to innovate, 
finance, and commercialize projects (Industry Canada, 2000b; Nasrullah, 2009; North 
Carolina Biotechnology Center, 2003). 
Some states, like North Carolina, have been able to attract new manufacturing 
jobs related to biotechnology. The new manufacturing facilities operate near an 
established cluster where process innovation is still occurring. Research shows that once 
a product has been commoditized, firms are likely to consider off shoring operations to 
cut down on tax obligations and labor costs (North Carolina Biotechnology Center, 2003; 
Reynolds, 2009).  
The pharmaceutical industry has undergone serious restructuring since the 1980s. 
The rise of biotechnology itself has contributed to these changes. Additionally, cost and 
pricing pressures, regulatory controls, and global markets have contributed to changes in 
the industry. Large vertically integrated firms are declining, discovery has lagged and 
there will be a disproportionate number of patents expiring on blockbuster drugs. But 
despite these pressures, profitability remains high, steady, and non-volatile in the 
pharmaceutical industry (Kapler & Puhala, 2008). 
The majority of jobs within the life sciences are in management, scientific, 
professional, and technical occupations. Speaking broadly about the scientific research 
and development services industry
4
 in the U.S., 68 percent of workers hold a bachelor’s 
                                                 
4
 This includes the aerospace, automotive, biotechnology, chemical and materials science, electronics, 
nanotechnology, and pharmaceutical fields. 
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degree or higher. Additionally, 47 percent of workers in R&D are working in science, 
technology, engineering, and mathematics (STEM) occupations; 20 percent are in 
management positions; and 15 percent perform administrative support. Jobs in 
biotechnology-related firms tend to pay more than the regional average. For example, 
average annual earnings in Massachusetts bio-pharmaceutical industries were $56,000 in 
2005 as compared to $32,000 for all workers in Massachusetts during that year. These 
jobs are also more likely to be full-time than those in other industries and they attract a 
large percentage of foreign-born workers (Sum et al., 2007b; Terrell, 2005). When a 
regional biotechnology sector begins to develop downstream operations, mid-skilled jobs 
increase and new job opportunities open up for the local workforce. A needs assessment 
of the North Carolina biomanufacturing workforce showed that 67 percent of workers 
needed an associate’s degree or less, 27 percent needed a bachelor’s degree, and 6 
percent needed a graduate degree (North Carolina Biotechnology Center, 2003).  
Employers within biotechnology-related industries report a skills gap and limited 
qualified applicant pools in a number of occupations considered vital for growth and 
production. There are at least two explanations for the skills gap: One, high industry 
growth rates coupled with a high demand for specialized skills make a skill gap 
inevitable, especially at the top end of the labor market. This includes scientists as well as 
cross-disciplinary management and professional staff. Second, employers usually require 
industry-specific experience for new hires – including entry-level workers. Employers 
have reported the most difficulty hiring pre-clinical and clinical researchers, regulatory 
affairs staff, technicians and engineers, and marketing and sales personnel. These 
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positions often require a four-year degree or less and they all require some industry 
knowledge and experience. These workforce needs are increasing for biotechnology 
firms, especially as “downstream” operations grow (e.g., clinical research and 
manufacturing) (BioTalent Canada, 2008a; R. W. DeVol, Perry; Ki, Junghoon; 
Bedroussian, Armen; Koepp, Rob, 2004; Munn-Venn & Mitchell, 2005; North Carolina 
Biotechnology Center, 2003; UMass Donahue Institute, 2008).  
 
Components of the case study research design 
The case study research design has five main components: the research questions; 
the unit of analysis or the object being studied; the use of pattern matching; and the 
criteria for interpreting findings. Each of these components is discussed below. 
Research questions 
1. Significant industry research has shown that Massachusetts is sustaining its 
competitive advantage in the life sciences, particularly with respect to research 
and development. There is also growing interest among economic development 
stakeholders in supporting manufacturing and clinical trial operations as a way to 
expand the economic benefits of the industry. How can sustained competitive 
advantage in the Massachusetts life sciences industry be measured and have 
downstream operations (e.g., manufacturing and clinical trials) expanded in 
Massachusetts? 
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a. Has Massachusetts sustained competitive advantage in the life sciences 
since 2000 and, if so, how does it compare to other high tech sectors in the 
innovation economy? 
b. To what extent has sustained competitive advantage been achieved in the 
“downstream” activities of the life sciences (e.g., in manufacturing and 
clinical trials)? 
2. Massachusetts has a strong and growing industry cluster in the state with many 
important assets, particularly its university and health systems and its access to 
venture capital. This growth has contributed to the stock of good jobs. Jobs in the 
life sciences are highly paid even at entry level and are well benefited. Has the 
growth in good jobs in the core life sciences industry been accompanied by more 
equitable outcomes and, in particular, have the number of life sciences jobs grown 
in regions outside of the metropolitan core and has workforce diversity expanded 
along with industry growth? 
a. Has sustained competitive advantage in the Massachusetts life sciences 
been accompanied by an increase in earnings inequality? 
b. How have jobs grown across different regions in the state and how does 
this growth align with different economic development investments? 
c. How, if at all, has workforce diversity (e.g., in skill level, sex, race, 
ethnicity, veteran status, and nativity) expanded in the life sciences? 
d. How have “downstream” activities contributed to the industry mix across 
the state and the occupational structure within the industry? 
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e. To what extent has the Massachusetts core life sciences industry 
contributed to more equitable outcomes with respect to sub-state regional 
growth and workforce diversity when compared to the rest of the 
innovation economy? 
3. Given what is learned about sustained competitive advantage and equitable 
outcomes, do stakeholders view the balance between the two as a tradeoff or an 
opportunity for shared prosperity? The third research question seeks to shed light 
on how equity goals and interests are incorporated into the economic development 
agenda. In concrete terms, how do stakeholders (e.g., development intermediaries, 
educators, and employers) view equity and efficiency as it relates to their role in 
supporting and growing the life sciences industry in Massachusetts? 
a. What are stakeholder views on industry outlook and regional 
competitiveness, particularly with respect to “downstream” operations? 
b. How do stakeholders view the objectives of economic development 
policies and initiatives with respect to efficiency and equity? 
c. How have employers engaged in regional economic development 
initiatives and what have they gained? 
 
 
Unit of analysis 
The unit of analysis is the object of study in the case. The “case” represents 
economic and workforce development efforts in the Massachusetts life sciences cluster. 
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The case study pays particular attention to changes in the labor market and whether those 
changes are reflective of sustained competitive advantage and equitable outcomes. 
Analysis focuses on how jobs are held by region, skill, and worker characteristic; how the 
distribution of these jobs change over time; how those changes compare to the other 
sectors in the innovation economy; and how changes are linked to economic development 
efforts. 
 
Pattern Matching 
Time series analytics allow for pattern matching. The timeline for the case study 
is 2000 through 2010. The case study uses 2005 as an approximate year that marks the 
start of a significant ramping up of policy and initiatives related to the life sciences 
industries in Massachusetts. This build up follows on the decision of a multinational 
pharmaceutical corporation to locate its largest biologics production facility in 
Massachusetts. Comparisons between the two time periods will show differences (if any) 
in outcomes during the 2000-05 period versus the 2005-10 period. For example, do 
outcomes that support competitive advantage (e.g., employment growth) intensify during 
the latter period of the decade and coincide with increased economic development 
activity? 
Lastly, pattern matching can be applied to a comparison with other industry 
clusters in the innovation economy. These comparisons are opportunities to provide 
additional support for (or against) linkages between industry and labor market outcomes 
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and economic development policy. For example, how does workforce diversity compare 
between the life sciences industries and other high tech industries? 
 
Criteria for interpreting findings 
Data triangulation is a method that allows for comparing evidence provided by 
multiple sources. When findings are corroborated by three different sources, this 
condition permits for stronger casual inferences by the researcher. This method is used in 
the case analysis. 
 
Limitations 
The case study is limited in creating a causal claim between industry performance 
and labor market outcomes with economic development policies and initiative. We do not 
know whether industrial activity in the life sciences would have maintained and 
intensified in the absence of the new policies implemented in the second half of the 
2000s. The combination of analytics used in the case study provides a best assessment of 
policy effects during the study period. 
The timeline on the case study is limiting as well. Many of the policies and 
initiatives of interest very likely have effects that will extend well beyond 2010. The case 
analysis and policy discussion appreciate this artificial cut off in time – meaning that 
analysis assumes that there is more to come from these policies in the following years. 
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Rationale for choosing the case study method 
In some respects, the research questions are straightforward. As the life sciences 
industries grow and mature in Massachusetts and as they continue to offer well paid 
promising employment opportunities, who gets access to the jobs and where are the jobs 
located? However, the research questions are also concerned with policy implementation 
and impact. What can be said about the impact of economic development policies and 
initiatives in influencing outcomes during the decade being studied? The influences of 
policy are occurring concurrently with other conditions. This includes the development 
path of industry and industry conditions. The trajectory of an industry within a particular 
region is influenced by the mix of companies, the actors (especially entrepreneurs, 
industry leaders, and investors), and by the socio-political environment. Industry 
conditions can change or intensify. Firm decision-making is done in the context of global 
competition; national policies impacting healthcare and research funding can influence 
company priorities; and the investment climate and business cycles help determine 
expansionary and cautionary times. 
Further, the intention is not just to measure industry performance but to also 
gauge equality of opportunity and equitable outcomes. There is a wealth of research in 
biotechnology and life sciences alone that uses secondary and proprietary data to track, 
benchmark, and analyze industry performance especially related to investment, 
employment growth, educational attainment, patenting, and product development. 
Learning about the extent to which policies are geared toward equity requires a closer 
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look at how policies and initiatives have been implemented and documenting stakeholder 
perspectives. 
The case study method allows the researcher to investigate industry performance 
and equitable outcomes in a context that closely resembles the real complexities and 
regional specificity of economic development efforts. Broadly speaking, the case study 
methodology (in reference to economic development) acknowledges the specific context 
of a regional project. It can contribute to understanding the industry’s trajectory, the 
development of governance structures, the role of institutions, and it can help identify 
promising practices in economic development and provide a forward-looking assessment 
of what might be next for the region. 
Massachusetts has been selected as a critical case example to study because it is a 
leading state in the life sciences industries. Massachusetts ranks #1 in the Biopharm 
Innovation Index and #1 in the State Technology and Science Index. Research has shown 
that Massachusetts leads the nation in terms of human capital, STEM workforce, R&D 
inputs, and risk capital (R. DeVol et al., 2011; Milken Institute, 2004). In addition to 
leading the nation in the life sciences, Massachusetts is also experiencing high levels of 
income inequality and rapid increases in inequality relative to other states (see for 
example, McNichol et al., 2012). 
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Description of data sources 
The case study relies on three main types of data and a range of methods for 
analyzing each source. These sources are documentation, secondary data sets, and 
interviews. They are each described below. 
 
Documentation 
A number of documents were reviewed for the case study analysis. This includes 
company and organization websites and annual reports, government documents, research 
specific to the life sciences cluster in Massachusetts, and media articles. The time frame 
for the documents was mostly between 2000 and 2010 in line with the case study 
timeline. Documents are used to describe particular policies and initiatives as well as 
supplement both the quantitative and qualitative analyses. 
 
Secondary data sets 
A number of public data sets are used in presenting case study evidence. These 
data are available through the U.S. Census Bureau and the U.S. Department of Labor, 
Bureau of Labor Statistics. This includes the Quarterly Census of Employment and 
Wages (2001-10), the Economic Census (1997, 2002, and 2007), the Census Population 
and Household Survey (5% PUMs 2000), and the American Community Survey Public 
Use Microdata Files (1-year estimates for 2005 and 2010).  In addition to these sources, 
the clinical trials data available through the National Institutes of Health were analyzed. 
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When analysis required the comparison of dollar amounts over time, the Consumer Price 
Index – All Urban Consumers for the Northeast was used. 
 Quarterly Census of Employment and Wages (QCEW): The QCEW data includes 
information on employment, establishments and payroll for workers covered by 
state and federal unemployment insurance programs. Data are available for 2001 
going forward on a monthly, quarterly, and annual basis. Annual data extracted 
and tabulated from the QCEW for the case study included employment and 
payroll information for private sector establishments by 6-digit NAICS codes (see 
APPENDIX B) by state and metropolitan statistical area (MSA) using Microsoft 
Excel. 
 Economic Census: The Economic Census provides detailed establishment 
statistics at national and local levels by 6-digit NAICS codes. The Economic 
Census began in 1935 and currently produces statistics every 5 years. Data for this 
case study were based on 1997, 2002, and 2007 and were downloaded into 
Microsoft Excel. Primary tables extracted for the case study are based on the 
Manufacturing – Geographic Series – Industry Statistics. These tables provide 
information on employment, establishment size, costs, shipments, and capital 
expenditures. In particular, information on shipments was analyzed. Shipments 
are defined as the net selling value of all products shipped plus other receipts for 
the year.  
 Census 2000 and the American Community Survey (ACS): The 5 percent Public 
Use Microdata Sample files for the population and household survey for the 
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Census 2000 and the American Community Survey 1-year estimates for 2005 and 
2010 were analyzed using Stata and/or SPSS. The U.S. Census website provides 
documentation for applying weights to the sample and for calculating margin of 
errors (U.S. Census Bureau - American Community Survey, 2009a, 2009b). The 
PUMS files for Census 2000 are available at the state level and represent a 5% 
sample of people and housing units for the area. The ACS files contain a 
subsample of housing units and the information on the people living in those 
units. ACS files are also available by state. The Census and ACS PUMS files 
provide detailed information on employment at time of survey, wage and salary 
earnings for the 12 months prior to the survey, and individual characteristics, 
including educational attainment. The three files also contain Census geographic 
codes. This includes PUMA codes which are assigned to the respondent’s place of 
work. These codes are listed in APPENDIX B and categorized by sub-state 
region. These files are generally comparable across the three time periods. The 
U.S. Census Bureau provides guidance in interpreting comparability (e.g. changes 
in NAICS codes over time) as well as calculating standard errors and other 
statistics. The analyses in the case study followed Census guidance. 
 ClinicalTrials.gov: The U.S. National Institutes of Health provides an online 
registry database for private and publicly funded clinical trials in the United States 
and around the world. Clinical trials are registered with the government as a 
precondition for publication. The online database is searchable by a number of 
variables, including start date, location, sponsor and disease and condition. 
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Clinical trials data was extracted and tabulated for studies starting between 2000-
2010, which had at least one location in Massachusetts by sponsor type (e.g., 
public, industry). 
 
Interviews 
Interviews were conducted in 2010 and 2011 with targeted development 
intermediaries and employers. The three development intermediaries included the 
Massachusetts Life Sciences Center, Massachusetts Biotechnology Council, and 
MassBio’s Education Foundation. The primary purpose of the interviews was to learn 
about the organization’s mandates and particular policy initiatives relevant to the case 
study, as well as interviewee perspectives on labor market conditions for the state’s life 
sciences industries. Interviewees were also asked to discuss how they saw their 
organization as supporting a well-functioning market or helping to solve a market or 
systems problem, especially with respect to entry-level and mid-skilled jobs. Interviewees 
were either heads of organization or program directors. The author interviewed one or 
two people from each organization and interviews lasted about one hour. These were very 
thoughtful and informative face-to-face interviews coming from organizations that hold a 
unique position within the state. Interviewees agreed to non-confidential interviews in the 
sharing of their expertise. 
Employers were selected for recruitment for interviews based on several criteria. 
These criteria included being a commercial life sciences company registered as a member 
of MassBio and known to be engaged in at least one of the policy initiatives addressed in 
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the case study. The author devised a recruitment list of twelve companies in 
Massachusetts that represented large companies, contract research organizations, and 
contract manufactures that were located across the state. Recruitment resulted in four 
confidential employer interviews that lasted 30 to 45 minutes. Semi-structured interviews 
were conducted face-to-face or over the phone with the human resource executive, 
operations executive or CEO. Gaining access to employers was challenging. Those that 
made themselves available were companies that were involved in a number of workforce 
education, training and coordination initiatives. The employer interviews are confidential. 
Interview protocols are attached in APPENDIX C. Detailed notes were taken 
during the interviews and interview notes were cleaned and finalized immediately 
following the interview. Interviews have been reviewed multiple times and were coded 
by hand. The coding criteria are further detailed in the case study section on “Stakeholder 
Perspectives.” 
Other important qualitative sources that were used in the research to augment the 
interviews included attending a number of industry events and drawing on a summary 
report written by the author for the Massachusetts Workforce Board Association 
(MWBA). Industry events attended by this author include The Massachusetts STEM Plan 
in Sturbridge, MA, 2010; The State and Future of Biotechnology in Massachusetts at 
UMass Boston, 2009; Massachusetts Alliance for Economic Development Annual 
Conference, 2011; Life Science Engines in Cambridge, MA, 2007; Futures in Life 
Sciences program in Cambridge, MA, 2011; and Women Entrepreneurs in Science & 
Technology (WEST) in Cambridge, MA 2010. The summary report for MWBA titled 
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“Report on the Central Massachusetts regional biomanufacturing phone interviews” was 
based on findings from interviews conducted in 2009 by the author and includes 
perspectives from three additional employers and two educational providers.  
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CHAPTER 5 
CASE STUDY FINDINGS 
 
 
The case study findings are organized in the same manner as the research 
questions that are outlined in the METHODOLOGY chapter. Quantitative analysis is 
used to examine outcomes related to economic development priorities, including 
sustaining competitive advantage in the life sciences industries and particularly in 
downstream operations; the extent to which the innovation economy contributes to 
income inequality in Massachusetts; sub-state regional development and investments; 
changes and comparisons related to workforce diversity; and changes in the industry mix 
and occupational structure. As relevant, the quantitative analysis includes a review of 
recent industry research conducted in the Massachusetts life sciences or 
biopharmaceutical cluster. The final section draws on qualitative analysis of interviews 
conducted with stakeholders between 2009 and 2011 to provide a deeper understanding 
of industry outlook and economic development priorities, as well as employer 
perspectives. Overall, outcomes are derived using a variety of data sources to examine 
changes overtime. Particularly, the case study compares changes between two time 
periods – 2000 through 2005 and 2005 through 2010. The time period covered (2000-10) 
includes two business peaks and two periods of economic contraction. The periods of 
contraction begin in 2001 and the end of 2007. Unlike the life sciences, many industries 
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had not recovered to pre-2001 employment and productivity levels before the 2007 
recession started. The study also puts these changes into the context of the innovation 
economy and provides some comparisons with other high tech sectors. 
 
Sustaining competitive advantage in Massachusetts 
This section evaluates industry performance for the core life sciences from 2000 
through 2010. The data analysis uses the Quarterly Census of Employment and Wages 
(QCEW) and focuses on changes in employment levels, location quotients and relative 
earnings. These are popular indicators used in other research to measure industry 
performance in biotechnology and other life sciences. Taken together over time, they 
show sustained competitive advantage in the innovation economy based on employment 
growth, the increasing concentration of industry, and maintaining high wages. Comparing 
these results to other high tech sectors
5
 provides context for how the life sciences 
industries are doing relative to the rest of the innovation economy. 
 
Employment growth 
Employment growth provides an indication of whether the life sciences industries 
are expanding and how that expansion compares to other sectors in the economy, 
particularly other high tech sectors. According to data provided by the Quarterly Census 
of Employment and Wages (QCEW), employment in the core life sciences industries 
grew from about 59,000 in 2001 to 74,000 employees in 2010 (see Figure 4). Life 
                                                 
5
 The high tech sectors are defined in APPENDIX B and include industries like computer, communications, 
and electronics manufacturing as well as software development and other engineering. 
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sciences supporting industries have also continued to expand. In 2001, these industries 
employed 368,000 workers in Massachusetts and this workforce grew to almost 443,000 
(by an average of 2.1 percent per year). With the exception of a slight dip in employment 
for the core life sciences in 2003, the core and supporting industries in life sciences did 
not contract in any other year between 2001 and 2010. This stands in contrast to other 
high tech industries that contracted in Massachusetts following the recession that started 
in 2001. High tech industries have not regained pre-recession employment levels from 
the beginning of the decade and they went through another contraction after 2007. On 
average, employment in high tech industries declined by 3 percent each year from 2001 
to 2010. 
Figure 4: Employment growth in the life sciences and other high tech industries 
 
Source: Quarterly Census of Employment and Wages, 2001-10, author’s calculations 
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Table 3 provides a detailed picture of growth rates in the three sectors. Life 
sciences employment experienced an average annual growth rate of 2.5 percent during a 
time that the private sector as a whole contracted 3.1 percent. Growth in life sciences 
employment was greater during the second half of the decade compared to earlier years. 
For example, growth in the core life sciences industries was much greater from 2005 to 
2010 than in the earlier period (3.6 percent versus 1.1 percent).  
 
Table 3: Decomposition of average annual growth for selected time periods by industry 
Massachusetts -- 
Statewide 
Life Sciences Core 
Industries 
Life Sciences 
Support Industries 
Other High Tech 
Industries 
Average annual 
growth in 
employment (2001-
10) 2.5% 2.1% -3.1% 
Average annual 
growth in 
employment (2001-
05) 1.1% 1.9% -6.6% 
Average annual 
growth in 
employment (2005-
10) 3.6% 2.2% -0.3% 
Source: Quarterly Census of Employment and Wages, 2001-10, author’s calculations 
 
Location quotient 
Location quotients (LQs) are used to measure the regional concentration of an 
industry. LQs for the case study are calculated as the ratio of the proportion of life 
sciences employment relative to total private sector employment in Massachusetts to that 
of the U.S. Observing LQs over time is particularly interesting because it shows the 
extent to which Massachusetts life sciences employment is growing relative to the nation. 
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Location quotients for each of the three industry clusters are greater than one (see Figure 
5). LQs greater than one indicates a greater concentration of industry employment in the 
state when compared to the nation. This means that these industries provide export base 
jobs that benefit the regional economy because they likely attract buyers from outside the 
region. For core life sciences industries the LQ has grown from 1.91 in 2001 to 2.26. 
Between 2005 and 2010, the LQ for core life sciences grew at rate more than twice what 
it had earlier in the decade. In contrast, high tech industries have seen the LQ go down 
over time from 1.78 in 2001 to 1.53 in 2010. This decrease in the LQ accompanied by the 
decrease in employment for high tech sectors suggests that competitive advantage is 
declining in this part of the innovation economy. Lastly, life sciences supporting 
industries have seen a stable LQ averaging about 1.2 during the decade. 
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Figure 5: Location quotient over time for core life sciences, supporting life sciences, and 
other high tech industries 
 
Source: Quarterly Census of Employment and Wages, 2001-10, author’s calculations 
 
Relative earnings 
Relative earnings are important because they compare earnings for workers in a 
particular industry with workers across the rest of the economy. Relative earnings in this 
section are defined as average annual wages for a sector divided by annual average wages 
for the private sector as a whole. First, Table 4 provides average annual earnings for each 
of the industry clusters and for the private sector as a whole. In 2010, average annual 
wages in the life sciences core industries was $106,262. Between 2004 and 2009 these 
wages grew on par with other high tech industries. Of interest, average annual wages in 
the life sciences supporting industries grew to surpass the economy-wide average during 
the 2000s. In 2001, the supporting industries average earnings were $7,000 below the 
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annual average for the private sector, but by 2010 average life sciences supporting 
industries wages exceeded wages in the private sector ($58,401 versus $58,359 
respectively). 
 
Table 4: Average annual earnings for Massachusetts by industry cluster (2010 $) 
Year 
Life Sciences 
Core Industries 
Life Sciences 
Support 
Industries 
Other High 
Tech Industries Total Private 
2001 90,822 49,120 97,622 56,492 
2002 90,334 50,075 94,907 54,746 
2003 91,351 52,577 96,127 54,231 
2004 96,795 53,245 99,512 55,795 
2005 101,002 53,010 97,642 55,330 
2006 97,939 53,934 101,883 56,235 
2007 106,244 55,420 106,148 58,261 
2008 105,033 56,243 103,018 57,788 
2009 104,331 57,928 104,368 57,548 
2010 106,262 58,401 113,451 58,359 
Source: Quarterly Census of Employment and Wages, 2001-10, author’s calculations 
 
Figure 6 charts relative earnings since 2001 for the three industry clusters, each of 
which experienced rising relative earnings between 2001 and 2010. Relative earnings in 
the core life sciences industries rose from 1.6 in 2001 to 1.8 in 2010. Similarly, relative 
earnings in other high tech industries rose from 1.7 to 1.9, and life sciences supporting 
industries rose from 0.9 to 1.0. 
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Figure 6: Relative earnings by industry cluster in Massachusetts (2001-10) 
 
Source: Quarterly Census of Employment and Wages, 2001-10, author’s calculations 
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processes opens up a new set of industrial activities which create new jobs. 
Manufacturing and clinical research benefits from proximity to a region’s upstream 
activities, but can be located outside of the metropolitan core where land is less 
expensive. Additional benefits from commercialization for a region include new jobs that 
increase demand for mid-skilled or entry level workers. In this section, downstream 
activities are measured by changes in shipments and receipts for manufacturing and 
changes in the volume of clinical trials. 
 
Shipments 
Using the Economic Census, examining shipments in life sciences manufacturing 
provides insight into the growth in downstream activities for the cluster. Data on 
shipments is also available for comparison with other high tech manufacturing, namely 
computer and communications equipment, electronic components and instrument 
manufacturing. Other research in Massachusetts found that between 1997 and 2002, 
shipments for life sciences manufacturing had high growth rates compared to other states, 
but a lower location quotient within the state when compared to the U.S. average 
(Khatiwada & Sum, 2007). 
Shipments in life sciences manufacturing doubled between 1997 and 2007; 
increasing almost 33 percent in 2002 from 1997 and then increasing 48 percent from 
2002 to 2007. Total shipments coming from Massachusetts were close to $15 billion and 
represented 5 percent of the U.S. total for the industries (Table 5). The gain in shipments 
for life sciences manufacturing has not been enough to make up for the loss of shipments 
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in other high tech manufacturing. Shipments in these manufacturing industries declined 
by almost 11 percent between 1997 and 2002 and then declined an additional 22 percent 
in 2007. The total shipments for high tech were just over $18 billion in 2007, at this point 
not much greater than the life sciences cluster (Table 6). 
 
Table 5: Massachusetts core life sciences manufacturing industries (1997, 2002, and 
2007) 
 1997 2002 2007 
Shipments ($1,000) 
($2007) $7,582,184 $10,047,048 $14,905,058 
Change in Shipments (%)   --   32.5% 48.4% 
Shipments/Employee 
($1,000) $279 $323 $450 
% of US Total 4.3% 3.9% 5.0% 
 
Table 6: Massachusetts other high tech manufacturing industries (1997, 2002, and 2007) 
 1997 2002 2007 
Shipments ($1,000) 
($2007) $26,246,655 $23,428,536 $18,271,197 
Change in Shipments (%)   --   -10.7% -22.0% 
Shipments/Employee 
($1,000) $272 $349 $374 
% of US Total 5.1% 6.4% 5.2% 
Source: Economic Census, 1997, 2002, 2007, author’s calculations 
 
 
Clinical trials 
Clinical trials are usually led by a medical doctor and conducted with human 
participants during the final phases of drug development under the U.S. Food and Drug 
Administration. Clinical trials can be sponsored and funded by pharmaceutical 
companies, medical centers or the government. This section uses clinical trial data from 
ClinicalTrials.gov for the U.S. and for Massachusetts to look at the extent to which 
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Massachusetts is a recruitment location for clinical trials, as well as the extent to which 
industry is sponsoring trials in the state.
6
  
For 2000 through 2010, the proportion of industry-sponsored clinical trials to all 
clinical trials for the U.S. and Massachusetts is shown in Figure 7. This demonstrates the 
relative importance of industry in generating clinical trials over time. The graph shows 
that compared to the U.S., a larger proportion of Massachusetts clinical trials were 
sponsored by industry as opposed to government institutions or universities. On average, 
58 percent of clinical trials located in Massachusetts during the decade were sponsored 
by industry (as compared to 43 percent for all U.S.). 
 
Figure 7: Proportion of clinical trials with industry sponsor, MA and U.S. (2000-10) 
 
Source: ClinicalTrials.gov, author’s calculations 
                                                 
6
 A clinical trial was assigned to Massachusetts if there was a recruitment location in the state, which does 
not necessarily mean that the clinical trial was initiated in Massachusetts. 
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In Massachusetts, industry-sponsored clinical trials versus clinical trials without 
an industry sponsor are shown in Figure 8. These are graphed as the percentage of all 
U.S. clinical trials with an industry sponsor that have a location in Massachusetts (blue 
line with diamond markers) and the percentage of non-industry sponsored U.S. clinical 
trials that have a location in Massachusetts (red line with square markers). This figure 
shows the declining share of clinical trial activity in Massachusetts relative to the U.S. by 
sponsor type during the 2000s. The relative number of clinical trials in Massachusetts, 
both industry and non-industry sponsored, trend down between 2000 and 2010. For 
example, the average percentage of total U.S. industry sponsored clinical trials in 
Massachusetts between 2000-05 was almost 29 percent. This averaged declined to just 
under 21 percent for the 2005-10 period (see Table 7).
 7
 
 
                                                 
7
 See M. Porter on clinical trial activity declining because of reluctance or disinterest on the part of the 
hospital system (Massachusetts Technology Collaborative, 2006). 
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Figure 8: Industry and non-industry sponsored clinical trials in Massachusetts (2000-10) 
as % of total U.S. 
 
 
Table 7: Multi-year averages of the proportion of clinical trials for selected ratios  
 2000-10 2000-05 2005-10 
Total MASS/U.S. 17.3% 19.8% 15.2% 
% Industry for U.S. 42.7% 31.7% 53.0% 
% Industry for MASS 58.1% 45.6% 69.8% 
Industry MASS/U.S. 24.5% 28.8% 20.7% 
Non-Industry 
MASS/U.S. 12.6% 15.1% 10.3% 
Source: ClinicalTrials.gov, author’s calculations 
 
The distribution of economic gains 
This section examines the distribution of growth in the life sciences as it relates to 
equity. First it looks at earnings inequality broadly across the state and the extent to 
which the innovation economy contributes to that inequality. Second, it considers the 
economic development policies and initiatives put into place during the 2000s which 
were intended to support industry performance, but to also to encourage participation in 
the industry. In part, this has meant improving access to the industry (or improving 
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equality of opportunity). In turn, this includes helping municipalities and sub-state 
regions address infrastructure and regulatory issues that support development, 
particularly in regions that need job growth; developing training programs for blue collar 
workers to address expected job growth in this area, and building diversity by 
encouraging women and minorities to pursue STEM careers. Additionally, economic 
development efforts, especially those that address participation in the life sciences have 
been more pronounced than in other sectors of the innovation economy. Therefore, when 
distributional outcomes of the life sciences and other high tech sectors are compared, we 
would expect to see increased equity measures for the life sciences. 
The analysis that follows relies primarily on Public Use Microdata files from the 
U.S. Census and the American Community Survey to study the distributional change in 
core life sciences employment during the decade. This includes assessing change in 
employment by sub-state region, educational attainment, and personal characteristics. 
Multivariate analysis is used in this section to compare these changes in life sciences 
employment with other high tech industries (the remaining base of the innovation 
economy). This comparison uses a multinomial logit model to examine which factors are 
related to being employed in each sector of the innovation economy and the private sector 
more broadly. These factors include education, age, gender, race, and location within the 
state.  
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Earnings inequality and the innovation economy 
As Massachusetts seeks to maintain its competitive advantage in the core life 
sciences industries, and given the growth in employment and relative earnings, the state 
might expect to incur an increase in earnings inequality. Sustained competitive advantage 
in the innovation sectors likely concentrates economic benefits to more prosperous metro 
regions and higher skilled workers. This section examines the possible impact of growth 
in the innovation economy on earnings inequality for the state broadly. 
In order to address this question, earnings quartiles are calculated using ACS and 
Census 2000 data for full-time, full year workers. Using 2010 dollars, quartiles are 
calculated for the innovation economy, total private sector employment, and private 
sector employment minus the innovation economy (core life sciences and other high tech 
industries). Table 8 provides the 25
th
 and 75
th
 percentile for each year – 2000, 2005, and 
2010. An earnings inequality ratio is also derived dividing the 75
th
 by the 25
th
 percentile. 
In the innovation economy only, the earnings inequality ratio has been between 
2.16 and 2.32. It is not clear that earnings inequality is growing in those industries. In 
contrast, regardless of whether we take the impact of the innovation economy into 
account or not, earnings for the 25
th
 percentile in the private sector decline over the 
decade from $32,924 in 2000 to $30,000 in 2010. Alternatively, earnings for the 75
th
 
percentile rise about 10 percent from $70,913 in 2000 to $77,000 in 2010. Therefore, 
with or without the innovation economy, earnings inequality grows during the decade. 
For example, the earnings inequality ratio for all private sector, full-time, full year 
workers in 2010 was 2.57, up from 2.15 in 2000. 
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Table 8: Earnings inequality (75
th
/25
th
 percentiles) by sector (2010 $) 
Year 2000 2005 2010 
Innovation Economy 
25
th
  $          46,853   $          45,777   $          48,500  
75
th
  $        101,304   $        106,069   $        105,000  
Inequality ratio 
(75
th
/25
th
) 2.16 2.32 2.16 
Total Private 
25
th
  $        32,924   $        31,263   $        30,000  
75
th
  $        70,913   $        72,574   $        77,000  
Inequality ratio 
(75
th
/25
th
) 2.15 2.32 2.57 
Total Private without Innovation Economy 
25
th
  $        32,291   $        30,146   $        30,000  
75
th
  $        67,114   $        66,991   $        70,000  
Inequality ratio 
(75
th
/25
th
) 2.08 2.22 2.33 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
The innovation economy appears to make little difference in earnings for the 
bottom quartile, but contributes to higher earnings for the top. For example, in 2010 
earnings for the 75
th
 percentile were 10 percent higher due to the inclusion of the 
innovation economy while earnings for the 25
th
 percentile were flat. The contribution of 
the innovation economy to higher earnings for the 75
th
 percentile has also increased over 
time. For example, in 2000 the innovation economy increased earnings for the 75
th
 
percentile by 6 percent and then, in 2005, by 8 percent. Overall, it appears that the 
innovation economy is not solely responsible for increased inequality; however, it is 
contributing to its magnitude over time. 
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Regional employment and investment 
This section focuses on changes in employment by region to understand whether 
or not there has been growth outside of the metropolitan core. Knowledge intensive 
industries, like the life sciences, have been known to concentrate in the metropolitan core 
and surrounding suburbs. Adjacent regions that may be less populated or less 
economically prosperous would likely benefit from industry expansion into their regions. 
These regions may also possess benefits for industry. For example, real estate costs in 
Massachusetts are lesser the farther out from the Boston-Cambridge core. Outside regions 
provide an important source of low cost real estate for large operations like 
manufacturing. Further, this section uses geographic visuals to illustrate how economic 
development investments correspond with employment growth across the state. These 
visuals provide an indication of how well policy tools are targeting growth, particularly 
outside of the Boston-Cambridge core. 
Table 9 provides estimated employment numbers for the core life sciences for 
2000, 2005, and 2010 by sub-state region. The margin of error was calculated for both the 
estimates and the distribution (not shown) to determine statistical significance of changes 
during the decade. The check marks in Table 9 indicate where statistically significant 
changes in employment and distribution occur at a 90% confidence interval for the given 
time period.. Employment in the core life sciences grew from 15,000 to 18,000 between 
2000 and 2005 in the Boston-Cambridge core; an increase of about 20 percent. The metro 
core is the only area in the state that experienced employment growth during this time. In 
the second half of the decade (2005 to 2010), employment increased again in Boston-
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Cambridge, growing beyond 22,000 employees. However, during the second half of the 
decade, employment also increased in the Worcester – I-495 area and on the South Shore. 
Core life sciences employment in the Worcester area increased from just over 17,000 in 
2005 to 23,500 in 2010 (a 37 percent increase). Employment on the South Shore 
increased from about 6,000 to 10,000 employees during the last half of the decade. This 
is a 61 percent increase in employment for the region. Employment estimates for the 
Northeast region for the three years being measured are not significantly different. Yet, 
with respect to distribution of employment across the state, the Northeast’s share declined 
from 23 percent in 2005 to 17 percent in 2010. Employment estimates are also depicted 
in Figure 9. The figure shows the estimated employment counts and distribution across 
the state. 
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Table 9: Changes in life sciences employment and distribution of employment for sub-
state regions (2000, 2005, and 2010) 
Estimated 
employment 2000 2005 2010 
Change  
from 2000-05 
(sig. 90%  
CI) 
Change 
from 2005-
10 (sig. 90% 
CI) 
Change 
from 2000-
10 (sig. 90% 
CI) 
Boston-Cambridge 
Core 
     
15,056  18,064 22,414 √ √ √ 
Suburbs/128  13,218  11,889 14,804    
Northeast  13,626  16,717 14,801    
South Shore, Cape 
and Islands 
        
6,614  6,393 10,277  √ √ 
Worcester/I-495  18,083  17,166 23,577  √ √ 
The West    2,182  1,117 2,230 √ √  
Total 68,779 71,346 88,103  √ √ 
Distribution of 
employment 2000 2005 2010 
Change  
from 2000-05 
(sig. 90% 
 CI) 
Change 
from 2005-
10 (sig. 90% 
CI) 
Change 
from 2000-
10 (sig. 90% 
CI) 
Boston-Cambridge 
Core 21.89% 25.32% 25.44%    
Suburbs/128 19.22% 16.66% 16.80%    
Northeast 19.81% 23.43% 16.80%  √  
South Shore, Cape 
and Islands 9.62% 8.96% 11.66%    
Worcester/I-495 26.29% 24.06% 26.76%    
The West 3.17% 1.57% 2.53% √   
Total 100% 100% 100%    
 
Figure 9: Core life sciences employment by sub-state region (2000, 2005, and 2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
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The maps that follow are based on county employment information; which is 
different from the regions used above. Figure 10 provides a map of Massachusetts and 
shows employment levels by county for 2010. Middlesex County, which encompasses 
Cambridge, has the highest employment level (dark blue). Essex County has the next 
highest level. The counties in Western Massachusetts, the South Shore and Cape and 
Islands have the lowest levels of life sciences employment. Worcester, Norfolk, and 
Suffolk Counties have 4,000 to 8,000 life sciences employees each and Bristol County 
has at least 2,000. 
A similar map is used to chart employment growth during the 2000-10 decade. 
Figure 11 shows that employment growth has been more variable then employment 
shares during the decade. This means that although some regions have experienced high 
rates of growth, this has not been enough to affect their employment share relative to 
regions like Middlesex and Essex Counties. The greatest growth rate (more than 20%) is 
in Hampden County in the western part of the state. Middlesex, Suffolk and Essex 
Counties grew as well between 11 and 20%. Worcester, parts of Western Massachusetts, 
the South Shore and the Cape and Islands experienced some growth; while employment 
in the life sciences declined in Berkshire, Norfolk and Bristol Counties. 
Figure 11 provides the base map for the subsequent three figures. This permits a 
closer examination of how different policies have targeted different regions that are either 
growing or declining. First, MassBio’s BioReady campaign rates municipalities by their 
locational advantage for supporting biotechnology activity across the state. BioReady 
community endorsements are based on a number of criteria mostly related to local 
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municipal policies that support the development of biotechnology industry operations. 
Figure 12 overlays the BioReady cities on the employment growth map. There are large 
clusters of BioReady cities in Middlesex and Essex Counties, but there is a significant 
spread of cities across the state including in Hampshire, Hampden and Bristol Counties. 
The map in Figure 13 exhibits the MLSC tax incentives disbursed between 2008 
and 2010. Firms become eligible for a number of tax credits through MLSC in exchange 
for meeting job creation commitments. The map shows that tax incentives have clustered 
substantially in Middlesex County while other regions that are growing have not been 
receiving large tax incentives. There were a few small tax credits awarded in Worcester 
and Western Massachusetts and a few medium-small credits in the southern counties. 
Since 2008, the MLSC has also invested in a number of infrastructure projects 
across the state, which, were stipulated by the Massachusetts Life Sciences Act in 2008. 
Designating these projects as priorities was part of the policy making process. Going 
forward, the MLSC will be using a competitive bidding process to decide on future 
infrastructure project investments. Importantly, over $100 million was invested in 
Worcester County infrastructure since 2008.
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Figure 10: Life sciences employment levels by county, 2010 
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Figure 11: Life sciences employment growth by county, 2000-2010 
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Figure 12: MassBio’s BioReady Cities 
 
111 
 
Figure 13: Massachusetts Life Sciences Center tax incentives 
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Figure 14: Massachusetts Life Sciences Center infrastructure projects 
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Workforce diversity 
This section measures workforce diversity by looking at several characteristics 
available in the Census and ACS data. Educational attainment of life sciences workers is 
examined as a proxy for skill level. The analysis seeks to understand the extent to which 
mid-skilled workers are employed in the life sciences industries and whether those 
employment levels have changed during the study period. This is important given the 
increased involvement of community colleges in providing technical training for the 
industry as well as understanding the extent to which workers at different skill levels 
obtain employment in the industry. Second, employment changes are examined with 
respect to personal characteristics (e.g., race, sex, and nativity) to provide an indication of 
diversity in the industry. This is an opportunity to show, regardless of equality of 
opportunity in the industry, how equitable the distribution is within the industry and 
whether or not it is shifting.  
 
Distribution of educational attainment in core life sciences industries 
In 2000, workers with at least a bachelor’s degree held 56 percent of jobs in core 
life sciences industries in Massachusetts. By 2010, this proportion had increased to 67 
percent. This increase over the 10-year period was primarily due to increased numbers of 
workers with graduate degrees. Indeed, increased employment in the core life sciences 
industry has resulted in economic benefits (e.g., job growth) accruing to high-skilled 
workers. 
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Figure 15 provides the distribution of employment by educational attainment. The 
horizontal axis tracks the percentage of workers in each group and the numbers 
embedded in the chart provide employment estimates for each of the three years. For 
mid-skilled workers and workers with only a high school diploma, employment has not 
expanded during the 2000s. In fact, employment for mid-skilled workers contracted 
between 2000 and 2005, from about 16,300 workers to 13,400. The estimated 
employment for mid-skilled workers in 2010 had trended back up to 15,000 workers – 
however, this change is not statistically significant. Overall, the share of the pie for mid-
skilled workers dropped from 23 percent in 2000 to 16 percent in 2010 (see Figure 15). 
 
Figure 15: Distribution of employment by educational attainment for core life sciences 
industries (2000, 2005, and 2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
 
Changes in workforce characteristics in the life sciences are also shown in Table 
10 and Table 11. These tables provide estimated employment and the distribution of 
employment in the life sciences by different characteristics. Check marks are used to 
designate change between the available time periods which is statistically significant at a 
90 percent confidence interval.  
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Table 10: Changes in estimated employment for core life sciences industries by worker 
characteristic (2000, 2005, and 2010) 
Estimated 
employment 2000 2005 2010 
Change  
from 2000-05 
(sig. 90%  
CI) 
Change 
from 2005-
10 (sig. 90% 
CI) 
Change 
from 2000-
10 (sig. 90% 
CI) 
Educational Attainment 
Low Skill 3,839 1,875 2,679 √  √ 
HS Diploma 11,018 13,349 12,794    
Mid Skill 16,373 13,474 15,098 √   
Bachelor 20,525 23,055 27,887  √ √ 
Graduate 19,904 25,177 35,011 √ √ √ 
Age 
16-17          97  86 84    
18-24    5,539  3,007 6,097 √ √  
25-34  17,753  17,843 24,008  √ √ 
35-54  39,210  43,520 47,270 √  √ 
55-64    7,765  10,781 13,436 √  √ 
65+    1,295  1,693 2,574   √ 
Race/Ethnicity 
White, NH  60,139  60,477 72,413  √ √ 
Black, NH    1,981  2,913 4,003   √ 
Asian, NH    5,885  9,254 11,782 √  √ 
Hispanic    2,509  3,545 3,957   √ 
Other    1,129  741 1,314    
All Minority  11,520  16,435 21,056 √ √ √ 
Sex 
Women  29,075  32,357 37,386  √ √ 
Men  42,584  44,573 56,083  √ √ 
Other Characteristics 
Foreign Born 14,083   18,304    23,107   √ √ 
Veteran 8,144     5,853      6,138    √ 
Total  71,659  76,930 93,469  √ √ 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
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Table 11: Changes in the distribution of employment for core life sciences industries by 
worker characteristic (2000, 2005, and 2010) 
Estimated 
employment 2000 2005 2010 
Change  
from 2000-05 
(sig. 90%  
CI) 
Change 
from 2005-
10 (sig. 90% 
CI) 
Change 
from 2000-
10 (sig. 90% 
CI) 
Educational Attainment 
Low Skill 5.4% 2.4% 2.9% √  √ 
HS Diploma 15.4% 17.4% 13.7%    
Mid Skill 22.8% 17.5% 16.2% √  √ 
Bachelor 28.6% 30.0% 29.8%    
Graduate 27.8% 32.7% 37.5% √  √ 
Age 
16-17 0.1% 0.1% 0.1%    
18-24 7.7% 3.9% 6.5% √   
25-34 24.8% 23.2% 25.7%    
35-54 54.7% 56.6% 50.6%  √ √ 
55-64 10.8% 14.0% 14.4% √  √ 
65+ 1.8% 2.2% 2.8%    
Race/Ethnicity 
White, NH 83.9% 78.6% 77.5% √  √ 
Black, NH 2.8% 3.8% 4.3%    
Asian, NH 8.2% 12.0% 12.6% √  √ 
Hispanic 3.5% 4.6% 4.2%    
Other 1.6% 1.0% 1.4%    
All Minority 16.1% 21.4% 22.5% √  √ 
Sex 
Women 40.6% 42.1% 40.0%    
Men 59.4% 57.9% 60.0%    
Other Characteristics 
Foreign Born 19.7% 23.8% 24.7%   √ 
Veteran 11.4% 7.6% 6.6% √  √ 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
Table 10 and Table 11 can be put into context with broader changes in private 
sector employment during the 2000s. Table 12 provides employment estimates for 2000 
and 2010 for the private sector in Massachusetts by worker characteristic and region. 
Change in the distribution is shown in the right hand column. Between 2000 and 2010, 
private sector employment grew 3 percent. The life sciences workforce is high skilled 
because of the large proportion of workers that possess a graduate degree. In the private 
sector, the proportion of the workforce that was highly educated (holding at least a 
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bachelor’s degree) grew. The part of the workforce holding a bachelor’s degree increased 
17 percent. Workers with graduate degrees increased 28 percent. Workers with a 
bachelor’s degree or higher constituted 34 percent of employment in 2000; rising to 41 
percent in 2010 (not shown in the table). There was no change in the size of the private 
sector workforce that was either mid-skilled or had a high school diploma. The number of 
low-skilled workers, workers with a high school diploma and mid-skilled workers 
employed in the private sector declined. These changes in employment by educational 
attainment in the private sector are similar to the trends in the life sciences.  
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Table 12: Estimated private sector employment, 2000 and 2010 by worker characteristic 
and region 
Characteristic 
Estimated Employment ± MOE Percent 
change 
with 
90% 
CI 
2000 2010 
Skill level 
Low Skill 291,610 ± 3,279 201,547 ± 9,828 -31% 
HS Diploma 603,977 ± 4,594 595,003 ± 15,988 0% 
Mid Skill 698,384 ± 4,899 684,923 ± 15,826 0% 
Bachelor 544,019 ± 4,383 633,867 ± 13,183 17% 
Graduate 303,629 ± 3,342 388,085 ± 10,936 28% 
Sex 
Women 1,189,730 ± 5,639 1,244,199 ± 16,484 5% 
Men 1,251,889 ± 5,749 1,259,226 ± 12,988 0% 
Race/Ethnicity 
White, NH 2,059,099 ± 6,760 1,940,585 ± 16,028 -6% 
Black, NH 100,081 ± 1,801 143,968 ± 6,736 44% 
Asian, NH 94,476 ± 1,751 151,926 ± 5,007 61% 
Hispanic 127,086 ± 2,025 211,054 ± 7,211 66% 
Other 57,527 ± 1,370 55,892 ± 5,025 0% 
Other Characteristic 
Foreign Born 351,555 ± 4,959 482,494 ± 14,062 37% 
Veteran 281,807 ± 4,466 141,909 ± 6,084 -50% 
Sub-state Region 
Boston-Cambridge Core 560,687 ± 5,127 610,195 ± 13,771 9% 
Suburbs/128 358,289 ± 4,170 356,485 ± 11,418 0% 
Northeast 353,001 ± 4,141 340,943 ± 9,819 0% 
South Shore, Cape and 
Islands 355,808 ± 4,156 355,151 ± 9,383 0% 
Worcester/I-495 418,801 ± 4,485 438,328 ± 11,457 5% 
The West 258,371 ± 3,571 246,442 ± 7,856 -5% 
TOTAL 2,441,619 ± 7,608 2,503,425 ± 19,953 3% 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
 
Other worker characteristics 
In addition to educational attainment, Table 10 and Table 11 provide detail on 
employment estimates and the distribution of employment by worker characteristics. 
These calculations show the number and percentage of jobs by different characteristics. 
119 
 
The three columns on the right hand side have check marks to indicate which changes 
were statistically significant at a 90 percent confidence interval. 
During the 2000s, employment for both men and women has expanded 
proportionate to total industry employment. However, women are underrepresented 
relative to the rest of the private sector (see Table 12) in the core life science industries. 
From 2000 to 2010, women represented about 40 percent of total employment in the life 
sciences (see Figure 16; Table 10 and Table 11). 
 
Figure 16: Distribution of employment by sex for core life sciences industries (2000, 
2005, and 2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
Estimated employment for white, non-Hispanic workers in the life sciences held 
steady between 2000 and 2005 and then expanded between 2005 and 2010. Their share of 
the workforce dropped during the decade as minority employment grew. In 2000, 84 
percent of employment in the core life sciences industries was attributed to white, non-
Hispanic workers. By 2010, this proportion had dropped to about 78 percent. Changes in 
minority employment are largely attributed to an increase in employment for Asian 
workers within the sector, particularly between 2000 and 2005. Black or African 
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American and Hispanic workers have seen increased employment in the core life sciences 
over the course of the decade. Black or African American employment increased from 
about 2,000 workers in 2000 to just over 4,000 in 2010. Hispanics saw a similar increase. 
However, neither black or African American or Hispanic workers increased their portion 
of the pie – as was seen for Asian workers (see Figure 17; Table 10 and Table 11). 
 
Figure 17: Distribution of employment by race and ethnicity for core life sciences 
industries (2000, 2005, and 2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
 Changes in minority employment in the private sector are more dramatic than 
those is witnessed in the life sciences. In fact, private sector employment would not have 
grown if not for minority employment. Black or African American employment in the 
private sector increased by 44 percent. Asian employment increased by 61 percent and 
Hispanic employment grew 66 percent (see Table 12). 
Two other characteristics that were examined over time using the ACS and 
Census data were workers who are foreign born and workers who are veterans. 
Immigrant workers in Massachusetts tend to cluster in high skill jobs and in lower skilled 
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jobs. Other research
8
 has shown that workers who are foreign born make up a sizeable 
portion of the core life sciences workforce. Figure 18 shows change in employment for 
workers who are foreign born. Employment for foreign-born workers significantly 
increased between 2005 and 2010 (from 18,000 to 23,000). The proportion of foreign-
born workers increased significantly between 2000 and 2010, from 20 percent to 25 
percent of the workforce. This increase coincides with an increase in the private sector as 
a whole (Table 12). 
Especially with respect to manufacturing work environments, it is expected that 
veterans are attractive candidates because they likely possess technical training through 
their military background. However, employment of veterans declined during the decade.  
In 2000, they constituted 11 percent of the life sciences workforce and in 2010 this had 
dropped to less than 7 percent (see also Table 10 and Table 11). This decrease is also 
mirrored in the private sector (Table 12). 
 
                                                 
8
 See for example: Monti, D. J., Smith-Doerr, L., & McQuaid, J. (2007). Immigrant entrepreneurs in the 
Massachusetts biotechnology industry. Boston, MA: Immigrant Learning Center, Inc. 
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Figure 18: Core life sciences employment attributed to foreign born and veteran workers 
(2000, 2005, and 2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
Changes in industry mix and occupational structure 
 As mentioned in an earlier section, economic development efforts have focused 
on increasing downstream operations in the state. This has meant not only working to 
make the state attractive for manufacturing activity, but also increasing the training 
programs for mid-skilled workers to meet this new demand. The question remains, 
however, to what extent have downstream operations grown? One way to examine this is 
to look at whether or not the industry mix has changed over time and what regions have 
benefited or not benefited from increased manufacturing activity. It is also possible to 
look at how occupations have grown and whether or not the state has seen an increase in 
the number of occupations suitable for mid-skilled workers. 
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Industry mix 
In order to explain employment changes by sub-state region, the Quarterly Census 
of Employment and Wages (QCEW) is used to look at which of the core industries are 
found by Metropolitan Statistical Area (MSA) across the state. Figure 19 and Table 13 
shows the contribution of each core industry to the MSAs total life sciences employment 
as of 2010. The industry mix in the Boston-Cambridge core has increasingly concentrated 
in R&D. In 2001, R&D comprised 63 percent of the cluster’s employment. In 2010, 73 
percent of life sciences employment in the Boston-Cambridge core was in R&D. The 
remainder of employment is spread across manufacturing in medical equipment, electro 
medical and irradiation apparatus manufacturing.  
The Worcester MSA, South Coast region and Essex County have greater 
concentrations of manufacturing than the metro core. For example, manufacturing 
constitutes about 58 percent of the clusters employment in the Worcester area. Also, 
during the decade, Worcester added manufacturing activity in electro-medical apparatus. 
In 2010, neither Springfield nor Pittsfield had any manufacturing activity in the life 
sciences. In the past, Pittsfield has had some medical equipment manufacturing, but at a 
low and variable level. 
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Figure 19: Employment by detailed life sciences industry by sub-state regions, 2010 
 
 
 
Table 13: Distribution of core life sciences employment by detailed industry for sub-state 
regions, 2010 
 
Pharmaceutical 
and medicine 
manufacturing 
Electromedical 
apparatus 
manufacturing 
Irradiation 
apparatus 
manufacturing 
Medical 
equipment and 
supplies 
manufacturing 
Scientific 
research and 
development 
services Total 
U.S. Total 22% 5% 1% 24% 49% 100% 
Massachusetts-
Statewide 13% 7% 1% 15% 64% 100% 
Barnstable - 
MSA/Bristol, 
Plymouth 
Counties 0% 0% 0% 51% 49% 100% 
Middlesex, 
Suffolk, and 
Norfolk 
Counties 14% 3% 1% 9% 73% 100% 
Pittsfield and 
Springfield - 
MSAs 0% 0% 0% 0% 100% 100% 
Worcester - 
MSA 27% 5% 0% 25% 43% 100% 
Essex County 8% 37% 0% 17% 38% 100% 
Source: Quarterly Census of Employment and Wages, 2001-10, author’s calculations 
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Occupational structure 
There are six occupations within the core life sciences industries that comprise 
about 95 percent of its total employment. These are depicted in Figure 20 and include 
management, finance and business operations; science, technology, engineering and 
mathematics (STEM) professionals; STEM technicians; sales; office and administrative 
support; and facilities, production, and material moving. The remaining occupations 
found in the core life sciences include building services, medical professionals, health 
care support staff and legal professionals and support staff. Industry analysis (Grillo, 
2007a, 2007b) shows that increased downstream activity in the state’s industry would 
result in an increase in jobs related to clinical research, regulatory affairs, operations, and 
sales and marketing. Further, this growth has the potential to increase demand for entry-
level and mid-skilled workers in the industry. 
Entry-level or mid-skill jobs require some previous industry experience (usually 
gained through an internship) and include STEM technicians like clinical data 
management, laboratory assistants, and animal technicians. These jobs also include 
production and facilities positions like manufacturing technicians and associates, 
environmental technicians, and material handlers. According to Figure 20, occupational 
growth in the past decade has concentrated in management, finance and business, and 
STEM professionals. Further, growth in management and STEM professionals has 
intensified during the second half of the decade when compared to earlier years. No 
growth, from a statistically significant perspective, is observed for STEM technicians or 
facilities and production personnel, or for sales and office staff. 
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Figure 20: Employment in the core life sciences industries by occupation (2000, 2005, 
and 2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
Comparison of core life sciences and high tech industry employment with respect to 
equitable outcomes – multivariate analysis 
The core life sciences industries are known to provide jobs to a large portion of 
highly skilled workers. This means there are fewer opportunities for blue collar or mid-
skilled workers available within the industry as compared to the private sector more 
broadly. The high skilled nature of the industry also means by extension that there will 
likely be gender, race and ethnic differentials when compared to the private sector as 
whole because some groups in society are underrepresented or overrepresented at higher 
levels of educational attainment. Furthermore, knowledge-intensive industries that cluster 
around a metropolitan core often do not extend beyond the suburbs to less populated or 
less prosperous regions within the state. With this in mind, high tech industry 
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employment is used as a comparison with life sciences to account for these significant 
differences within the innovation economy (not just with the private sector in general). 
Similar to life sciences, the high tech cluster in Massachusetts contains a mix of 
manufacturing and high-skilled services and is considered an important component of the 
state’s economy. 
This section seeks to answer the question: To what extent, if at all, has the 
Massachusetts’ core life sciences industry contributed to more equitable outcomes with 
respect to sub-state regional growth and workforce diversity when compared to the rest of 
the innovation economy? 
 
The multinomial logit model 
Outcomes for the two industry clusters are compared using a multinomial logit 
model. The model is designed to examine what factors help predict employment in the 
core life sciences and high tech industries relative to each other and to the rest of the 
private sector. A multinomial logit design is used to address the unordered, qualitative 
dependent variable representing three possible outcomes: employment in the life sciences 
core industry cluster, employment in the high tech industry cluster, or employment in 
other industries in the private sector. The dependent variable meets the assumption of 
independence from irrelevant alternatives in that employment in each of the specified 
sectors of the economy is discrete. Based on Liao (1994), the logit form of the equation 
is: 
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                                                           K 
log [Prob(y=j) / Prob(y=J)] = Σ βjkxk 
                                                                                        k=1 
 
 
The dependent variable (y) is a dummy variable with the three possible outcomes 
(j). The unit of observation is the individual. The three possible outcomes are being 
employed in the life sciences, being employed in other high tech industries in the 
innovation economy, and being employed in another industry in the private sector. In a 
logit model, the dependent variable is calculated as a logged ratio of two probabilities. 
For example, the probability that y equals the outcome of being employed in the life 
sciences is divided by the probability that y equals being employed in other industries in 
the private sector. The ratio for the dependent variable is logged to ensure that outcomes 
fall within the range of 0 and 1. The explanatory variables (x) include those already 
described in an earlier section: educational attainment, age, sub-state region, and personal 
characteristics (gender, race/ethnicity, foreign born and veteran) (see Table 10 and Table 
11). In the equation, K equals the number of observations and β equals the vector of 
coefficients. 
All explanatory variables are qualitative in nature and are treated as dummies in 
the logit model.  Corresponding reference variables for the model are workers with 
graduate degrees, prime age workers 35-54 years old, the Boston-Cambridge Core, male, 
white non-Hispanic, native born and non-veteran. There is no explanatory variable for 
industry size. Industry size is accounted for in the logit function as the denominator in the 
ratio of two probabilities. 
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The data source used is the 2000 Census and the 2005 and 2010 one-year estimates of the 
American Community Survey. These data were analyzed using Stata. Multinomial logit 
models were run for each of the three years using weights and provide a comparison of 
the factors that help predict employment outcomes by industry cluster. The number of 
observations for each year is listed in  
Table 14. In particular, it provides a comparison between employment in life sciences 
and high tech industries. 
 
Table 14: Observations available for analysis in the Census 2000 and American 
Community Survey data sets 
 Census 2000 ACS 2005 ACS 2010 
# of individuals 
employed in the 
private sector 
104,005 19,744 20,245 
# of individuals 
employed in the life 
sciences industries 
3,492 799 969 
# of individuals 
employed in other 
high tech industries 
6,930 1,615 1,550 
 
Interpretation of results 
The tables that follow provide a summary of the output based on three different 
comparisons: 1) being employed in the life sciences industry versus being employed in 
other industries in the private sector (Table 15), 2) being employed in other high tech 
industries versus being employed in other industries in the private sector (Table 16), and 
3) being employed in the life sciences industries versus being employed in other high 
tech industries (Table 17). The tables provide the list of explanatory variables with the 
exception of the reference variables. The table contains output for the three years being 
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studied which are 2000, 2005, and 2010. The coefficients for each year are in the first 
three columns. These coefficients are logged and difficult to interpret, at least beyond 
showing the sign and significance of the variable. Therefore, the relative risk ratios (or 
odds ratios) are calculated for explanatory variables that are significant. The relative risk 
ratio (RRR) is calculated by exponentiating the coefficient. RRRs are reported in the last 
three columns of the table for each year being studied. The RRRs can be interpreted as 
the odds of an event relative to the reference or comparison group which is easier to 
understand than the coefficients in the output. 
For example, Table 15 shows that in 2010 the odds for mid-skilled workers to be 
employed in the core life sciences industries when compared to the rest of the private 
sector are only 0.23 times as high as the same odds for workers holding a graduate 
degree. Further, the relative risk ratio for mid-skilled workers has fallen from 0.48 in 
2000. In other words the odds for a mid-skilled worker to be employed in the life 
sciences have declined by more than half. Alternatively, in 2010, the odds for someone 
working in the Worcester I-495 region to be employed in the core life science industries 
was more than two and a quarter times as high as the same odds for someone working in 
the Boston-Cambridge core. This indicates a strong concentration of life sciences 
employment in Central Massachusetts relative to other employment in the private sector, 
for that region especially when compared to the Boston-Cambridge core.  
Additionally, Table 16 provides a summary of output for a comparison of other 
high tech industries and the private sector. We see some similar results. The odds for 
being employed as a mid-skilled worker have declined over time in other high tech 
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industries. The odds for being employed in other high tech in the Worcester region in 
2010 are three times higher than that for the Boston-Cambridge core. 
 
Table 15: Factors influencing employment in the core life sciences industries versus the 
rest of the private sector (2000, 2005 and 2010) 
Variables 
Coefficients RRR 
2000 2005 2010 2000 2005 2010 
Low skill -1.25 *** -2.35 *** -1.79 *** 0.29 0.10 0.17 
HS diploma -1.06 *** -1.29 *** -1.60 *** 0.35 0.27 0.20 
Mid skill -0.74 *** -1.26 *** -1.49 *** 0.48 0.28 0.23 
Bachelor -0.34 *** -0.50 *** -0.74 *** 0.71 0.60 0.48 
Suburbs 128 0.43 *** 0.23  0.37 *** 1.54  1.45 
Northeast 0.50 *** 0.82 *** 0.57 *** 1.65 2.28 1.76 
South coast -0.17 ** -0.17  0.24  0.84   
Worcester 495 0.65 *** 0.57 *** 0.81 *** 1.92 1.78 2.26 
The West -0.98 *** -1.61 *** -1.02 *** 0.38 0.20 0.36 
Age 16 to 17 -2.13 *** -1.14  -1.68  0.12   
Age 18 to 24 -0.28 *** -0.96 *** -0.46 ** 0.75 0.38 0.63 
Age 25 to 34 -0.07  -0.26 ** -0.04   0.77  
Age 55 to 64 -0.07  -0.03  -0.21 *   0.81 
Age 65 plus -0.56 *** -0.68 *** -0.62 ** 0.57 0.51 0.54 
Female -0.36 *** -0.33 *** -0.51 *** 0.70 0.72 0.60 
Black, NH -0.26 ** -0.25  -0.17  0.77   
Asian, NH 0.49 *** 0.65 *** 0.48 *** 1.63 1.91 1.61 
Other race, NH -0.29 * -0.33  -0.47  0.75   
Hispanic -0.21 * -0.20  -0.55 ** 0.81  0.58 
Foreign 0.39 *** 0.21  0.30 ** 1.48  1.35 
Veteran -0.04  0.04  0.28 *   1.32 
Constant -3.10 *** -2.46 *** -2.29 ***    
*p-value<0.10, ** p-value<0.05, *** p-value<0.01 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
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Table 16: Factors influencing employment in other high tech industries versus the rest of 
the private sector (2000, 2005 and 2010) 
Variables 
Coefficients RRR 
2000 2005 2010 2000 2005 2010 
Low skill -2.27 *** -2.31 *** -2.32 *** 0.10 0.10 0.10 
HS diploma -1.29 *** -1.61 *** -1.68 *** 0.27 0.20 0.19 
Mid skill -0.46 *** -0.91 *** -0.96 *** 0.63 0.40 0.38 
Bachelor 0.19 *** -0.07  0.03  1.21   
Suburbs 128 0.27 *** 0.63 *** 0.58 *** 1.31 1.87 1.78 
Northeast 0.40 *** 1.49 *** 1.03 *** 1.49 4.42 2.80 
South coast -0.70 *** 0.07  0.09  0.50   
Worcester 495 0.47 *** 1.12 *** 1.09 *** 1.60 3.07 2.96 
The West -0.91 *** -0.38 ** -0.14  0.40 0.69  
Age 16 to 17 -0.51  -0.73  -1.45     
Age 18 to 24 -0.11 ** -0.71 *** -0.96 *** 0.89 0.49 0.38 
Age 25 to 34 0.16 *** -0.05  -0.18 ** 1.18  0.83 
Age 55 to 64 -0.38 *** -0.21 ** -0.24 *** 0.69 0.81 0.79 
Age 65 plus -0.56 *** -0.89 *** -0.56 *** 0.57 0.41 0.57 
Female -0.79 *** -0.84 *** -1.05 *** 0.45 0.43 0.35 
Black, NH -0.55 *** -0.59 ** -0.63 ** 0.58 0.56 0.53 
Asian, NH 0.53 *** 0.62 *** 0.85 *** 1.70 1.87 2.35 
Other race, NH -0.16  -0.36  0.14     
Hispanic -0.54 *** -0.35  -0.35 * 0.58  0.71 
Foreign 0.22 *** 0.43 *** 0.24 ** 1.24 1.54 1.27 
Veteran -0.10 ** 0.21 * 0.24 * 0.90 1.23 1.27 
Constant -2.35 *** -2.26 *** -2.17 ***    
*p-value<0.10, ** p-value<0.05, *** p-value<0.01 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
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Table 17: Factors influencing employment in the core life sciences versus other high tech 
industries (2000, 2005 and 2010) 
Variables 
Coefficients RRR 
2000 2005 2010 2000 2005 2010 
Low skill 1.01 *** -0.04  0.53  2.75   
HS diploma 0.23 *** 0.31  0.08  1.26   
Mid skill -0.29 *** -0.35 ** -0.52 *** 0.75 0.70 0.59 
Bachelor -0.53 *** -0.43 *** -0.77 *** 0.59 0.65 0.46 
Suburbs 128 0.17 ** -0.39 ** -0.21  1.18 0.67  
Northeast 0.10  -0.66 *** -0.46 ***  0.52 0.63 
South coast 0.52 *** -0.24  0.15  1.69   
Worcester 495 0.18 *** -0.55 *** -0.27 * 1.20 0.58 0.76 
The West -0.07  -1.24 *** -0.88 ***  0.29 0.42 
Age 16 to 17 -1.62 *** -0.41  -0.23  0.20   
Age 18 to 24 -0.17 * -0.26  0.50 ** 0.84  1.64 
Age 25 to 34 -0.23 *** -0.20  0.15  0.79   
Age 55 to 64 0.31 *** 0.18  0.03  1.37   
Age 65 plus 0.01  0.21  -0.07     
Female 0.43 *** 0.51 *** 0.54 *** 1.53 1.67 1.71 
Black, NH 0.29 * 0.34  0.46  1.33   
Asian, NH -0.04  0.02  -0.38 **   0.69 
Other race, NH -0.13  0.03  -0.61     
Hispanic 0.33 ** 0.15  -0.20  1.39   
Foreign 0.17 ** -0.22  0.06  1.19   
Veteran 0.07  -0.17  0.04     
Constant -0.74 *** -0.20  -0.12     
*p-value<0.10, ** p-value<0.05, *** p-value<0.01 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
The comparison between the innovation economy industries and the private sector 
yielded fairly predictable outcomes. The innovation economy has more demand for 
higher skilled workers, while minorities (especially Hispanic and African American or 
black) and women are less likely to be represented in the innovation economy than other 
private sector industries. There is also similarities overtime. The odds for mid-skilled 
workers to be employed in the innovation economy have declined between 2000 and 
2010. This is true for both the life sciences and other high tech industries. Also, the odds 
of being employed in other regions outside the Boston-Cambridge core (especially 
Worcester I-495) have increased for workers in the innovation economy. Therefore, of 
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particular interest to this case study are the odds for being employed in the core life 
sciences compared with other sectors in the innovation economy.  
The results of the multinomial logit (see Table 17) show that relative risk ratios 
for mid-skilled workers (as well as workers with a bachelor’s degree) are lower for core 
life sciences when compared to high tech industries. In 2010, the odds for mid-skilled 
workers to be employed in the life sciences cluster when compared to other high tech 
industries was only 0.59 times as high as the same odds for workers with graduate 
degrees. Again, the relative risk ratios have fallen since 2000. This outcome implies 
fewer and declining opportunities for mid-skilled workers in the innovation economy 
broadly and specifically in the core life sciences. It is also worth noting that workers with 
a bachelor degree have low odds of being employed in the life sciences compared to 
other high tech industries. This output implies that the life sciences have a much higher 
demand for workers with graduate degrees than other sectors in the innovation economy. 
With respect to diversity in worker characteristics, there are some interesting 
results, particularly for women and minority workers. In 2010, the odds for a woman to 
be employed in the life sciences cluster relative to men were 1.71 times as high when 
compared to high tech industries. In terms of the field of science, women are more likely 
to be represented in biology than in computer science and the output here supports that. 
In 2000, coefficients for black or African American and Hispanic relative to non-
Hispanic white workers and foreign born workers relative to native born were positive 
and significant. This resulted in higher relative risk ratios for these three groups when 
compared to high tech industries; however in the latter two years (2005 and 2010) these 
coefficients were not significant. 
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Predicted probabilities are another way to help interpret the results of the logit 
model. Predicted probabilities help illustrate different cases depending on the explanatory 
variables. For example, it is possible to calculate the predicted probability for mid-skilled 
workers while holding other variables at their means. The predicted probabilities for 
being employed in the two main industry clusters for the innovation economy for 2000, 
2005, and 2010 are below. Predicted probabilities were calculated for each explanatory 
variable while holding the remaining variables at their mean. 
Table 18: Predicted probabilities calculated for selected variables (2000, 2005 and 2010) 
Variable 2000 2005 2010 Variable 2000 2005 2010 
Any worker Women 
Core Life Sciences 0.023 0.034 0.039 Core Life Sciences 0.019 0.029 0.030 
Other High Tech 0.044 0.069 0.064 Other High Tech 0.029 0.039 0.034 
HS Diploma Men 
Core Life Sciences 0.015 0.020 0.020 Core Life Sciences 0.027 0.040 0.049 
Other High Tech 0.018 0.028 0.023 Other High Tech 0.058 0.099 0.094 
Mid-skilled Boston-Cambridge core 
Core Life Sciences 0.019 0.022 0.020 Core Life Sciences 0.022 0.038 0.042 
Other High Tech 0.039 0.051 0.040 Other High Tech 0.049 0.048 0.048 
Bachelor's degree Suburbs-128 
Core Life Sciences 0.030 0.045 0.047 Core Life Sciences 0.031 0.039 0.043 
Other High Tech 0.082 0.114 0.107 Other High Tech 0.057 0.076 0.076 
Graduate degree Northeast 
Core Life Sciences 0.044 0.074 0.089 Core Life Sciences 0.031 0.050 0.046 
Other High Tech 0.069 0.122 0.108 Other High Tech 0.060 0.130 0.099 
White, non-Hispanic South coast 
Core Life Sciences 0.023 0.034 0.038 Core Life Sciences 0.014 0.022 0.025 
Other High Tech 0.045 0.068 0.063 Other High Tech 0.018 0.030 0.031 
Black, non-Hispanic Worcester-I495 
Core Life Sciences 0.017 0.020 0.024 Core Life Sciences 0.034 0.046 0.058 
Other High Tech 0.022 0.028 0.023 Other High Tech 0.062 0.108 0.099 
Asian The West 
Core Life Sciences 0.053 0.076 0.091 Core Life Sciences 0.007 0.004 0.010 
Other High Tech 0.099 0.170 0.149 Other High Tech 0.015 0.022 0.027 
Hispanic     
Core Life Sciences 0.017 0.021 0.020     
Other High Tech 0.020 0.039 0.033     
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
Overall, the probability of any worker being employed in the core life sciences 
grew from 2.3 percent to 3.9 percent between 2000 and 2010. The probability of any 
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worker being employed in the high tech industries increased between 2000 and 2005 (4.4 
percent and 6.9 percent) and then dropped a little to 6.4 percent in 2010. For the high tech 
industries, declining probabilities are observed across the board by worker characteristic 
and most regions; whereas, the core life sciences had increasing probabilities for most 
worker characteristics and most of the regions measured by the model. However, for the 
life sciences cluster the increased probability of being employed in the life sciences did 
not benefit all groups measured in the model; namely, mid-skilled workers and Hispanic 
workers. Mid-skilled workers and Hispanic workers saw declining probabilities in the 
core life sciences between 2005 and 2010. 
With respect to sub-state regions, there are some variations in outcomes for The 
West and the South coast regions, but these are the regions with the smaller number of 
observations as well as the least amount of activity and therefore require more caution in 
drawing conclusions from. The Northeast region, however, has absorbed more volatility 
than any other region, particularly with respect to high tech industries. By 2010, the 
Worcester I-495 region showed the greatest concentration of predicted employment in the 
state – almost 6 percent in core life science industries and 10 percent in high tech (Figure 
21). 
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Figure 21: Predicted probabilities of being employed in the life sciences and high tech 
industries by sub-state region (2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
Lastly, the multinomial logit results suggest that although women and minority 
workers are underrepresented in both the life sciences and high tech industries, they have 
fared better in the life sciences – with respect to accessing employment opportunities. 
There could be a number of reasons why this is. Perhaps women and minorities are more 
attracted to fields related biology rather than computer science or the manner in which the 
industries are organized or the types of occupations available. For 2010, Figure 22 and 
Figure 23 provide the predicted probabilities for being employed by industry cluster for 
women and minorities. In particular for women and black or African American workers, 
the predicted probabilities for being employed in either life sciences or high tech are 
equal despite the fact that high tech employment is two-thirds larger than that of the core 
life sciences (3 percent for women, 2 percent for black or African American). 
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Figure 22: Predicted probabilities of being employed in the life sciences and high tech 
industries by gender (2010) 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
 
Figure 23: Predicted probabilities of being employed in the life sciences and high tech 
industries by race/ethnicity 
 
Source: American Community Survey, 2005 and 2010, and Census 2000, author’s calculations 
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Stakeholder Perspectives on regional competitiveness, the distribution of economic gains 
and the trajectory of economic development 
In summary, the evaluation of economic and labor market outcomes shows that 
Massachusetts has sustained its competitive advantage in the core life sciences industries. 
This competitive advantage is driven by research and development services and a highly 
skilled workforce. By 2010, efforts to expand the state’s competitive advantage to 
downstream activities has had mixed results. The state has seen some increase in 
manufacturing activities (e.g., as measured by shipments). There are regions outside of 
the Boston-Cambridge core that have benefited from this, namely the Worcester I-495 
area. There is, however, little evidence that industry growth coupled with increased 
efforts on the part of development intermediaries and community colleges have provided 
benefits to workers with less than a bachelor’s degree (at least so far). Indeed, the role of 
mid-skilled workers across the Massachusetts innovation economy has diminished during 
the decade. Lastly, women and particular minority groups (especially black or African 
American and Hispanic workers) are underrepresented in the innovation economy, but 
have had greater access to employment in the core life sciences when compared to other 
high tech industries. 
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Given this context, how do various stakeholders evaluate the economic 
development policies and initiatives in the life sciences? This section draws on qualitative 
data
9
 to answer the following questions: 
 What are stakeholder views on industry outlook and regional competitiveness – 
particularly with respect to downstream operations? 
 How do stakeholders view the objectives of economic development policies and 
initiatives with respect to both efficiency and equity? 
 How have employers engaged in regional economic development initiatives and 
what have they gained? 
 
Regional competitiveness, industry outlook and downstream operations 
Across the board stakeholders hold an optimistic outlook for the industry and 
convey a general sense of pride in what the industry has accomplished in the state and its 
position in the global economy. For example, one stakeholder described the 
Massachusetts life sciences this way: 
 
o Massachusetts is a global starting place…. We’ve cultivated expertise, not only 
do we have great scientists; we have great business managers…. [A company 
might grow up] in Massachusetts, but for the sake of business health needs to be 
closer to markets everywhere – this [global] expansion helps Massachusetts too. 
(Development Intermediary, 2011) 
 
The development intermediaries have continued to focus on issues related to 
increasing manufacturing activity and encouraging location and expansion in regions 
                                                 
9
 The qualitative data for this section includes: semi-structured interviews conducted in 2010 and 2011 with 
four employers and three development intermediaries; a summary report I authored for the Massachusetts 
Workforce Board Association based on interviews I conducted in 2009 with three additional employers and 
two educational providers; notes from attending a number of industry events between 2008-11; discussions 
with a few key informants; and organizational documents. 
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across the state with the view that more needs to be done. Massachusetts is well 
positioned to take a lead in early stage manufacturing and process innovation, but it is not 
clear to stakeholders that the region has achieved its goal.  
 
o The manufacturing base in Massachusetts is impressive. We’re at least in the top 
10. We have important assets and are a strong competitor on the biologics side. 
(Development Intermediary, 2011) 
 
o [There is a] growing interest in biologics manufacturing by traditional 
pharmaceutical companies…. These companies are viewing the development of 
biologics as part of their future…. [The industry has seen] lots of merger and 
acquisition activity to chase after that part of the market…. Massachusetts has 
benefited a great deal from this activity – in terms of jobs and investment in the 
state. (Development Intermediary, 2011) 
 
o [Central Massachusetts] has all the components…to be a top notch cluster - 
academia, industry, hospitals, and research. WPI and UMass play an important 
role. (Employer, 2009) 
 
Development intermediaries and educational providers are looking for ways to 
improve on what is being done to address access to jobs for a greater range of workers – 
particularly Massachusetts residents, women, minorities, and first generation college 
students. For example, the Massachusetts Life Sciences Center (MLSC) is focused on the 
community college system and internships, as well as building the manufacturing base 
across the state. 
 
o Massachusetts has a well-skilled workforce which is an important component in 
terms of driving success…but we’re not sitting on our laurels. Workforce 
development is one priority…not just science degrees or doctorates, “strong 
skills” are needed in every part of value chain. (Development Intermediary, 2010) 
 
o We want a well-distributed workforce and we want employers to know how to find 
them…make it easy to match-make. (Development Intermediary, 2010) 
 
o [We’re] looking across the state [in supporting industry], not just Boston or 
Cambridge…. Manufacturing can be done in other parts of the state…. We want 
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biomanufacturing jobs to stay in the state, but they’re not necessarily going to be 
done in Cambridge or Boston. (Development Intermediary, 2010) 
 
The views of development intermediaries regarding the future include expecting 
to see the industry mature and observing employers becoming more concerned with 
operational efficiencies (not just innovation) which will impact how firms organize their 
workforce and where they choose to locate within the state. Development intermediaries, 
educators and employers reason that the increased growth in recent years, despite the 
recession, will spur additional growth in the future. 
 
o East Cambridge and Boston space is at a premium. Companies take it if it makes 
strategic sense to be located in the hub…. As a company matures, maybe they go 
public, they have commercial ready products – then companies start making 
decisions about costs. They start looking to Route 128 and I-495 and the different 
places you can be for space at a lesser cost. (Development Intermediary, 2011) 
 
o We have the workforce in the short term, but if in fact we see an explosion in 
activity – in new technology and products, it will put strain on workforce needs 
again. [In the long term], you need the pool of people. (Development 
Intermediary, 2011) 
 
 
Perspectives on the mid-skilled workforce and leveraging efficiency for equity 
Interviews with development intermediaries conducted in 2010 and 2011 in part focused 
on a set of particular policy objectives addressing workforce development. This includes 
the Internship Challenge and the equipment and supplies grants offered through the 
Massachusetts Life Science Center and the Massachusetts Life Sciences Education 
Consortium facilitated by the Massachusetts Biotechnology Education Foundation. These 
policy objectives are included in an earlier description in CHAPTER 3 and are detailed in 
APPENDIX A. Development intermediaries have a firm grasp on the competitive 
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position of the life sciences industry, its economic importance, and its innovative capacity 
to improve quality of life – from both a health and wealth perspective. However, 
interviewees were simultaneously concerned about workforce diversity and the economic 
outlook for the state as a whole. There is recognition on the part of the interviewees that 
the culture of science and its translation to industry, while receiving public support and 
generating new wealth, can be perceived as exclusionary. Stakeholders address equity 
issues in the implementation of policy and initiatives, most often this comes in the form 
of improving access to the industry (e.g., increasing equality of opportunity). For 
example, connecting industry to the community college system was a priority for the 
MLSC’s Internship Challenge and the Massachusetts Life Science Education Consortium 
(MLSEC). 
The Internship Challenge facilitates access to jobs for students and new entrants. 
Internships build industry experience for new entrants, interns learn their way around a 
company, get hands-on experience with equipment, learn about both the business and 
science sides of an operation, and move up on the learning curve. In addition to concrete 
skill development, the Internship Challenge provides a paid work experience, encourages 
peer networking among interns, and mentoring relationships with industry professionals. 
The MLSC can shape the Internship Challenge to help ensure an equitable distribution of 
opportunities across the state. For example, the Internship Challenge has targeted 
stipends to community college and vocational schools with the hope of improving 
diversity. In fact, the Internship Challenge increased the representation of Latino and 
African Americans among interns from 2009 to 2010. Also, the Center is interested in 
looking at ways to train non-traditional workers and to re-skill displaced workers 
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(Massachusetts Biotechnology Education Foundation, 2008b; Massachusetts Life 
Sciences Center, 2009, 2010; Windham-Bannister & Mudawar, 2010). 
 
o [We’re] targeting stipends to community college and vocational schools. These 
education programs include students who can’t afford to go to 4-year programs; 
these [internship] programs also hold a disproportionately higher share of 
diverse students…. What can we do to get a diverse pool of workers training for 
life science jobs and how do we help employers find these workers? (Development 
Intermediary, 2010) 
 
Overall, the participation of community college students has been low with 
respect to the Internship Challenge. The demand for mid-skilled workers through the 
Internship Challenge may be limited because only small and medium sized firms are 
eligible for the wage subsidy through the program. Small and medium sized firms (at 
least the ones focused on research and development) have less demand for community 
college students as compared to larger firms with manufacturing operations. The 
equipment and supplies grant program was implemented with the express interest of 
building educational capacity for the mid-skilled workforce in the life sciences industries 
and address the drawback in the Internship Challenge.  It is intended to benefit students 
who are training (or being retrained) to work as laboratory and biomanufacturing 
technicians through community college and vocational programs. The launch of this new 
program is expected to be in alignment with increased commercial activity in the state 
(which increases the demand for technicians) and a possible shift in hiring strategies 
among some employers which would increase the demand for mid-skilled workers. The 
program is also a response to the concerns of workforce development stakeholders that 
the life sciences industry needs to create more pathways to jobs for mid-skilled workers. 
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As a third-party, MBEF is well positioned to facilitate links between industry and 
education. Part of MBEF’s mission is to use collective resources to encourage 
collaboration across industry stakeholders and contributing to the sum of its parts. The 
MLSEC is intended to improve information with respect to employer hiring and training 
needs. Prior to the formation of the consortium, community college biotechnology 
programs had engaged industry employers, but engagement was limited to one-off 
relationships. Participation in the MLSEC has increased industry contact with community 
colleges and commitments to on-going efforts to build industry support (Hartford, 2010).  
 
o Employers do not really understand what the institutions [of higher education] 
are turning out. [Employers reported] low confidence in the system…  
(Development Intermediary, 2010) 
 
o We’re in a time now when industry is looking how to be more efficient and more 
conscious of expenses related to drug development…. The community college 
programs are providing more training on the machines… [and community college 
graduates are important] when concerned about the longevity of the employee. 
(Development Intermediary, 2010) 
 
o When companies work with community college graduates, we know [those 
workers] stay in Massachusetts. (Development Intermediary, 2010) 
 
Additionally, the consortium has created a venue for faculty to network across 
schools, augmenting professional development efforts and has become viewed by some 
stakeholders as taking on a role that a professional association might provide for the 
program graduates. In September 2011, MBEF announced that they had received a 
$150,000 grant from The Boston Foundation to support the consortium, develop 
connections to industry employers, and build on professional development activities for 
faculty at the community colleges (Hartford, 2010; Massachusetts Biotechnology 
Education Foundation, 2011). 
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Development intermediaries have leveraged policies and initiatives that support 
industry expansion to also position themselves to assist with labor market planning and 
coordination. Within the particular contexts of each of their organizations, they are 
learning how to provide planning and coordination services that firms value and 
simultaneously encourage workforce diversity and development in regions outside the 
metropolitan core. The internal evaluations on these efforts have shown positive results, 
but the interviews pointed to some concerns, namely: 
 
 Participation in the Internship Challenge by community college students is very 
low. This is a valued service with respect to placing bachelor and graduate degree 
students, but has been challenging to match mid-skilled students. This is likely 
related to limiting eligibility for wage subsidies to smaller companies who have 
less of a demand for technical workers. 
 The MLSEC has had some success with employer involvement, but would benefit 
from increased employer engagement related to training entry-level workers. 
 
 
Employers have choices in how they hire and develop their entry-level workforce 
There are a number of mid-skilled and entry-level job types in the life sciences, 
particularly related to downstream operations. These are in addition to business support 
positions in clerical or IT functions, which are less numerous and have been less of a 
focus in workforce and economic development initiatives. Targeted jobs are related to 
laboratory and manufacturing support at the technician level. In laboratory environments 
these include technicians, animal technicians, and data management. In manufacturing 
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environments, these jobs include production, facilities, and environmental technicians; 
some quality control, documentation, and quality assurance. 
The extent to which these jobs are represented in a company’s workforce mix 
depends on the type of company. They are most prominent in large employers, contract 
manufacturers and contract research organizations. For example, one employer – a large 
multinational – estimated that 25 percent of its Massachusetts workforce was employed 
in these positions. A medium sized contract manufacturer estimated that about 75 percent 
of its workforce had a bachelor’s degree or less whereas a small contract research 
organization had very few entry-level, mid-skilled jobs (Employer Interviews, 2011). 
In interviews with employers, there was very little concern expressed about a 
shortage of qualified candidates for these jobs. However, they know that they are not 
drawing from a large pool.  
 
o There are more candidates now than before…we are generally getting enough 
people, but could use better quality. (Employer, 2009) 
 
o The state is a leader in generating a qualified and educated workforce, we need to 
maintain it. (Employer, 2011) 
 
o The market has been pretty good for hiring at the technical level…people could 
always be better. We can often find people for the job, but we know we are not 
pulling from a large pool. (Employer, 2009) 
 
One employer who was in the process of opening a new facility has attracted and 
hired workers employed at other companies in the area. This type of poaching created 
some strain on the pipeline in the immediate term (Holgate, 2009). It is also indicative of 
a very consistent requirement across employers that “entry-level” workers have some 
industry experience. 
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o People coming from different industries might come from work environments 
where corner cutting is easier, less costly, and more tolerable. We need industry 
experience – meaning at least pharmaceutical manufacturing if not biopharm…. 
Workers coming from industries with higher accidents are not sufficiently trained 
to work in this environment. (Employer, 2009) 
 
Beyond a technician position, there is little opportunity to advance in life sciences 
companies without a four-year degree. Manufacturing technicians are usually graded and 
interviewees report that someone will work and train for two or three years to learn all the 
processes and advance through those grades. For workers with a bachelor’s degree, there 
are opportunities in clinical research as well as regulatory affairs with respect to 
documentation and QA. Within manufacturing, there are process development and 
engineering positions that require a four-year degree and some years of industry 
experience. This has meant that for some entry-level workers with a bachelor’s degree, it 
is possible to take a technician position for two years, build industry experience and then 
advance, either within the company or elsewhere (Employer Interviews, 2009 and 2011). 
 
o After the 90 day period from first hired, people are active in the work 
environment, but it takes 2 or 3 years for technicians [entry-level/mid-skilled 
worker] to qualify for all the processes…. Two or three years is a long time to get 
someone trained across the different processes, it's expensive to lose people too 
early. (Employer, 2011) 
 
o [I]t is a stretch for operators to move into supervisory positions because of the 
degree requirements. And the work requirements don’t match with the skill set 
held by an operator. (Employer, 2009) 
 
o Operators do move up through four grades that are non-supervisory… [but] there 
are not opportunities for operators to move into supervisory positions. Operators 
perceive a lack of opportunity. (Employer, 2009) 
 
o A bachelor's degree is more transferable…someone can move from a technician 
position to the microbiology department or to QA. (Employer, 2011) 
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Interviews with employers revealed a number of consistent standards in the 
structure of entry-level technical positions regardless of company type or management 
style and preferences. Most of these are described above and include requiring industry 
experience for technicians, estimates of 2 to 3 years of on the job training for technicians 
to be fully proficient in all processes of the operation, advancement beyond a technician 
or operator position required at least a 4-year degree, and all employers interviewed 
provided employees with educational benefits. There was far more variability across 
employers with respect to whom they hired and how they hired them. In part this 
variability is attributable to company type and size, but it is also a product of 
management preference. 
Some companies, especially small and medium sized firms, showed a preference 
for hiring entry-level workers with bachelor degrees. Because of this strategy, some 
companies experience high turnover in their technician positions. New entrants use the 
technician positions to get their foot in the door and then move to the research side of the 
operation. One example of a solution for this problem comes from a contract 
manufacturer. By instituting more formal HR systems
10
 and incorporating behavioral 
interviewing, the company was able to lower its turnover.  The company maintained a 
preference for hiring technicians with bachelor degrees, but improved its ability to screen 
for individuals who are a good match for the operations side. Thereby, a new entrant with 
a bachelor’s degree can work through the technician grades in two or three years and be 
                                                 
10
 See (Finegold & Frenkel, 2006) on biotechnology and HR systems 
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ready to transfer into QA, process development, or other positions within the company or 
with a new company (Employer, 2011).  
 
o For manufacturing technicians, we like to hire people with bachelor's degrees, 
but the flip side of doing that is they don't stay as long. People use that position as 
a stepping stone or to get a foot in the door. (Employer, 2011) 
 
o A typical manufacturing worker is blue collar – but we operate at a new level of 
importance [within the company] – we are currently filling our operating 
positions with individuals who are degreed –through WPI for example, or MWCC 
– individuals [who] are skilled and knowledgeable about the basics. (Employer, 
2009) 
 
o [From the operator’s position] the workforce is highly educated…a new facility 
requires new skills…requires problems solving skills. (Employer, 2009) 
 
     A larger employer may take exception to this strategy. For example, one employer 
suggested that there was a period of time when “everyone you touched had to have a 
bachelor’s degree” for entry-level positions. This resulted in poor job matches in that the 
aspirations of the individual did not match the nature of the job. Instead of “over hiring” 
or “staffing up,” this employer reported that mid-skilled workers or high school graduates 
stayed on longer with the company, were more prepared to work in the manufacturing 
environment, contributed to workforce diversity, and were still able to build a career 
(advance) through employer provided educational benefits if they desired (Employer, 
2011). 
 
o There was a period of time when everyone you touched had to have a bachelor’s 
degree…the aspirations of the individual didn't match the job. [It’s possible to 
align] the job requirements with the diversity of the workforce…. Good 
partnerships at various levels are important - we don't need to staff up - plus you 
have [mid-skilled workers] for longer. (Employer, 2011) 
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o The educational minimum for entry-level operators is a high school diploma or 
equal and no experience. However, we don’t usually hire someone at that level. 
Operators usually come in at the next level – high school diploma with one year 
of experience in biopharm production. (Employer, 2009) 
 
 
Employers use a variety of strategies for recruiting entry-level workers. These 
strategies depend on the type of company, the size of the company, the extent of their 
demand and management preferences. Employers attend job fairs; connect with schools 
in their area; and post on company websites and online job boards. All employers 
interviewed use staffing services to some extent (Employer Interviews, 2011; Holgate, 
2009). Smaller employers limit their use of staffing services to harder to fill positions 
(e.g. sales) and rely on Monster.com and Craig’s List to recruit entry-level candidates. 
Large employers use staffing services to build their entry-level workforce. Staffing 
services provide these employers with their main pipeline of new workers. Workers are 
usually hired on temporary status for six to eight months. This allows the employer to 
screen candidates before committing additional training dollars and provides flexibility in 
when and how many people they are able to convert to full time positions. There is a 
difference among large employers who have a national contract with a staffing service 
and large employers who use multiple staffing services. Namely, with national contracts, 
all new hires must go through the designated staffing company. Whereas, employers that 
use multiple services are also able to engage with educational programs to provide 
internships for students as part of their entry-level hiring strategy. Staffing services pose a 
challenge for educational programs. In those employers using national contracts it leaves 
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educators to figure out how to either circumvent or leverage those services which has 
proven difficult to do (Employer, 2011; Holgate, 2009). 
 
o Our recruitment strategies include working with colleges and attending career 
fairs…we recruit mostly locally for operators, [whereas] we recruit from all parts 
of the country for other positions. (Employer, 2009) 
 
o We only hire temporary workers for entry level…. People can transition at the 
end of that initial period of time. Hiring people is costly. Talent acquisition is 
centralized [at headquarters]; we don’t have people on site doing HR… [we use 
a] preferred [staffing] vendor. (Employer, 2009) 
 
o We do a lot of temp-to-perm…a lot. But I try to have diversity. For that I use 
Minuteman and Middlesex. (Employer, 2011) 
 
 
All the employers interviewed described the importance of being engaged in 
educational initiatives related to science and how this fit with the company’s perspective 
on corporate social responsibility. Many of these employers are engaged in educational 
initiatives that expand beyond the focus area of this case study – these initiatives extend 
beyond Massachusetts, include K-12, or focus on professional development for scientists. 
The MBEF Job Shadow Days for young students provides one relevant example. 
Employers are enthusiastic about the program and happy to support it. However, 
employers do not usually report direct benefits for participating in educational initiatives 
and they mostly focus on how the education system needs to be accountable to industry. 
 
o The purpose of collaborating [with a community college] is to have a college 
develop the expertise to provide us with the right kind of talent. (Employer, 2009) 
 
o Training needs to meet the needs of industry. These are tough economic times. 
We’ll see what happens in about 6 months, but the [community college] program 
is off to a good start. (Employer, 2009) 
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o The communication between industry and education is important - letting 
education know what industry needs. (Employer, 2011) 
 
o The business is contributing to [the community college program], but can't say 
we're getting anything out of it. (Employer, 2011) 
 
 
Employers who engage in initiatives for reciprocity and mutual benefit expect 
them to yield benefits in terms of meeting training needs and improving recruitment and 
hiring in the firm. These employers also engage at a planning and coordination level. 
Organizations and collaborations draw on employer expertise to design and improve 
programs and contribute to planning. Benefits for employers are often understood to be 
long term: better conditions for the industry and region as a whole. For organizations and 
collaborations, employer engagement is viewed as essential for program success and 
coordinating efforts across the region. 
 
o Community college programs for associate's and certificates are great. Having 
those programs cuts down on the learning curve for a technician. (Employer, 
2011) 
 
o [Industry] need[s] to be involved in science education and workforce training, 
and it's trickier than you think to align across different institutions. (Employer, 
2011) 
 
o Partnerships with the schools work by reaching out both ways…We provide 
internships…. We take on…roles in terms of advisory and curriculum. This way 
we know the program. It's nothing dramatic, they call when they need a spot and 
we try to fit it in. (Employer, 2011) 
 
 
In this case study, the Massachusetts Life Science Education Consortium 
(MLSEC) is the most prominent example of an effort to improve workforce coordination 
and labor market planning broadly across the state. Employer engagement is critical to 
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the success of such an effort. To date, several employers have consistently engaged in 
MLSEC; however efforts to increase employer engagement are underway (Hartford, 
2010). One employer representative viewed participation much in the same way as those 
describing their involvement in Job Shadow days; meaning the employer does not 
directly benefit from participation, but is fulfilling social responsibility objectives for the 
firm. Another employer argued that industry involvement is not just about social 
responsibility. Employers have a responsibility to participate in the educational system. 
In other words, employers and industry experts that hire and train workers should be an 
integral part of the education system; however, coordination efforts pose challenges with 
respect to aligning efforts across institutions (or silos) (Employer Interviews, 2011). 
 
Case summary 
The case study analysis finds that the core life sciences industries in 
Massachusetts have experienced consistent growth during the past decade and that this 
growth has been primarily driven by research and development services. In comparing 
industry performance for 2000-05 and 2005-10, the analysis also finds that employment 
growth and industry concentration intensified during the second half of the decade. 
Further, it finds that the core life sciences have outperformed the remainder of the 
innovation economy during the decade. 
Case study findings raise the concern that economic development efforts and the 
innovation economy are contributing to increased earnings inequality more broadly. 
Meaning that the innovation economy is providing benefits to the highest skilled and 
highest paid members of the workforce while leaving many others behind. In fact, 
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development in the innovation sectors has contributed to higher earnings at the top of the 
income ladder and has made no difference in earnings for those at the bottom. The case 
study also notes that the innovation sectors alone do not explain increasing earnings 
inequality in Massachusetts; there are many forces in the state’s economy contributing to 
this growing divide. 
Expanding downstream operations in the Massachusetts life sciences has been a 
desirable goal for the state. The opportunity to increase manufacturing activity in the state 
is attractive to most stakeholders, namely because it would help rebuild a job base 
accessible to many residents possessing blue collar or technical skills and to other regions 
outside the metro core with less costly real estate. Massachusetts has seen some 
commercial growth related to manufacturing in these sectors, but there is no evidence that 
growth is concentrating in the state (relative to other states). Industry growth outside of 
the metropolitan core has been relatively minimal with the exception of the Worcester I-
495 region. Although the Northeast region of Massachusetts has not expanded in terms of 
life sciences employment, that region of the state provides a substantial amount of life 
sciences employment opportunities. The case study analysis finds that mid-skilled or 
technical jobs in downstream operations have experienced limited growth, while 
management, business and professional STEM occupations have seen the greatest 
growth. Lastly, biotechnology and pharmaceutical firms are driving a large part of the 
growth in clinical trial activity and Massachusetts has been able to attract a portion of 
this. However, the proportion of clinical trial activity that the state is getting is declining 
relative to all clinical trial activity in the United States. 
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With respect to equitable outcomes, the case study finds that outside of the 
Boston-Cambridge core, the Worcester I-495 region has benefited from growth and 
concentration of life sciences industries. Other regions in the state have seen little or 
declining changes in employment. Growth for sub-state regions has been most prominent 
in the second half of the decade. The study also shows that mid-skilled workers and 
workers with a high school diploma have not benefited from industry growth. Further, 
both mid-skilled workers and workers with a bachelor’s degree have been at least twice 
as likely to be employed in other high tech industries as in the life sciences. Finally, 
although women and minorities (particularly black or African American and Hispanic) 
are underrepresented in the innovation economy, they appear to have greater access to 
employment in the life sciences when compared to high tech industries. 
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CHAPTER 6 
POLICY DISCUSSION AND CONCLUSION 
 
 
The goal of this research is to understand whether economic development 
planning can simultaneously ensure efficient outcomes for industry while encouraging 
more equitable outcomes for different communities or groups of workers within the state. 
It uses a case study methodology to examine growth and change in the Massachusetts life 
sciences sector between 2000 and 2010. In addition to showing that the life sciences 
cluster has sustained competitive advantage in Massachusetts, the research pays 
particular attention to equity outcomes. The research finds that in the context of sustained 
competitive advantage, the life sciences industry has expanded outside of the Boston-
Cambridge core to the Worcester I-495 region and has provided greater access to 
employment for women and minorities than other sectors in the innovation economy. At 
the same time, however, the benefits associated with growing the industry downstream 
have not been realized. Although manufacturing shipments have increased in the 
Massachusetts life sciences sector during the case study this has not coincided with an 
increase in production jobs for the sector. Further, there is a broader concern that 
increased growth in this industry has been accompanied by greater earnings inequality for 
the state. This case study is limited in that it is not possible to make a causal claim 
between the effects of economic development policies and industry performance and 
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labor market outcomes. The timeline for the case study is limiting as well since we would 
expect the effects of the policies to carry out beyond 2010.  
This case study defines efficiency as sustained competitive advantage achieved 
through continuous innovation and through the support of a number of public and private 
institutions resulting in job growth and the generation of new wealth. Ideally, state public 
policies should not interfere with innovative progress or job creation and should work to 
make the state attractive to new and expanding businesses. For the most part, this is what 
we have seen economic development policies and initiatives aim to do in the 
Massachusetts life sciences cluster. At the same time, at least between 2000 and 2010, 
income inequality in the state has grown at increasing rates. Despite industry growth and 
new wealth, shared economic prosperity has not been secured, inequality is not 
diminishing and economic conditions are not improving for everyone. Obviously the 
burden of inequality does not rest on the life sciences industries or the innovation 
economy alone. Yet, economic development and industry stakeholders could make 
greater contributions to equality of opportunity and equitable outcomes, including 
acknowledging equity goals in their agenda setting. These contributions need not 
sacrifice the state’s leading competitive assets; for example, the state’s academic anchors, 
its lead in venture capital funding, and its ability to capture strategic and productive 
activities within the global pharmaceutical and healthcare markets. 
Is sustaining the state’s competitive advantage in the life sciences really a tradeoff 
with equity? Or are there ways to strike a balance and encourage shared economic 
prosperity? Equity goals present in the current economic development agenda (e.g., 
advancing the role of community colleges and increasing manufacturing activity across 
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the state) have not posed a tradeoff with sustained competitive advantage; more often 
they have been viewed as complimentary. Therefore, the extent that these goals have 
become a reality is the product of a social bargain amongst stakeholders – it has not been 
about a tradeoff. The Massachusetts Life Sciences Education Consortium’s ability to 
advance the role of the community college system in the life sciences industries is an 
important example in the case study. The consistent, reputable leadership of a third party 
(MBEF) coupled with objectives that accommodated the needs of multiple stakeholders 
worked. Too often though, economic development agendas have relied on the actions and 
decisions of individual employers to lead efforts; therefore gains in equity have been ad 
hoc. Since no single firm determines whether the state sustains competitive advantage in 
the life sciences, broader industrial and economic outcomes should be used to guide 
decision makers. Voices from across institutions should be considered. Reframing the 
goal more broadly with respect to shared economic prosperity to include both the 
generation of new wealth and the decline of inequality encompasses a larger group of 
stakeholders; therefore requiring more sophisticated policy deliberation, not just the usual 
profit or cost motivated objections voiced by employers. 
Sustaining competitive advantage and increasing wealth alone is not sufficient for 
a region that also cares about social inclusion. Shared economic prosperity must include a 
reduction (or at least not a worsening) in inequality. In part, this can be accomplished by 
improving equality of opportunity. Our existing institutions set a framework for doing 
this, but we need stronger standards and more innovative practices. Recent program 
developments under the STEM initiative and through our educational system that 
explicitly address advancement for women, minorities, unemployed blue collar workers 
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and first-generation college students, are good examples. But these programs have not yet 
come to scale relative to the industry. Additionally, achieving equitable outcomes (e.g., a 
fair distribution of new jobs) requires non-market mechanisms. A region’s residents and 
planners must decide how and to what extent economic gains will be distributed. Overall, 
this calls for a more active and assertive role for government to lead equity objectives in 
the sphere of economic development and for a greater expectation on employers 
operating in the state’s economy to participate in planning. 
 
A more active role for government with respect to equity 
The government needs to be a leader with respect to setting and implementing 
equity goals within economic development policy. When making policy choices about 
economic development and the innovation economy, the discussion needs to include a 
broad group of stakeholders, not just industry and science. The region’s workforce 
contributes to the fiscal health of the state and these revenues can be used to support the 
local service sector and workforce diversity initiatives. 
 
Tax revenues 
Khatiwada et al., (2007) found that the life sciences workforce makes higher 
mean net fiscal contributions when compared to all other workers in the state. Authors 
calculated the mean contribution of a life sciences worker to Social Security, retirement, 
state and federal taxes to be $21,019 per year. This is $9,700 more per year than the 
average worker in all industries for the state. For state income taxes only, the average life 
sciences worker pays $3,334 per year compared to the average of $1,992. This is a 
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difference of $1,342. We can use this average to estimate the additional fiscal impact of 
the life sciences workforce for a year to the state. In 2010, the life sciences workforce 
was more than 90,000. This equals more than $125,000,000 in additional revenue per 
year for the state. This additional contribution made by the life sciences workforce is 
already more than enough to cover the 10-year, $1 billion Life Sciences Act and could be 
used specifically to fund programs and initiatives that address equity goals. Some ideas 
are addressed below. 
 
Local services sector 
Economic development in the innovation economy can include parallel initiatives 
so that investments in the life sciences and other high technology are accompanied by 
improved standards in the local services sector. Many scholars (e.g., Bartik, 2003) 
continue to advocate for federal intervention in the low-wage labor market. Stronger 
national policies that address poverty and work are viewed as essential in diminishing 
inequality in our economy. However, other authors (Clark & Christopherson, 2009; 
Donegan & Lowe, 2008; Osterman & Shulman, 2011) argue that more can be done at the 
state or local level. For example, Osterman and Shulman (2011) provide a recent review 
of local and state initiatives that are aimed at improving standards in the labor market – 
particularly the low-wage labor market that encompasses many local services. These 
authors argue that education and training initiatives are only part of the solution and 
employment standards must be addressed through formal policies and better practices to 
improve job quality. Job quality includes both wages and working conditions. Jobs in the 
local services sector support professionals in other sectors, including the life sciences. 
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Retail, food services, and accommodation industries (to name a few) provide needed 
services for other workers who need, for example, their clothes cleaned or to eat lunch 
during the workday. Political leadership can have sway over job conditions in the local 
services sector, but making real change takes time, especially meaningful changes that 
both support improving wages and working conditions and simultaneously providing 
needed services to working professionals. The local services sector needs to become a 
priority when thinking about shared prosperity. 
Recent federal increases in the minimum wage have been followed by state and 
city level increases above the mandated threshold. Washington State has the highest state 
minimum wage of $9.19. The City of San Francisco has a minimum wage of $10.74. 
Recently, the city of San Jose (the heart of Silicon Valley) voted by ballot referendum to 
raise the city’s minimum wage to $10 an hour and Seattle voted to raise their city’s 
minimum wage to $15 an hour. These are cities that have benefited greatly from the 
innovation economy as has Boston and Cambridge. Similar legislation has been proposed 
in Massachusetts although it has not been enacted.  
Economic development can also recognize and support union organizing in the 
local services sector. Massachusetts has a strong union base (compared to many other 
states) and a number of labor unions experienced in organizing and bargaining in the 
services sectors. For example, SEIU Local 615 has been raising awareness in the 
biotechnology industry about employment standards for building services workers, 
including rallying at the BIO International Convention in June 2012. Workers reason that 
biotechnology has received significant public investment and has thrived in 
Massachusetts. Therefore, the industry has a responsibility to help improve conditions 
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across the labor market, not just at the top (Service Employees International Union, 
2012). 
 
Workforce diversity 
Stakeholders are interested in workforce diversity issues and improving access to 
the industry for a wider (and deeper) pool of workers. Improving equality of opportunity 
will enhance the region’s competitive position, however it is not a costless endeavor and 
it is not clear that our existing institutions are structured well for doing this, at least not to 
the scale of the industry. In Massachusetts there are good program models and practices 
to build on. For example, in this past year Worcester Polytechnic University has 
developed a STEM engagement program for middle school girls. This has included 
hosting a Girl Scout event called “Geek is Glam” where girls learn about STEM 
innovations and talk with women who work in these fields. Advancing Women in the 
Business of Science and Technology (WEST) is a women’s forum launched in 2000. 
WEST is now a developed network for women with advanced degrees who are interested 
in working for industry. There are also a few examples of programs that have focused 
explicitly on minority students. Most recently, there are initiatives tied to the community 
college system and, although they are not exclusively minority, are believed to help 
advance minority students through the community college system to graduation or 
transfer to a 4 year institution.
11
 The Massachusetts Transformation Agenda, which 
                                                 
11
 For examples, see The Massachusetts Transformation Agenda at http://www.masscc.org/partnerships-
initiatives/redesigning-community-college-education-and-training and a report from Jobs For the Future 
(2013) “Advancing Underrepresented Minorities in STEM Education and Careers” at 
http://www.jff.org/sites/default/files/u3/JFF-ATD-NACME_101513.pdf. 
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envelopes these community college initiatives, is also expected to improve job market 
prospects for the unemployed and first-generation college students. 
In addition to women and minorities, we need better ways to measure the impact 
of hiring on local unemployment, first generation college graduates, the state’s veterans, 
and young adults. The Internship Challenge run through the MLSC could alter some of 
their criteria. Instead of having a primary focus on the type of firm (esp. small firms), 
criteria could be focused on types of workers. Not including large employers in the 
Internship Challenge has meant cutting out participants’ access to a large swath of jobs 
and career paths. Wage subsidies could be attached to STEM programs that address 
diversity issues, as well as the public education system which graduates mostly state 
residents. Further, infrastructure projects and tax credits funded through the MLSC could 
operate on a community benefit agreement model. This would mean setting hiring 
standards and diversity goals based on the immediate community and could include 
ongoing operations, not just the construction and expansion phases of a project. 
 
A more responsible role for employers 
Employers make choices. There is not just one way to do things and it is possible 
to develop new best practices and set better standards. Employers need to participate in 
economic development in general, not just when they have specific, immediate unmet 
needs. Economic development agendas should put more responsibility on employers to 
participate in initiatives that engage the education and training system, improve standards 
in the hiring process and contribute to occupational development. 
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Engaging with public education 
Workforce training poses a conundrum in this sector. Despite the fact that life 
sciences employers need a well trained workforce; employers can be reluctant investors 
in the training and education system. Ultimately those training investments will be held 
by the worker and are portable. Well-trained workers from one firm can move on to 
another. However, training and education programs know that to deliver a quality 
program they must engage employers in the process. These efforts usually result in 
engaging a few firms with medium term skill needs that match the program. It may not be 
practical to require education and training programs to be highly flexible and adaptable to 
the immediate needs of employers. These programs often have longer time horizons 
when compared to the immediate hiring needs of employers. Traditionally training and 
education programs are not that fungible, nor should they be because of the long time 
horizon needed to develop human capital for future economic development. To address 
the immediate needs of employers there need to be special types of training and education 
programs for specific employers (e.g. corporate education and extension programs). 
These are good, but these programs benefit incumbent workers and individual firms, they 
are not producing broad benefits for the regional economy. 
Alternatively, what would happen if all firms were required to be at the training 
table – or at least all firms that benefit from the public economic development incentives 
to have to be at the training table? Can the industry find a way to collectively invest in the 
public university and college system or collectively utilize public training subsidies with 
the goal of benefiting the competitive regional environment? Designing career pathways 
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for the state’s residents, developing thoughtful diversity initiatives, and identifying best 
practices related to job structures could go a long way if accomplished collaboratively. 
Economic development agendas should require life sciences employers to invest 
resources and be accountable to the system and participate in labor market planning. 
Employers are but one stakeholder in the system of education and training and they have 
a responsibility to invest in and support the system. Particularly in a field like the life 
sciences where entry-level workers need general skills training, those skills are 
transferable across firms and all employers are relying on the educational system to 
provide them. Asking employers to voluntarily engage in the education and training 
planning only when it meets a specific or immediate skill need is insufficient (and likely 
inefficient). 
For example, stakeholders can work together to advance the agenda for the 
Biomanufacturing Roundtable to address workforce and training issues. The 
Biomanufacturing Roundtable has been successful at pulling together business leaders in 
the sector from across the state to work on business environment issues, particularly state 
and national tax structures (Reynolds, 2009). It would be good to expand the agenda of 
this group to look at workforce issues and sub-state regional issues. The group is well 
situated to engage in labor market planning and address specific issues for different 
regions across the state. The Roundtable could work together with public higher 
education as well as the MassBio Education Foundation in a similar structure to what 
MBEF has already set up. Further, more consideration could be given to expansion across 
the state and the opportunities and challenges faced by different regions in the state. For 
example, the Roundtable could identify the impediments to attracting new and additional 
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manufacturing in parts of the state that have seen less growth or decline like Western 
Mass and the South Shore. 
Additionally, workforce development stakeholders have been skeptical about the 
claim that technical jobs have high demand for mid-skilled workers. Case study findings 
support this skepticism. There is no evidence presented here that suggests mid-level 
workers have been in high demand or growing demand in the innovation economy during 
the 2000 to 2010 period. However, the efforts of employers to work with community 
colleges and extension programs and the work of the MLSEC suggests differently. More 
realistic labor market planning and making employers accountable for their investments 
in the training and education system would provide a better understanding of what 
community colleges can do and ultimately can be conducted in conjunction with diversity 
efforts. 
 
 
Recruitment and hiring  
Becoming more transparent about hiring and recruitment strategies is a good 
thing. This does not cause good employers to lose their edge. Third party intermediation, 
for example, staffing services and Monster.com, does not ensure equality of opportunity 
by itself. These services may help make efficient hiring decisions, but need to be more 
closely examined in terms of who is being screened out and why (see Davidson, 2013 for 
example). Intermediaries must be part of any employer engagement strategy. Employers 
can require their staffing services to engage in economic and workforce development 
initiatives. Staffing services often have a wealth of information about what skills 
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employers are looking for. Large staffing companies will benefit from networking by 
being involved in economic development initiatives and workforce strategies like those at 
MBEF. This may mean encouraging a longer term view among staffing services or 
compelling them to participate as part of contract with their customer. 
Small employers who use Monster.com could give more thought to how they use 
these tools. Because they operate in smaller workplaces, they have more immediate 
information on job needs that allows them to plan ahead; in small workplaces this 
information is more apparent. A larger pool of small employers participating in labor 
market planning could be hugely beneficial to both them and the workforce. They would 
learn from each other on workforce strategies and as a group they have a significant 
number of jobs. 
 
Occupational development 
 Employers structure job opportunities, job access, and job outcomes (e.g. wages) 
based on operational and competitive concerns, while relying heavily on a region’s 
educational and training system. They are the ones primarily in charge of occupational 
development, especially in the absence of unions and professional associations. 
Therefore, they have a responsibility to create linkages across the training and education 
system and the industry. In order to deepen the impact of economic development 
strategies, other actors know that employer engagement is critical. In this context, other 
actors can learn about the kinds of work systems and skill requirements in place inside 
companies and help identify common needs across groups of firms. Only once employers 
are engaged in this manner, can economic and workforce development effectively devise 
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strategies and subsidize training. Through this type of collaboration, economic 
development actors can begin to offer insights that illustrate the value of equity goals and 
the manner in which equity goals align with efficiencies. 
For example, the MBEF has taken an important leadership position in this area 
with its new community college rating system, which has resulted from collaboration 
with numerous stakeholders both in the field of education and firms within the industry. 
In a manner of speaking, the Massachusetts Life Sciences Education Consortium with 
MBEF at the helm has taken on the role of a professional association for technicians 
trained in life sciences laboratory and manufacturing environments. In addition to helping 
set standards in curriculum and programs and engage industry in the educational process, 
this consortium benefits students and workers in the fields of biotechnology 
manufacturing and laboratory technicians. Students and workers benefit from increased 
transparency in the school to career trajectory. They also benefit when graduating from a 
program that has approved standards that industry agrees with. MBEF helps form a focus 
point for which students and graduates can be in the spotlight. The consortium also has 
the potential to improve labor market planning, which increases job security for program 
graduates. 
 
Conclusion 
The state of Massachusetts is a leader in the life sciences. This leadership position 
has been secure as the industry sector continues to grow and innovate. Given this, it is 
now time to focus more clearly on how growth in the life sciences can contribute to 
shared economic prosperity. Equity does not need to come at the price of efficiency. 
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Instead, the government can ensure a broader debate and enable stronger social bargains. 
Likewise, employers alone do not lead this effort, but have a responsibility to engage in 
development efforts and planning initiatives. 
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APPENDIX A 
 
DESCRIPTIONS OF SELECTED ECONOMIC DEVELOPMENT POLICIES AND 
INITIATIVES IN THE MASSACHUSETTS LIFE SCIENCES INDUSTRIES 
 
 
 
 
Exhibit 1 MLSC Infrastructure Investments 
The Massachusetts Life Sciences Act of 2008 designated a number of capital investments 
to be stewarded by the Massachusetts Life Sciences Center (MLSC). These capital 
investments were targeted at infrastructure projects believed to stimulate long term job 
growth and expand the number of areas in the state that were “life sciences ready”. These 
projects include: 
 
 Albert Sherman Center at UMass Medical School: The Sherman Center is a 
research and education facility, housing a number of research outfits (including 
bioinformatics) and provides space for 100 individual investigators. The 
completed project should generate 730 new life sciences jobs in central 
Massachusetts. 
 Worcester Polytechnic Institute/Gateway Park: The Gateway Park in Worcester 
expands Worcester Polytechnic Institute’s biomanufacturing facility for training. 
The park also includes an existing location for Massachusetts Biotechnology 
Initiative (business incubator space) which has graduated 30 companies since 
2000, and has about 40,000 sq. ft. in lab and office space. 
 Framingham Wastewater and Pumping Station: This is an infrastructure project at 
Framingham Technology Park to improve the waste water system and assist 
Genzyme in completing their expansion in this area. This project is expected to 
encourage other companies to locate in the area. 
 MBL in Woods Hole: Investment in Woods Hole leveraged private and public 
financing to renovate the Marine Biological Laboratory and build a training 
program on stem cell and regeneration for new scientists. 
 Tufts/Cummings School of Veterinary Medicine, NE Regional Biosafety Lab: 
Investment in Grafton helped complete the New England Regional Biosafety 
Laboratory for Tufts University. 
 UMass Boston/Dana Farber Center for Personalized Cancer Therapy: This 
infrastructure project supports joint research and training with the University of 
Massachusetts Boston and Dana Farber in building the Center for Personalized 
Cancer Therapy.  
 
These investments have totaled $131 million and are projected to create more than 1,000 
permanent jobs in the life sciences. Going forward, MLSC has instituted a competitive 
process for identifying new infrastructure projects for the state. 
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(Sources: Massachusetts Life Sciences Center, 2009, 2010, 2011) 
Exhibit 2 MLSC Tax Credits 
In 2008, the Massachusetts Life Sciences Center (MLSC) established a tax incentive 
program for life sciences companies who were committed to creating new jobs in 
Massachusetts. Eligible companies must be a registered life sciences firm with MLSC 
and demonstrate a viable expansion plan. There is a variety of tax credit options designed 
to support the higher cost processes associated with moving a product to market. 
Companies who receive the tax incentive commit to creating a specified number of jobs 
and consent to being audited on an annual basis to ensure that the new jobs created 
remain over a five year period. Tax incentives have been awarded for 2009 and 2010 and 
the companies who have received tax incentives for 2009 have submitted their first 
annual progress report. In 2009, the MLSC awarded $24.5 million in tax credits to 28 
companies which in total committed to creating 918 jobs during the year. The first round 
of annual progress reports resulted in some “claw backs” as a handful of companies failed 
to meet their commitments. In total for 2009, MLSC provided $17 million in tax credits 
in return for 607 new jobs. In 2010, a new round of tax incentives worth $23.9 million 
has been awarded to 30 companies for nearly 1,000 new jobs. By the end of fiscal year 
2011, $45 million had been committed in tax credits with life sciences companies 
committed to creating at least 1,600 new life sciences jobs. This translates into costing 
the state just under $27,000 per new life sciences job. 
 
(Sources: Massachusetts Life Sciences Center, 2008, 2009, 2010, 2011; State House 
News Service, 2010) 
Exhibit 3 MLSC Internship Challenge 
The Internship Challenge is funded through state appropriations each year and hosted by 
the Massachusetts Life Sciences Center (MLSC). This internship program has run each 
summer since 2009. In its first year, the Internship Challenge attracted over 500 
applicants, where 100 interns were placed in 59 companies. Students eligible to apply 
include those working towards master’s and undergraduate degrees (either 4-year or 2-
year), occupational certificates and vocational training. The MLSC conducts outreach to 
schools and employers, promotes the program, hosts the web interface where students 
upload resumes and employers search and review candidates, and provides assistance to 
users as needed. MLSC pays qualifying employers up to $15 an hour for a 12 week 
internship. The maximum cost per intern is $7,200.  
 
A major programmatic change to the Internship Challenge starting in 2010 was that it 
limited eligibility for wage subsidies to employers with 100 or fewer employees. MLSC 
reported that smaller employers gained greater value from the paid internship experience, 
whereas larger companies usually had an affordable internship program in place. 
Additionally, the Internship Challenge grew in its second year in respect to all aspects. In 
2010, there were 899 applicants, of which 170 interns were placed with 94 employers. 
The length of the internship was increased from 8 to 12 weeks and the investment from 
the Center increased from $500,000 to $1,160,000. Forty-seven educational institutions 
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were represented by student interns, six of which were community colleges. Students 
representing community colleges increased from 2 in 2009 to 13 in 2010.
12
 In 2010, the 
MLSC conducted a survey of its 2009 intern cohort. The Center found that one year later, 
21% of the interns had moved into graduate STEM programs, 19% were employed at the 
company where they interned and 29% were employed in the sector, but not with the 
interning company. 
 
(Sources: Massachusetts Life Sciences Center, 2008, 2009, 2010, 2011; Windham-
Bannister & Mudawar, 2010) 
Exhibit 4 MLSC Equipment and Supplies Grant Program 
Most recently, the Massachusetts Life Sciences Center (MLSC) launched an equipment 
and supplies matching grant program in October 2010. Eligible grant recipients are 
vocational schools, community colleges and other 2-year degree and certificate programs, 
workforce development and labor organizations. Maximum grant awards are $250,000 
per institution and grants greater than $100,000 must have an industry match. In its first 
year, the grant program awarded $3.4 million to 32 institutions in the state. Nine 
community colleges received awards, four of which included an industry match from 
biotechnology companies. Awards were also given to Boston University and Worcester 
Polytechnic Institute for non-degree certificate programs. The Massachusetts 
Biotechnology Education Foundation also received an award and a matching grant from 
the state’s trade association, MassBio. The majority of the remaining awards went to 
vocational/technical high schools. 
 
(Sources: Connolly, 2010; Massachusetts Life Sciences Center, 2011) 
Exhibit 5 MLSEC Community College Endorsements 
The Massachusetts Life Science Education Consortium (MLSEC) is an initiative led by 
the MBEF starting in 2009. Following the completion of the Life Sciences Talent 
Initiative in 2008, MassBio’s Education Foundation (MBEF) and other stakeholders 
strategized on ways to better connect industry with the state’s college and university 
biotechnology educational programs. The LSTI report had indicated that there was a 
disconnect between the higher education system and industry. Evidence collected from 
focus groups and surveys suggested that employers did not understand what the system of 
higher education was turning out. Further, a survey of education and training programs 
showed that biotechnology and other industry relevant programs were many and varied.  
 
The Massachusetts Life Science Education Consortium (MLSEC) was formed in 2009 
under MBEF’s leadership to help create linkages between the higher education system 
and industry employers. The consortium is composed of college and university presidents 
and some industry leaders. MBEF is responsible for facilitating the consortium and 
                                                 
12
 The MLSC annual report for 2011 shows that community college involvement did not grow in the third 
year, despite the overall program growing and having positive outcomes for more highly educated students. 
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providing administrative oversight, staff support and organizational resources. External 
funding for the consortium has been limited until recently.   
 
The first area of focus for the consortium has been to develop standards and core 
competencies for community college curriculums which are industry endorsed. In 
December 2010, eight community colleges received industry endorsements for their 
biotechnology related education and training programs. Silver endorsements were 
provided to programs that offered curriculums that addressed a set of required 
competencies. Gold endorsements were provided to programs that met the competencies 
but also provided an internship as part of the program. 
 
(Sources: Hartford, 2010; Massachusetts Biotechnology Education Foundation, 2009; 
Procknal, 2010) 
Exhibit 6 MassBio BioReadyTM Communities Campaign 
Since 2008, MassBio has assisted municipalities in assessing communities as location 
sites for biotechnology companies. To date, there are more than 60 communities in 
Massachusetts that have a BioReady
TM
 rating. MassBio provides informational seminars 
which describe the types of facilities that biotechnology companies need and the 
regulatory issues related to locating a biotechnology facility. MassBio works with city 
officials to develop a rating for the community. Biotechnology facilities are very similar 
to other industrial facilities, but do have distinct requirements with respect to exhaust 
systems and climate control. Progressive ratings provided through BioReady
TM
 are 
bronze, silver, gold and platinum. A platinum rated community meets several layers of 
requirements. These include having: 
 
 Water and sewer capacity for industrial areas 
 An official point of contact for the biotechnology business community 
 Mechanisms to help speed regulatory and development processes 
 Participates in state-wide economic development initiatives 
 Pre-permitted sites for biotech or existing biotech industry activity, including 
buildings or shovel ready land with at least 20,000 sq. ft. of capacity 
 Adopted NIH rDNA guidelines 
 
(Sources: Abair, 2011; Massachusetts Biotechnology Council, 2012) 
Exhibit 7 Biomanufactuing Roundtable 
Research by Reynolds (2009) found that for companies locating their first clinical 
manufacturing site, 60 percent located within 100 miles of their research and 
development facility. And about 40 percent of companies located their first commercial 
manufacturing facility within 100 miles of their research operations. Subsequently, these 
percentages decline as a company expands to additional facilities. Industry research 
developed by the Collaborative found that executives were resistant to locating 
downstream activities in Massachusetts, not because of labor costs, but because of 
permitting and regulatory issues. Although MassDevelopment and MassBio (among 
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others) have initiatives in place to help with locating and attracting business in the life 
sciences, there had been little economic development activity focused specifically on 
manufacturing.  
 
Massachusetts holds a competitive advantage in biomanufacturing because of its cluster 
assets, talent and innovation capacity, and strong research and development sector. 
However, impediments to industry growth have been federal tax policy, underdeveloped 
infrastructure, the cost of living, and a number of workforce issues. The ground work for 
the Roundtable has been set and additional outcomes from this work may become 
apparent in the future. Most recently, the Biomanufacturing Roundtable has been moved 
out of the Collaborative and now resides under the MLSC. 
 
(Sources: Massachusetts Life Sciences Center, 2011; Massachusetts Life Sciences 
Collaborative, 2012; Reynolds, 2009) 
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APPENDIX B 
LIST OF NAICS CODES 
 
 
 
Table 19: Core Life Sciences Industries 
NAICS 
Codes 
Industry Name 
3254 Pharmaceutical and medicine manufacturing 
334510 Electromedical apparatus manufacturing 
334517 Irradiation apparatus manufacturing 
3391 Medical equipment and supplies manufacturing 
5417 Scientific research and development services 
 
Table 20: Supporting Life Sciences Industries 
NAICS 
Codes 
Industry Name 
 Industry Name 
325188 All other basic inorganic chemical mfg. 
325199 All other basic organic chemical mfg. 
333314 Optical instrument and lens manufacturing 
423450 Medical equipment merchant wholesalers 
423460 Ophthalmic goods merchant wholesalers 
42421 Druggists' goods merchant wholesalers 
44611 Pharmacies and drug stores 
44613 Optical goods stores 
524114 Direct health and medical insurance carriers 
541380 Testing laboratories 
621 Ambulatory health care services 
622 Hospitals 
6231 Nursing care facilities, skilled nursing 
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Table 21: Other High Tech Industries 
NAICS 
Codes 
Industry Name 
3341 Computer and peripheral equipment mfg. 
3342 Communications equipment manufacturing 
3344 Semiconductor and electronic component mfg. 
3345 Electronic instrument manufacturing (w/o LSCore) 
3364 Aerospace product and parts manufacturing 
5112 Software publishers 
5161 Internet publishing and broadcasting 
5179 Other telecommunications 
5181 ISPs and web search portals 
5182 Data processing, hosting and related services 
5415 Computer systems design and related services 
5413 
Architectural and engineering services (w/o Testing 
Labs) 
 
Table 22: Census PUMA codes by sub-state region in Massachusetts 
Sub-state region Corresponding PUMA codes 
Boston-Cambridge Core 2900; 3000; 3100; 3200; 3300       
Suburbs/128 2600; 2700; 2800; 3400; 3500; 3700; 3800   
Northeast  500; 600; 700; 800; 900; 1000; 1100; 1200; 1300  
South Shore, Cape and 
Islands 
 3900; 4000; 4100; 4200; 4300; 4400; 4500; 4600; 4700; 
4800       
Worcester/I-495 
 300; 400; 1400; 1500; 2100; 2200; 2300; 2400; 2500; 
3600 
The West  100; 200; 1600; 1700; 1800; 1900; 2000 
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APPENDIX C 
INTERVIEW PROTOCOLS 
 
 
 
 
Topic areas for in-depth interviews with targeted stakeholders.  
 Recent economic development successes and current priorities supported by 
MassBio 
 Recent political/economic changes or industry trends (e.g. economic recession, 
policy initiatives, business strategies) which may impact job growth for 
Massachusetts or for the biotechnology sector in general 
 Perspective on the labor market needs of employers who are locating or expanding 
their operations in the state 
 With respect to the LSTI report, thoughts regarding the recommendation that the 
Commonwealth should strive to improve coordination and communication between 
industry and higher education 
 Descriptions of targeted programs designed to address labor market/workforce 
needs in the region. 
 Overview of other stakeholder initiatives 
 
Main protocol for focused interviews with HR/operations executives/CEOs  
 Approximately, what percentage of your workforce holds a bachelor’s degree or 
less? And what kinds of jobs do those employees fill? 
 What kinds of strategies does the company use to recruit and hire these workers? 
 What are the advancement prospects for this portion of your workforce? 
o Internally (e.g. promotion, skill upgrading, increased responsibilities) 
o Externally (e.g. when employees leave your company, what do you know 
about where they go?) 
 How have you benefited from engaging [particular policy initiatives]?  
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